TWI243853B - Glucuronofucan sulfate - Google Patents

Glucuronofucan sulfate Download PDF

Info

Publication number
TWI243853B
TWI243853B TW090115173A TW90115173A TWI243853B TW I243853 B TWI243853 B TW I243853B TW 090115173 A TW090115173 A TW 090115173A TW 90115173 A TW90115173 A TW 90115173A TW I243853 B TWI243853 B TW I243853B
Authority
TW
Taiwan
Prior art keywords
sulfated
fucoidan
glucuronidated
cns
present
Prior art date
Application number
TW090115173A
Other languages
Chinese (zh)
Inventor
Takeshi Sakai
Kumiko Ishizuka
Kaoru Kojima
Kazuo Shimanaka
Katsushige Ikai
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of TWI243853B publication Critical patent/TWI243853B/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Three enzymes degrading sulfated glucuronofucan; processes for producing these enzymes; activators for these enzymes; glucuronofucan sulfate and degradation products thereof; and a novel microorganism.

Description

1243853 A7 B7 五、發明説明(1 ) 技術範疇 本發明係關於一種可被用於生產能將褐藻類所含多種硫 酸化多糖分解之酵素之新穎微生物,於糖鏈工學範疇中可 被用於分解硫酸化葡糖醛酸化岩藻聚糖之酵素,該酵素之 製造方法,使該酵素活性化之各種因子,可做爲糖鏈工學 用試藥之脱乙醯化且脱葡糖醛酸化之硫酸化葡糖醛酸化岩 藻聚糖及硫酸化葡糖醛酸化岩藻寡聚糖,以及彼等之製造 方法。 背景技術 褐藻類中含有各種硫酸化多糖。舉例而言,已知有①只 由岩藻糖與硫酸基形成之硫酸化岩藻糖、②含有葡糖醛 酸、甘露糖、岩藻糖及硫酸基之硫酸化葡糖醛酸化岩藻甘 露聚糖,例如W097/26896公報中記載之含有岩藻糖硫酸之 多糖-U(構成糖及其莫耳比爲岩藻糖··甘露糖··半乳糖: 葡糖醛酸:硫酸基=約1 0 ·_ 7 : 4 : 5 ·· 2 0,以下稱爲U -岩 藻依聚糖(fucoidan))、③從岩藻糖及半乳糖形成之硫酸化 岩藻半乳聚糖,例如PCT/JP00/00965號説明書中記載之硫 酸化岩藻半乳聚糖(構成糖及其莫耳比爲岩藻糖··半乳糖 =1 : 1〜6,以下稱爲G-岩藻依聚糖)等之含有硫酸化岩藻 糖之多糖。 此等多糖總稱爲岩藻依聚糖或岩藻多糖,其構造多隨著 其來源之海藻而異。例如,已知從海芭麻塔藻、眞昆布、 沖繩海蘊藻、海蘊藻或裙帶菜雌株分別萃取之硫酸化多糖 具有不同之構造。更且,此等含有硫酸化岩藻糖之多糖, -4- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) A7 B7 1243853 五、發明説明(3 ) 因此,期望使用已鑑定出之單離菌生產硫酸化多糖分解 酵素,或從一種菌株生產若干種硫酸化多糖分解酵素。 再者,最近在關於沖繩海蘊藻之硫酸化多糖研究中,報 導該多糖會抑制引起胃潰瘍之微生物幽門螺旋桿菌在胃黏 膜之定著,該多糖與纖維芽細胞增殖因子之複合體可做爲 纖維芽細胞增殖促進劑,以及口服該多糖可預防細菌及病 毒等引起之感染症等。因此,關於沖繩海蘊藻之生理活性 及有關從沖繩海蘊藻而來硫酸化多糖之化學結構正在研究 中。例如,對於該多糖有2個報告,一個爲Glycoconjugate Journal,第16卷,19-26頁(1999)中記載之硫酸化葡糖趁 酸化岩藻聚糖,其中岩藻糖:葡糖趁酸:硫酸基:乙酿基 之莫耳比爲6.1 : 1.0 : 2.9 : 1,分子量爲約56,000 ;另一 個爲應用糖質科學第43卷,143 - 148頁(1996)中記载之硫 酸化葡糖醛酸化岩藻聚糖,其中岩藻糖··葡糖醛酸:木 糖:硫酸基:乙醯基之莫耳比爲3〜4 : 〇.8〜1.2 : 0·1〜0.3 : 0.8〜1.2 ·· 0.5〜1,分子量爲約50萬〜60萬。然 而,藉由當今之物理化學分析,只不過判定其之平均構 造〇 再者’爲了醫藥品之開發,必須得到能保持構造均一之 寡聚糖,但要從來自例如沖繩海蘊藻之硫酸化多糖獲得構 造保持均一之寡聚糖甚爲困難。 由於以上所述,所以亟求能分解來自多種褐藻類之硫酸 化多糖之微生物,特異性分解來自沖繩海蘊藻之硫酸化多 糖(亦即硫酸化葡糖醛酸化岩藻聚糖)之酵素,以及以酵素 -6- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明 化葡糖醛酸化岩藻聚糖及硫酸化葡糖醛酸化岩藻寡聚糖, 而將乙醯基加水分解,使醋酸游離,其之最佳p Η爲約 6〜9.1之範圍,最佳溫度在約2 3〜4 5 之範圍内。 本發明之第2發明,係關於一種“ _ d -葡糖嘗酸酶,其特 徵爲具有下列物理化學性質:該酵素作用於脱乙醯化硫酸 化葡糖酸化岩藻聚糖及脱乙醯化硫酸化葡糖醛酸化岩藻 暴聚糖’而將α-D -葡糖膝酸基鍵結加水分解,使d -葡糖 搭酸游離’其之最佳pH爲約5·8〜7 8之範圍,最佳溫度在 約1 4〜2 9 °C之範圍。 本發明之第3發明,係關於一種内_ q _ L _岩藻糖答酶,其 特徵爲具有下列物理化學性質。該酵素作用於脫乙醯化硫 酸化葡糖遂酸化岩藻聚糖及脱乙醯化硫酸化葡糖醛酸化岩 溧暴聚糖’而將α-L -岩藻糖基内向式加水分解,生成在 還原性末端具有L-岩藻糖之寡聚糖,其之最佳pH爲約 4.5〜7.5之範圍,最佳溫度在約23〜4 2 t之範圍内。 本發明之第1〜第3發明中,岩藻依聚糖脱乙醯酶、a-D-葡糖苷酸酶及内- α- L-岩藻糖甞酶,可藉由培養具有該酵 素生產能力之微生物,再從其培養物取得該酵素而製造。 本發明之第4發明,係關於脱乙醯化硫酸化葡糖醛酸化岩 藻聚糖之製造方法,其特徵爲使本發明第1發明之岩藻依 聚糖脱乙醯酶作用於硫酸化葡糖醛酸化岩藻聚糖,以取得 除去至少1分子以上乙醯基之脱乙醯化硫酸化葡糖醛酸化 岩藻聚糖。 在本發明之第4發明中,脱乙醯化可在氯化鈉、鈣鹽及/ -8 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐)1243853 A7 B7 V. Description of the invention (1) Technical scope The present invention relates to a novel microorganism that can be used to produce enzymes capable of decomposing various sulfated polysaccharides contained in brown algae, and can be used in the field of sugar chain engineering. An enzyme that decomposes sulfated glucuronidated fucoidan, and a method for manufacturing the enzyme, which activates various factors of the enzyme, can be used as a deacetylation and deglucosylation of sugar chain engineering reagents Sulfated glucuronidated fucoidan and sulfated glucuronidated fucoidan, and methods for their production. Background Art Brown algae contains various sulfated polysaccharides. For example, ① sulfated fucose formed only from fucose and sulfate groups, and ② sulfated glucuronide fucose containing glucuronic acid, mannose, fucose, and sulfate groups are known Glycans, for example, polysaccharide-U containing fucose sulfuric acid described in the W097 / 26896 gazette (the constituent sugars and their molar ratios are fucose, mannose, galactose: glucuronic acid: sulfate group = about 1 0 · _ 7: 4: 5 ·· 2 0, hereinafter referred to as U-fucoidan), ③ sulfated fucoidan formed from fucose and galactose, such as PCT / JP00 / 00965 The sulfated fucose galactan (the constituent sugar and its molar ratio is fucose · galactose = 1: 1 ~ 6, hereinafter referred to as G-fucoid Sugar) and other polysaccharides containing sulfated fucose. These polysaccharides are collectively referred to as fucoidan or fucoidan, and their structure varies depending on the seaweed from which they are derived. For example, it is known that sulfated polysaccharides extracted separately from females of Haiba Mata, Kumbu, Okinawa algae, algae or Wakame have different structures. Moreover, these polysaccharides containing sulfated fucose, -4- This paper size applies to the Chinese National Standard (CNS) A4 specifications (210X 297 mm) A7 B7 1243853 V. Description of the invention (3) The identified isolates produce sulfated polysaccharide-degrading enzymes, or produce several sulfated polysaccharide-degrading enzymes from one strain. Furthermore, in a recent study on the sulfated polysaccharide of Okinawa algae, it was reported that the polysaccharide can inhibit the fixation of the bacterium Helicobacter pylori causing gastric ulcer in the gastric mucosa. The complex of polysaccharide and fibroblast proliferation factor can be used as Fibroblast proliferation promoter and oral administration of the polysaccharide can prevent infections caused by bacteria and viruses. Therefore, the physiological activity of Okinawa algae and the chemical structure of sulfated polysaccharides derived from algae of Okinawa are under study. For example, there are two reports of this polysaccharide, one is the sulfated glucose while acidifying fucans described in Glycoconjugate Journal, Vol. 16, pages 19-26 (1999), where fucose: glucose is acidic: Molar ratio of sulfate group: ethyl group is 6.1: 1.0: 2.9: 1, molecular weight is about 56,000; the other is sulfated glucose described in Applied Glycan Science Vol. 43, 143-148 (1996) Alkylated fucose, in which the molar ratio of fucose: glucuronic acid: xylose: sulfate group: acetamyl group is 3 ~ 4: 0.8 ~ 1.2: 0 · 1 ~ 0.3: 0.8 ~ 1.2 ... 0.5 ~ 1, molecular weight is about 500,000 ~ 600,000. However, with today's physical and chemical analysis, the average structure is judged. Furthermore, for the development of pharmaceuticals, oligosaccharides that can maintain a uniform structure must be obtained. It is very difficult for polysaccharides to obtain oligosaccharides with uniform structure. Because of the above, there is an urgent need for microorganisms that can decompose sulfated polysaccharides from various brown algae, and specifically decompose enzymes of sulfated polysaccharides (that is, sulfated glucuronidated fucose) from marine algae in Okinawa, And Enzyme-6- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Explanation of the invention Glucuronidated Fucoidan and sulfated glucuronidated Fucoid The oligosaccharide is hydrolyzed to dissociate the acetamyl group to make the acetic acid free. The optimal p Η is in the range of about 6 to 9.1, and the optimal temperature is in the range of about 2 3 to 4 5. The second invention of the present invention relates to a "_d-glucose acidase", which is characterized by the following physical and chemical properties: the enzyme acts on deacetylated sulfated gluconofucoid and deacetylated Sulfated glucuronidation of fucoxanthin 'and the hydrolysis of α-D-glucosaccharic acid-based bond to dissociate d-glucoside acid', its optimal pH is about 5 · 8 ~ 7 The range of 8 and the optimal temperature is in the range of about 14 to 2 9 ° C. The third invention of the present invention relates to an endo_q_L_fucosylase, which is characterized by having the following physicochemical properties. The enzyme acts on deacetylated sulfated gluconate and then acidified fucoidan and deacetylated sulfated glucuronidated fucoidan to decompose α-L-fucosyl hydrolyzed inwardly. An oligosaccharide having L-fucose at the reducing end is produced, and the optimum pH is in the range of about 4.5 to 7.5, and the optimum temperature is in the range of about 23 to 4 2 t. In the invention, fucoidan deacetylase, aD-glucuronidase, and endo-α-L-fucosidase can be cultivated by culturing Then, the enzyme is obtained from the culture and produced. The fourth invention of the present invention relates to a method for producing deacetylated sulfated glucuronidated fucoidan, which is characterized by making the rock of the first invention of the present invention Fucoidan deacetylase acts on sulfated glucuronidated fucoidan to obtain a deacetylated sulfated glucuronidated fuctan that removes at least one molecule of ethyl amidinyl group. In the fourth invention, deacetylation can be performed on sodium chloride, calcium salts, and / -8-This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm)

裝 訂Binding

1243853 A7 B7 五、發明説明(6 ) 或蛋白質共存下進行。 本發明之第5發明,係關於一種脱乙醯化硫酸化葡糖醛酸 化岩藻聚糖或其鹽,其係藉由本發明第4發明之方法得 到0 本發明之第6發明,係關於一種脱乙醯化脱葡糖醛酸化硫 酸化葡糖醛酸化岩藻聚糖之製造方法,其特徵爲使本發明 第2發明之a - D -葡糖苷酸酶作用於脱乙醯化硫酸化葡糖醛 酸化岩、藻聚糖,以取得除去至少1分子以上葡糖酸酸殘基 之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻聚糖。 在本發明之第6發明中,脱葡糖醛酸化可在氯化鈉、鈣鹽 及/或蛋白質共存下進行。 本發明之第7發明,係關於一種脱乙醯化脱葡糖醛酸化硫 酸化葡糖醛酸化岩藻聚糖或其鹽,其係藉由本發明第6發 明之方法得到。 本發明之第8發明,係關於一種硫酸化葡糖醛酸化岩藻寡 聚糖之製造方法,其特徵爲使岩藻依聚糖脱乙醯酶、泛-D -葡糖甞酸酶、及内-a - L -岩藻糖茹酶作用於硫酸化葡糖 醛酸化岩藻聚糖而取得硫酸化葡糖醛酸化岩藻寡聚糖。在 此場合,可使岩藻依聚糖脱乙醯酶、π-D -葡糖甞酸酶及 内- 岩藻糖甞酶同時作用,亦可將岩藻依聚糖脱乙醯 酶、a - D -葡糖甞酸酶及内-a - L -岩藻糖茹酶依順序作 用。 本發明之第9發明,係關於一種硫酸化葡糖醛酸化岩藻寡 聚糖之製造方法,其特徵爲使π-D -葡糖甞酸酶及内- α- -9- 本紙張尺度適用中國國家標準(CNS) Α4規格(210X297公釐)1243853 A7 B7 5. Description of the invention (6) or coexistence of protein. The fifth invention of the present invention relates to a deacetylated sulfated glucuronidated fucoidan or a salt thereof, which is obtained by the method of the fourth invention of the present invention. The sixth invention of the present invention relates to a method of A method for producing deacetylated deglucouronated sulfated glucuronidated fucoidan is characterized in that a-D-glucuronidase of the second invention of the present invention acts on deacetylated sulfated glucose Uric acid and rock fucoidan are obtained to remove at least one molecule of glucuronic acid residues, and deacetylated and deglucourated sulfated glucuronidated fucose. In the sixth aspect of the present invention, the deglucuronidation can be performed in the coexistence of sodium chloride, calcium salt, and / or protein. The seventh invention of the present invention relates to a deacetylated deglucouronated sulfonated glucuronidated fucoidan or a salt thereof, which is obtained by the method of the sixth invention of the present invention. The eighth invention of the present invention relates to a method for producing a sulfated glucuronidated fucoidan oligosaccharide, which is characterized in that fucoidan deacetylase, pan-D-glucuronidase, and Endo-a-L-fucose enzyme acts on sulfated glucuronidated fucose to obtain sulfated glucuronidated fucoidan. In this case, fucoidan deacetylase, π-D-glucosaminidase and endo-fucosinase can act simultaneously, and fucoidan deacetylase, a -D-Glucosidase and endo-a-L-fucosylase act in sequence. The ninth invention of the present invention relates to a method for producing a sulfated glucuronidated fuco-oligosaccharide, which is characterized in that π-D-glucuronidase and endo-α--9- China National Standard (CNS) Α4 specification (210X297 mm)

裝 玎Pretend

1243853 A7 _____ B7_______ 五、發明説明(7 ) L -岩藻糖苷酶作用於經鹼處理之脱乙醯化硫酸化葡糖醛酸 化岩藻聚糖而取得硫酸化葡糖醛酸化岩藻寡聚糖。在該場 合’可使a _D -葡糖甞酸酶及内-a - L-岩藻糖甞酶同時作 用’再者,亦可使α-D -葡糖甞酸酶作用後,再使内-以-L -石藻糖菩酶作用。 在本發明之第8及第9發明中,可在氯化鈉、鈣鹽及/或蛋 白質共存下進行。 本發明之第1 〇發明,係關於一種硫酸化葡糖醛酸化岩藥 寡聚糖或其鹽,其係藉由本發明第8〜第9發明之方法得 到。 本發明之第1 1發明,係關於一種具有從下列通式(I)〜 (111)選出之化學結構之糖化合物··1243853 A7 _____ B7_______ 5. Description of the invention (7) L-fucosidase acts on alkali-treated deacetylated sulfated glucuronidated fucoidan to obtain sulfated glucuronidated fucoidan . In this case, 'a-D-glucuronidase and endo-a-L-fucosinase can be simultaneously acted on'. Alternatively, α-D-glucuronidase can be used, and then -Take -L-Fucose enzyme. The eighth and ninth inventions of the present invention can be carried out in the coexistence of sodium chloride, calcium salt and / or protein. The tenth invention of the present invention relates to a sulfated glucuronidated rock drug oligosaccharide or a salt thereof, which is obtained by the method of the eighth to ninth inventions of the present invention. The 11th invention of the present invention relates to a sugar compound having a chemical structure selected from the following general formulae (I) to (111) ...

裝 訂Binding

-10- 本紙張尺度適用中國國家標準(CNS)A4规格(210X297公f) 1243853 A7 B7 五、發明説明(8 )-10- This paper size applies to China National Standard (CNS) A4 specifications (210X297 male f) 1243853 A7 B7 V. Description of the invention (8)

本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 1243853 A7 B7 V. Description of the invention (

〔I 二〔I 2

XX

OH.HOH.H

〇° X 0H〇 ° X 0H

2 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 裝· •訂· 1243853 A7 B72 This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm).

本紙張尺度適用中國國家標準(CNS) A4規格(210x 297公釐) 1243853 A7 B7 五、發明説明(11 ) (式中,R爲Η,S03H或CH3CO ;以及η爲0以上之整數)。 本發明之第1 2發明,係關於一種硫酸化葡糖醛酸化岩藻 聚糖或其鹽,其特徵爲具有下列物理化學性質:該硫酸化 多糖含有作爲構成糖之岩藻糖及葡糖醛酸,其莫耳比爲 3 5〜44 : 1 0,例如以下列通式(VIII)表示之硫酸化糖做爲 構成糖之必需成分者: -14- 本紙張尺度適用中國國家標準(CNS) Α4規格(210X297公釐) 1243853 A7 B7 五、發明説明(12This paper size applies to China National Standard (CNS) A4 (210x 297 mm) 1243853 A7 B7 V. Description of the invention (11) (where R is Η, S03H or CH3CO; and η is an integer greater than 0). The twelfth invention of the present invention relates to a sulfated glucuronidated fucoidan or a salt thereof, which is characterized by the following physical and chemical properties: The sulfated polysaccharide contains fucose and glucoaldehyde as constituent sugars For acid, its molar ratio is 3 5 ~ 44: 10. For example, the sulfated sugar represented by the following general formula (VIII) is used as an essential component of sugar: -14- This paper size applies Chinese National Standard (CNS) Α4 specifications (210X297 mm) 1243853 A7 B7 V. Description of the invention (12

本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(14 ) 圖7表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖i _ (工)之1 H_NMR光譜圖。 圖8表示藉本發明得到之硫酸化葡糖路酸化岩藻寡聚糖i _ (1)之13C-NMR光譜圖。 圖9表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖i _ (1 )之質量分析光譜(質譜)圖。 圖1 0表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1 _(2)之質量分析光譜(質譜)圖。 圖1 1表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 iO)之1 H_NMR光譜圖。 圖1 2表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1-(3)之 I3c-NMR 光譜圖。 圖1 3表示藉本發明得到之硫酸化葡糖趁酸化岩藻寡聚糖 1 一(3)之質量分析光譜(質譜)圖。 圖1 4表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1-(4)之質量分析光譜(質譜)圖。 圖1 5表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1-(5)之1H-NMR光譜圖。 圖1 6表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1-(5)之13〇NMR光譜圖。 圖1 7表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 h(5)之質量分析光譜(質譜)圖。 圖1 8表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1_(6)之質量分析光譜(質譜)圖。 -17- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(15 ) 圖1 9表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1-(7)之1 H-NMR光譜圖。 圖2 0表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 1- (7)之 13C_NMR 光譜圖。 圖2 1表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 ^(7)之質量分析光譜(質譜)圖。 圖2 2表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 ^(8)之質量分析光譜(質譜)圖。 圖2 3表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 2- (3)之1H-NMR光譜圖。 圖2 4表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 2-(3)之 13C-NMR 光譜圖。 圖2 5表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 2-(3)之質量分析光譜(質譜)圖。 圖2 6表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 2-(5)之1H-NMR光譜圖。 圖2 7表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 2- (5)之 13C-NMR 光譜圖。 圖2 8表示藉本發明得到之硫酸化葡糖醛酸化岩藻聚糖低 分子化物,即寡聚糖2-(5),之質量分析光譜(質譜)圖。 圖2 9表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 3- (3)之1H-NMR光譜圖。 圖3 0表示藉本發明得到之硫酸化葡糖醛酸化岩藻寡聚糖 J - (J )之 C-NMR光譜圖。 -18- 本紙張尺度適財S國冢標準(CNS) A4規格(;297公爱)This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 B7 V. Description of the invention (14) Figure 7 shows the sulfated glucuronidated fucoidan i_ obtained by the present invention i _ ( 1) 1 H_NMR spectrum. FIG. 8 shows a 13C-NMR spectrum chart of the sulfated glucosyl acid-fucose oligosaccharide i_ (1) obtained by the present invention. FIG. 9 shows a mass analysis spectrum (mass spectrogram) of the sulfated glucuronidated fuctooligosaccharide i_ (1) obtained by the present invention. FIG. 10 shows a mass analysis spectrum (mass spectrum) chart of the sulfated glucuronidated fuctooligosaccharide _ (2) obtained by the present invention. FIG. 11 shows a 1 H-NMR spectrum chart of the sulfated glucuronidated fuco-oligosaccharide iO) obtained by the present invention. Fig. 12 shows an I3c-NMR spectrum chart of the sulfated glucuronidated fuco-oligosaccharide 1- (3) obtained by the present invention. Fig. 13 shows a mass spectrometry (mass spectrum) chart of the sulfated glucose obtained by the present invention while acidifying the fucoidan oligosaccharide 1-(3). Fig. 14 shows a mass spectrometry (mass spectrum) chart of the sulfated glucuronidated fuctooligosaccharide 1- (4) obtained by the present invention. Fig. 15 shows a 1H-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 1- (5) obtained by the present invention. FIG. 16 shows a 13 NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 1- (5) obtained by the present invention. FIG. 17 shows a mass analysis spectrum (mass spectrum) of the sulfated glucuronidated fuco-oligosaccharide h (5) obtained by the present invention. FIG. 18 shows a mass analysis spectrum (mass spectrum) of the sulfated glucuronidated fuco-oligosaccharide 1_ (6) obtained by the present invention. -17- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 B7 V. Description of the invention (15) Figure 19 shows the sulfated glucuronidated fucoid oligomer obtained by the present invention 1 H-NMR spectrum of sugar 1- (7). Fig. 20 shows a 13C_NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 1- (7) obtained by the present invention. FIG. 21 shows a mass analysis spectrum (mass spectrum) of the sulfated glucuronidated fuco-oligosaccharide ^ (7) obtained by the present invention. Fig. 22 shows a mass analysis spectrum (mass spectrum) of the sulfated glucuronidated fuco-oligosaccharide ^ (8) obtained by the present invention. Fig. 23 shows the 1H-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 2- (3) obtained by the present invention. Fig. 24 shows a 13C-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 2- (3) obtained by the present invention. Fig. 25 shows a mass analysis spectrum (mass spectrum) of the sulfated glucuronidated fuctooligosaccharide 2- (3) obtained by the present invention. Fig. 26 shows a 1H-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 2- (5) obtained by the present invention. Fig. 27 shows a 13C-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 2- (5) obtained by the present invention. Fig. 28 shows a mass analysis spectrum (mass spectrogram) of the sulfated glucuronidated fucoidan low molecular compound obtained by the present invention, namely, oligosaccharide 2- (5). Fig. 29 shows the 1H-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide 3- (3) obtained by the present invention. FIG. 30 shows a C-NMR spectrum chart of the sulfated glucuronidated fuctooligosaccharide J-(J) obtained by the present invention. -18- The paper size is suitable for the National Suzuka Standard (CNS) A4 specification (; 297 public love)

裝 訂Binding

12438531243853

ATAT

之細菌 以下所列 其細菌學上之性質如 a .形態上之性質 本菌爲直徑1.2〜1.6 # m之球菌 孢子之有無··無 革蘭氏染色性:陰性 b ·生理上之性質 (1)繁殖溫度··在25°C繁殖 (2 )對氧氣之喜好度:好氣性 (3 )觸酶:陽性 (4 )氧化酶:陰性 (5 )鹽類需要性: 於〇%食鹽培養基之繁殖:陰性 於1%食鹽培養基之繁殖:陰性 於海水培養基之繁殖:陽性 (6 ) g昆系:甲基莕g晃7 (7)菌體内DNA之GC含量·· 52% (8 ) 〇 F測試··不生成酸 (9) 群落之色調:不生成具特徵之群落色素 (10) 運動性:陰性 ' (1 1 )滑走性:陰性 (12)鞭毛:無 本菌株若根據伯捷氏鑑定細菌學手册(Bergey,s Manuai 〇fThe bacteria listed below have the bacteriological properties such as a. Morphological properties The bacteria are the presence or absence of cocci spores with a diameter of 1.2 ~ 1.6 # m. · No Gram staining: negative b · Physical properties (1 ) Reproduction temperature ·· Reproduction at 25 ° C (2) Preference for oxygen: aerobic (3) catalase: positive (4) oxidase: negative (5) salt requirement: reproduction in 0% salt medium : Reproduction negative in 1% salt medium: Reproduction negative in seawater medium: positive (6) g Kun line: methyl hydrazine 7 (7) GC content of DNA in the bacteria 52% (8) 〇F Test ·· No acid generation (9) Tone of the community: Does not produce characteristic community pigments (10) Mobility: Negative '(1 1) Slip-out: Negative (12) Flagella: None Handbook of Bacteriology (Bergey, Manuai 〇f

Determinatlve Bacteri。丨〇gy)第9卷Π"4)記載之基本分類 法’可被歸類爲第4類(格蘭氏陰性好氣性捍菌及菌)。然而 -21 - 本纸張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 B7Determinatlve Bacteri.丨 〇gy) The basic taxonomy described in Volume 9 Π " 4) can be classified as Category 4 (Grann-negative aerobic bacteria and bacteria). However -21-This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 1243853 A7 B7

本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853 A7 B7 五、發明説明(22 ) (式中,R爲 Η,S03H 或 CH3CO)。 再者,上述硫酸化葡糖醛酸化岩藻聚糖之分子量、糖組 成及硫酸基含量,隨者該硫酸化葡糖醛酸化岩藻聚糖原料 之收穫期、該原料之乾燥方法、該原料之保存方法、硫酸 化葡糖醛酸化岩藻聚糖萃取時之加熱條件、或p Η條件等而 不同。例如有硫酸化葡糖醛酸化岩藻聚糖被酸加水分解之 情況。因此,本説明書中記載之硫酸化葡糖醛酸化岩藻聚 糖之分子量、分子量分布、糖組成或硫酸基含量,不過爲 其之一例,依據該硫酸化葡糖醛酸化岩藻聚糖之萃取處理 條件,可輕易地使其分子量、分子量分布、糖組成或硫酸 基含量改變。舉例而言,若藉由pH6.0、95°C、2小時之萃 取方法從沖繩海蘊藻萃取,可得到顯示上述分子量與糖組 成之硫酸化葡糖醛酸化岩藻聚糖。亦即,藉由調節調製時 之諸條件,可調製出任意分子量、分子量分布、糖組成或 硫酸基含量之硫酸化葡糖醛酸化岩藻聚糖。例如,上述硫 酸化葡糖醛酸化岩藻聚糖之主要構成糖,雖平均每4個岩 藻糖大約含有2個硫酸基之殘基,但一般而言於糖上進行 酯結合之硫酸基化學性不安定,容易因酸、鹼或熱而被切 斷。舉例而言,若在酸性或鹼性條件下進行加熱處理,其 硫酸含量或乙醯基含量將減少。亦即,意圖對硫酸化葡糖 醛酸化岩藻聚糖進行脱硫酸或脱乙醯處理係可能的。再 者,脱硫酸或脱乙醯時,若調整酸與鹼之種類與濃度、加 熱處理時之溫度與時間,亦可調整切斷硫酸基及乙醯基之 量。雖無特別限定,但舉例而言,藉由約0.5〜1 N氫氧化鈉 -25- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(23 ) 溶液於2 5 °C處理2 4小時得到之脱乙醯化硫酸化葡糖醛酸化 岩藻聚糖適合做爲本發明之α-D -葡糖甞酸酶或内- a- L-岩藻糖答酶之基質。 因此,本説明書中之硫酸化葡糖醛酸化岩藻聚糖,包含 具備前述特徵之硫酸化葡糖醛酸化岩藻聚糖,或者藉由本 發明之硫酸化葡糖醛酸化岩藻聚糖分解酵素而被低分子化 之硫酸化葡糖醛酸化岩藻聚糖等全部由褐藻類而來者。其 來源雖無特別限定,但例如沖繩海蘊藻、石海蘊藻、似粗 海蘊藻、粗海蘊藻等長松藻科之褐藻類,因硫酸化葡糖醛 酸化岩藻聚糖含量多,所以特別適合作爲原料。 例如來自沖繩海蘊藻之硫酸化多糖,由於其主鏈係由對 酸抗性比一般糖弱之L -岩藻糖形成,所以藉由p Η 3.0及 0.2Ν等鹽酸萃取時,被認爲會引起硫酸化多糖之低分子 化。亦即,來自沖繩海蘊藻之硫酸化多糖,與其他以硫酸 化L_岩藻糖爲主要構成糖之多糖一樣,藉由加熱或酸處理 可容易地被低分子化。 本發明之硫酸化葡糖醛酸化岩藻聚糖於分子中具有硫酸 基及/或羧基,該基可與各種鹼反應而形成鹽。本發明之硫 酸化葡糖醛酸化岩藻聚糖形成之鹽狀態安定,通常以鈉及/ 或鉀及/或鈣等鹽之形態被提供。此等物質之鹽,可利用陶 外克斯(Dowex)50W等陽離子交換樹脂,而導入游離之本 發明硫酸化葡糖醛酸化岩藻聚糖中。再者,彼等視需要可 進行公知之鹽交換法,以變換成各種所期望之鹽。 本發明之硫酸化葡糖醛酸化岩藻聚糖之鹽,可使用醫藥 -26- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 B7 五、發明説明(24 ) 上容許之鹽,例如鈉及钾等驗金屬、|弓、鎂及鋅等驗土金 屬及銨等鹽。 製造本發明所使用之硫酸化葡糖醛酸化岩藻聚糖時,首 先取得褐藻類之水溶性溶份萃取液。此時,爲防止硫酸化 葡糖路酸化岩藻聚糖之低分子化,以使用pH4〜9、溫度 100 °C以下得到之水溶性溶份萃取液爲較佳。再者,上述 萃取液中胺基酸及低分子性色素等,可藉由超遽法有效地 除去。再者,在疏水性物質之除去上,活性碳處理等亦有 效。依此種方式,可得到來自褐藻類之硫酸化多糖溶份。 又,將該溶份若藉由陰離子交換管柱分離,將可得到純度 較高之硫酸化葡糖醛酸化岩藻聚糖。 藉由上述方法得到之硫酸化葡糖醛酸化岩藻聚糖顯示育 毛效果。因此,例如可做爲育毛劑之構成成分。 再者,上述方法得到之硫酸化多糖溶份或藉由陰離子交 換管柱精製之硫酸化葡糖醛酸化岩藻聚糖,均可被用做本 發明之α-D -葡糖菩酸酶及内- a- L-岩藻糖芬酶之基質。 再者,可在本發明之岩藻依聚糖脱乙醯酶、α-D -葡糖甞 酸酶、及内-a - L -岩藻糖甞酶精製時做爲測定活性用之基 質,或者亦可做爲製造脱乙醯化硫酸化葡糖醛酸化岩藻聚 糖、脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻聚糖、 及硫酸化葡糖醛酸化岩藻寡聚糖時之原料。 本説明書中之硫酸化葡糖醛酸化岩藻寡聚糖,意指從硫 酸化葡糖醛酸化岩藻聚糖生成之寡聚糖。雖然基本上包含 硫酸基、葡糖醛酸基、岩藻糖基、乙醯基,但亦有例如只 -27- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(25 ) 由硫酸基與岩藻糖基形成之情況;來自硫酸化葡糖醛酸化 岩藻聚糖之情況,稱爲硫酸化葡糖醛酸化岩藻寡聚糖。 本發明中之岩藻依聚糖脱乙醯酶,係指可作用於硫酸化 葡糖醛酸化岩藻聚糖及硫酸化葡糖醛酸化岩藻寡聚糖,而 將乙醯基加水分解,使醋酸游離之酵素。本發明岩藻依聚 糖脱乙醯酶之物理化學性質如以下所述。 (I) 作用:作用於硫酸化葡糖酸酸化岩藻聚糖及硫酸化葡 糖酸化岩藻寡聚糖等,而將乙醯基加水分解,使醋酸游 離。 (II) 最佳pH値:本酵素之最佳pH値在約6〜9.1之範圍内 (圖 1)。 亦即’圖1爲表示本酵素反應時p Η値與相對活性之關係 圖,其中縱軸表示相對活性(〇/〇),以及橫軸表示pH値。 (III) 最佳溫度:本酵素之最佳溫度在約2 3〜4 5 t之範圍 内(圖2)。 亦即,圖2爲表示本酵素反應時溫度與相對活性之關係 圖’其中縱軸表示相對活性(%),以及橫軸表示溫度 rc)。 (IV) 分子量:藉凝膠過濾測定時,爲約3萬〜5萬。 本發明之岩藻依聚糖脱乙醯酶之確認,藉由測定具有乙 醯基之硫酸化葡糖醛酸化岩藻寡聚糖及其還原性末端基以 螢光標識之化合物之分解活性而進行。藉由使用此等螢光 標識之寡聚糖可構築微量、高感度之活性測定系統。再 者,使岩蕩依聚糖脱乙酿酶作用於硫酸化葡糖駿酸化岩藻 -28-This paper size applies to Chinese National Standard (CNS) A4 (210 x 297 mm) 1243853 A7 B7 V. Description of the invention (22) (where R is Η, S03H or CH3CO). Furthermore, the molecular weight, sugar composition, and sulfate group content of the sulfated glucuronidated fucoidan, along with the harvest time of the sulfated glucuronidated fucoidan raw material, the drying method of the material, and the raw material The preservation method, the heating conditions during the extraction of the sulfated glucuronidated fucoidan, or the pΗ conditions are different. For example, there is a case where sulfated glucuronidated fucoidan is hydrolyzed by acid. Therefore, the molecular weight, molecular weight distribution, sugar composition, or sulfate group content of the sulfated glucuronidated fucoidan described in this specification are just examples, and the sulfated glucuronidated fucoidan is described as an example. The extraction treatment conditions can easily change its molecular weight, molecular weight distribution, sugar composition, or sulfuric acid group content. For example, if extracted from Okinawa algae by an extraction method at pH 6.0, 95 ° C, and 2 hours, a sulfated glucuronidated fucoidan having the above molecular weight and sugar composition can be obtained. That is, by adjusting the conditions at the time of preparation, a sulfated glucuronidated fucose having an arbitrary molecular weight, molecular weight distribution, sugar composition, or sulfate group content can be prepared. For example, the main constituent sugars of the above-mentioned sulfated glucuronidated fucose, although the average fucose contains about 2 sulfate residues, but in general, the sulfate-based chemistry of ester binding on sugars Sexual instability, easily cut off by acid, alkali or heat. For example, if heat treatment is performed under acidic or alkaline conditions, the sulfuric acid content or acetamidine content will decrease. That is, it is possible to desulfurize or deacetylate the sulfated glucuronidated fucoidan. In addition, when desulfurizing or deacetylating, adjusting the types and concentrations of acids and bases, and the temperature and time during heat treatment, the amount of sulfuric acid groups and acetic acid groups can be adjusted. Although there is no special limitation, for example, with about 0.5 ~ 1 N sodium hydroxide-25- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention ( 23) The deacetylated sulfated glucuronidated fucoidan obtained by treating the solution at 25 ° C for 24 hours is suitable as the α-D-glucosidase or endo-a-L- The substrate of fucose enzyme. Therefore, the sulfated glucuronidated fucans in this specification include the sulfated glucuronidated fucans having the aforementioned characteristics, or they are decomposed by the sulfated glucuronidated fucans of the present invention. Enzymes and low-molecular sulfated glucuronidated fucans are all derived from brown algae. Although its source is not particularly limited, for example, brown algae of the genus Pinnaceae, such as Okinawa sea algae, stone sea algae, rough sea algae, rough sea algae, etc., due to the large content of sulfated glucuronidated fucoidan Therefore, it is particularly suitable as a raw material. For example, sulfated polysaccharides from algae in Okinawa, because their main chain is formed by L-fucose, which is weaker in acid resistance than ordinary sugars, so it is considered to be extracted with hydrochloric acid such as pΗ 3.0 and 0.2N. Will cause low molecular weight of sulfated polysaccharides. That is, the sulfated polysaccharide derived from the seaweed of Okinawa, like other polysaccharides mainly composed of sulfated L-fucose, can be easily lowered by heating or acid treatment. The sulfated glucuronidated fucoidan of the present invention has a sulfate group and / or a carboxyl group in the molecule, and the group can react with various bases to form a salt. The state of the salt formed by the sulfonated glucuronidated fucoidan of the present invention is stable, and it is usually provided in the form of a salt such as sodium and / or potassium and / or calcium. The salts of these substances can be introduced into the free sulfated glucuronidated fucoidan of the present invention using a cation exchange resin such as Dowex 50W. Furthermore, they can perform a known salt exchange method as necessary to convert them into various desired salts. The salt of sulfated glucuronidated fucoidan of the present invention can be used in medicine. 26- This paper size is applicable to Chinese National Standard (CNS) A4 specifications (210X297 mm) 1243853 A7 B7 V. Description of the invention (24) Permissible salts, such as metals such as sodium and potassium, salts such as bow, magnesium and zinc, and ammonium. When producing the sulfated glucuronidated fucoidan used in the present invention, a water-soluble soluble extract of brown algae is first obtained. At this time, in order to prevent the low-molecularization of the sulfated gluconic acid fucoidan, it is preferable to use a water-soluble solvent extract solution obtained at a pH of 4 to 9 and a temperature of 100 ° C or lower. Furthermore, amino acids, low-molecular-weight pigments, and the like in the above-mentioned extracts can be effectively removed by the ultra-fluoridation method. Furthermore, activated carbon treatment and the like are effective in removing the hydrophobic substance. In this way, a sulfated polysaccharide solution from brown algae can be obtained. Further, if this solvent is separated by an anion exchange column, a sulfated glucuronidated fucoidan having a higher purity can be obtained. The sulfated glucuronidated fucoidan obtained by the above method showed a hair-growing effect. Therefore, for example, it can be used as a component of a hair growth agent. Furthermore, the sulfated polysaccharide solution obtained by the above method or the sulfated glucuronidated fucoidan refined through an anion exchange column can be used as the α-D-glucosaccharinase and Endo-a-L-fucose fenase substrate. Furthermore, the fucoidan deacetylase, α-D-glucosidase, and endo-a-L-fucosinase of the present invention can be used as a substrate for measuring activity during purification, Alternatively, it can also be used to manufacture deacetylated sulfated glucuronidated fucoidan, deacetylated deglucuronated sulfated glucuronidated fucoidan, and sulfated glucuronidated fucoidan. Raw materials for oligosaccharides. The sulfated glucuronidated fucoidan in this specification means an oligosaccharide generated from the sulfurized glucuronidated fucoidan. Although it basically contains sulfate group, glucuronyl group, fucosyl group, and acetamyl group, there are also only -27- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (25) The situation formed by sulfate group and fucose group; from the case of sulfated glucuronidated fucose, it is called sulfated glucuronidated fucoidan. The fucoidan deacetylating enzyme in the present invention refers to the action of sulfated glucuronidated fucoidan and sulfated glucuronidated fuctooligosaccharide to hydrolyze the acetamyl group. An enzyme that releases acetic acid. The physical and chemical properties of the fucoidan deacetylase of the present invention are as follows. (I) Action: It acts on sulfated glucono-acid fucoidan and sulfated gluco-acid fucoidan, etc., to hydrolyze the acetamyl group and free acetic acid. (II) Optimum pH: The optimum pH of this enzyme is in the range of about 6 to 9.1 (Figure 1). That is, Fig. 1 is a graph showing the relationship between pΗ 値 and relative activity during the reaction of the present enzyme, in which the vertical axis represents relative activity (0 / 〇) and the horizontal axis represents pH 値. (III) Optimum temperature: The optimal temperature of this enzyme is in the range of about 2 3 ~ 4 5 t (Figure 2). That is, Fig. 2 is a graph showing the relationship between temperature and relative activity during the reaction of the present enzyme, wherein the vertical axis represents relative activity (%) and the horizontal axis represents temperature (rc). (IV) Molecular weight: When measured by gel filtration, it is about 30,000 to 50,000. The confirmation of fucoidan deacetylase of the present invention was performed by measuring the degradation activity of a sulfonated glucuronidated fuctooligosaccharide having an acetamyl group and its reducing terminal group with a fluorescently labeled compound. get on. By using these fluorescently labeled oligosaccharides, a trace and high-sensitivity activity measurement system can be constructed. In addition, the fumaran deacetylase was allowed to act on sulfated glucosamine acidified fucoid -28-

1243853 五、發明説明(26 寡聚糖後,將反應生成物所 糖駿酸化岩讓寡聚糖分離乙醒化硫酸化葡 之量,或藉由進行反應生成醋酸量及-基 依聚糖脱乙酿酶之活性。本發明===可確認岩藥 ..,,、 心石/来依聚糖脱乙醯酶之 可用生產菌之無細胞萃取液或用藉由各種管柱層 析法精製後之酵素液加以測定。 :::施態樣中,本發明之脱乙酿酶可於氣化鋼及/或蛋 且右外耍 ^ ^ …_早獨或猎由二者組合均 睡 。首先’對氣化納加以説明,試藥之氣化納、食 二、母7 、人工海水等’只要含有氯化納,無論任何物質 句可使用。添加至本發明脱乙酿酶反應液之氣化納濃度以 ^•^河韻之範圍爲較佳^則囊〜咖福之範圍 更佳。 繼而,對於蛋白質加以説明,以使本發明之岩藻依聚糖 脱乙醯酶活性化爲目的而添加於反應液中之蛋白質,只要 既不會分解本發明之岩藻依聚糖脱乙酿酶,亦不會阻害其 反應’則任何蛋白質皆可。其中以使用牛血清白^白等爲 較佳。再者’舉例而言’亦可使用從本發明岩讓依聚糖分 解嗜岩藻菌SI- 1234菌株之菌體萃取而來之蛋白質。添加 於本發明石藻依聚糖脱乙酿酶反應液之蛋白質濃度以 0.001〜1 0毫克/毫升之範圍爲較佳,而以〇 〇1〜丨毫克/毫升 之範圍爲更佳。 本發明中之以-D •葡糖苷酸酶者,係指可作用於脱乙醯 化硫酸化葡糖醛酸化岩藻聚糖及脱乙醯化硫酸化葡糖醛酸 -29 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 裝 訂 1243853 A7 ______ B7 五、發明説27—) ' ' ' 化岩藻寡聚糖等,而將葡糖醛酸與岩藻糖間之α-D-葡糖 酸酸基鍵結加水分解,使D -葡糖醛酸游離之酵素。本發明 a - D -葡糖荅酸酶之物理化學性質如以下所述。 (I) 作用··作用於脱乙醯化硫酸化葡糖醛酸化岩藻聚糖及 脱乙酿化硫酸化葡糖醛酸化岩藻寡聚糖等,而將-葡 糖趁酸基鍵結加水分解,使D -葡糖醛酸游離。 (II) 最佳pH値:本酵素之最佳ρΗ値在約5.8〜7.8之範圍 内(圖3)。 亦即,圖3爲表示本酵素反應時ρ η與相對活性之關係 圖’其中縱軸表示相對活性(% ),以及橫轴表示ρ Η値。 (III) 取佳溫度:本酵素之最佳溫度在约14〜29 °C之範圍 内(圖4)。 亦即,圖4爲表示本酵素反應時溫度與相對活性之關係 圖’其中縱軸表示相對活性(%),以及橫軸表示溫度 (°C) 〇 " (IV) 分子量:藉由凝膠過濾測定時,爲約12萬〜18萬。 本發明之a - D-葡糖菩酸酶之確認,可藉由測定脱乙醯 化硫酸化葡糖醛酸化岩藻聚糖之分解活性而進行。再者, 將硫酸化葡糖醛酸化岩藻寡聚糖及其還原性末端基藉由2_ 胺基吡啶螢光標識之化合物亦可成爲本酵素之基質,且藉 由使用此等螢光標識寡聚糖,可構築微量、高感度之活性 測定系統。於硫酸化葡糖遂酸化岩藻寡聚糖使泛_D_葡糖 苷酸酶作用後,將反應生成物所含之葡糖醛酸及硫酸化葡 糖酸酸化石藻券聚糖分離,藉由分別測定總糖量及總糖趁 «30- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 ______B7 五、發明説明(28一) " ~ - 酸量,且藉由進行反應生成物之質量分析,亦可確認“ · D_匍糖苷酸酶之活性。本發明之葡糖荅酸酶之活 亦可藉由生產菌之無細胞萃取液、或藉由各種管柱層 析法精製後之酵素液加以測定。 於一實施態樣中,本發明之從-D-葡糖苷酸酶可於氣化 鈉、鈣離子及/或蛋白質存在下活性化。此等因素無論單獨 或藉由兩種或三種組合均具有效果。首先,對於氣化鈉加 以說明,試藥之氣化鈉、食鹽、海水、人工海水等,只要 含有氣化鈉,無論任何物質均可使用。添加於本發明以· D-葡糖:y:酸酶之反應液中之氣化鈉濃度以〇^ mM〜iM之範 圍爲較佳,而以i mM〜600 mM之範圍爲更佳。 繼而,對於鈣離子加以説明,只要可使鈣離子產生,無 論任何物質均可使用。較佳之可溶性鈣鹽,可使用例如氯 化鈣及醋酸鈣等。再者,即使爲難溶性鈣鹽,例如碳酸 鈣、磷酸鈣、檸檬酸鈣及硫酸鈣等,在硫酸化葡糖醛酸化 岩藻聚糖等硫酸化多糖爲溶解狀態下,會慢慢地產生鈣離 子,因此可被用於本發明a - D _葡糖菩酸酶之活性化。再 者,在硫酸化葡糖醛酸化岩藻聚糖之硫酸基及羧基之平衡 離子含有鈣鹽之情況,由於基質成爲鈣離子之產生來源, 因此爲活性化而添加之鈣離子源可予以減少。視情況,縱 使不添加鈣鹽,本酵素亦可作用。添加於本發明π _D-葡 糖甞酸酶反應液中之鈣離子濃度以在0 i mM〜200 mM之範 圍内爲較佳’而以在1 mM〜100 mM之範圍内爲更佳。 繼而,對於蛋白質加以説明,在以使本發明之泛_D_葡 -31 - 本纸張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 12438531243853 V. Description of the invention (26 After the oligosaccharide, the sugar product acidified rock of the reaction product is used to separate the oligosaccharide and the amount of sulfated glucose, or the reaction is performed to generate the amount of acetic acid and the Bacterial enzyme activity. The present invention === can confirm the rock drug .. ,, heart stone / lysin deacetylase can be used to produce cell-free extracts of bacteria or by various column chromatography The purified enzyme solution is measured. ::: In the application state, the deethylated enzyme of the present invention can be used on gasified steel and / or eggs and played outside right ^ ^ _ _ early alone or hunting by a combination of the two to sleep First of all, the explanation of gasification sodium, the gasification sodium of the test reagent, food two, mother 7, artificial seawater, etc. can be used regardless of any substance as long as it contains sodium chloride. Add to the deacetylation enzyme reaction solution of the present invention The gasification sodium concentration is preferably in the range of ^ • ^ he rhyme, and the range of sac ~ cafu is more preferable. Then, the protein is explained to activate the fucoidan deacetylase of the present invention. For the purpose of adding the protein to the reaction solution, as long as it does not decompose the fucoidan deacetylase of the present invention, Any protein can be used without hindering its reaction. Among them, bovine serum white and white are preferred. Furthermore, by way of example, fucoidan can be degraded from the rock of the present invention by fucoidan SI- Protein extracted from the bacterial cell of strain 1234. The concentration of protein added to the fucoxan deacetylase reaction solution of the present invention is preferably in the range of 0.001 to 10 mg / ml, and 0.001 to 丨The range of mg / ml is more preferable. In the present invention, -D • glucuronidase refers to deacetylated sulfated glucuronide and fucoidan and deacetylated sulfated glucanase. Uronic acid-29 This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) Binding 1243853 A7 ______ B7 V. Invention 27—) '' 'Chemical fucoidan, etc. The α-D-glucuronic acid bond between the acid and fucose is hydrolyzed to make the enzyme free of D-glucuronic acid. The physicochemical properties of the a-D-glucosaminidase of the present invention are as follows. (I) Action ·· It acts on deacetylated sulfated glucuronidated fucoidan and deethylated sulfated glucuronidated fuctooligosaccharide, etc., while -glucose is bonded to the acid group It is hydrolyzed to make D-glucuronic acid free. (II) Optimum pH: The optimal pH of this enzyme is in the range of about 5.8 to 7.8 (Figure 3). That is, Fig. 3 is a graph showing the relationship between ρ η and relative activity when the present enzyme reacts, wherein the vertical axis represents relative activity (%), and the horizontal axis represents ρ Η 値. (III) Optimum temperature: The optimal temperature of this enzyme is in the range of about 14 ~ 29 ° C (Figure 4). That is, FIG. 4 is a graph showing the relationship between temperature and relative activity during the reaction of the present enzyme, wherein the vertical axis represents relative activity (%), and the horizontal axis represents temperature (° C). (IV) Molecular weight: by gel During filtration measurement, it was about 120,000 to 180,000. Confirmation of the a-D-glucosaccharinase of the present invention can be carried out by measuring the degradation activity of the deacetylated sulfated glucuronide fucose. Furthermore, a compound labeled with sulfated glucuronidated fuco-oligosaccharide and its reducing end group by 2-aminopyridine fluorescence can also be used as the substrate of this enzyme, and by using these fluorescently labeled oligosaccharides Glycan can build a trace and high sensitivity activity measurement system. After sulfated glucosyl acid and fuco-oligosaccharides react with pan-D_glucuronidase, the glucuronic acid and sulfated glucuronidated fucoidan contained in the reaction product are separated and separated by Determination of total sugar content and total sugar content «30- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 1243853 A7 ______B7 V. Description of the invention (28 一) " ~-Acid content, and by The mass analysis of the reaction product can also confirm the activity of "D_ 匍 glucosidase. The activity of the glucuronidase of the present invention can also be obtained by the cell-free extract of the producing bacteria or by various column layers. The enzyme solution after purification is measured. In one embodiment, the slave-D-glucosidase of the present invention can be activated in the presence of sodium gas, calcium ion and / or protein. These factors are independent of each other. Or it can be effective by combining two or three kinds. First, the sodium gasification will be explained. Sodium gasification, salt, seawater, artificial seawater, etc. of the test reagent can be used regardless of any substance as long as it contains sodium gasification. In the present invention, D-glucose: y: the opposite of acidase The concentration of sodium vaporized solution in the liquid is preferably in the range of 0 mM to iM, and more preferably in the range of i mM to 600 mM. Next, as for the calcium ion, as long as calcium ion can be generated, regardless of any substance Both can be used. Preferred soluble calcium salts include, for example, calcium chloride and calcium acetate. Furthermore, even poorly soluble calcium salts, such as calcium carbonate, calcium phosphate, calcium citrate, and calcium sulfate, are used in sulfated glucose. Sulfated polysaccharides such as alkyd fucoidan will slowly generate calcium ions in a dissolved state, so they can be used for the activation of a-D glucoglucosidase in the present invention. Furthermore, in sulfated glucose In the case where the ions of the sulfonic acid group and the carboxyl group of uronic acid contain calcium salts, since the matrix becomes a source of calcium ions, the calcium ion source added for activation can be reduced. Depending on the situation, even if not added The calcium salt can also act. The calcium ion concentration added to the π_D-glucosaminidase reaction solution of the present invention is preferably in the range of 0 i mM to 200 mM, and is in the range of 1 mM to 100. The range of mM is more preferable. The protein is described in order to make the present invention general_D_ Portuguese -31-This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 1243853

發明説明(29 糖a酶活性化爲目的而於反應液中添 既不分解本發明“·D_葡糖甞酸酶 蛋白…、要 則任何蛋白質均可。其中以使用牛血清=其反應, 再者舉例而1,料使毅本發明 ^• 1234菌株之菌體萃取而來之 石 明--D-葡糖菩酸酶反應液中之:二、加於本發 戽古/古1、从 貝/辰度以在0.001〜10 毛克/笔升&lt;範圍内爲較佳,而在 圍内爲更佳。 在0.01〜克/毫升之範 化:!:月中之内…L-岩藻糖菩酶,係指可作用於脱乙酿 乂匍搪.酸化硫酸化葡糖醛酸化岩藻聚糖及硫酸化葡糖 恥酸化石澡寡聚寿唐,而將-岩藻糖基鍵結以内向方式 加水分解,以使還原性末端具有[•岩藻糖之寡聚糖生成之 酵素:本發明之内…岩藻糖I酶,對天然之硫酸化葡 糖路酸化石藻I糖幾典作用,然而對於預先以岩藻依聚糖 脱乙醯酶及泛_D-葡糖茹酸酶處理之硫酸化葡糖醛酸化岩 藻聚糖,或對於與岩藻依聚糖脱乙醯酶及“ _D·葡糖答酸 酶共存下之硫酸化葡糖醛酸化岩藻聚糖則作用良好。不過 即使爲天然硫酸化葡糖醛酸化岩藻聚糖,若藉由來自例如 其他海洋細菌之酵素或物理或化學因素等任何理由使乙醯 基及葡糖趁酸基除去,則適合做爲本發明内-岩藻糖 苷酶之基質。 本發明之内-以-L -岩蕩糖芬酶之物理化學性質如以下所 述0 (I)作用:作用於脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸 -32- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 ___B7 五、發明説明(3Q&quot;&quot;)^ &quot; 化石藻聚糖及硯酸化葡糖醛酸化岩藻寡聚糖等作用,而將 以-L-岩藻糖基鍵結内向方式加水分解,以使還原性末端 具有L-岩藻糖之寡聚糖生成。 (II) 最佳pH値:本酵素之最佳pH値在約4 5〜7 4之範圍 内(圖5)。 亦即,圖5爲表示本酵素反應時pH値與相對活性之關係 圖,其中縱軸表示相對活性(%),以及橫軸表示pH値。 (III) 最佳溫度:本酵素之最佳溫度在約23〜42Ό之範圍 内(圖6 )。 亦即,圖6爲表示本酵素反應時溫度與相對活性之關係 圖,其中縱軸表示相對活性(%),以及橫軸表示溫度 (。。)。 (iv)分子量··藉由凝膠過濾測定時,爲約15萬〜2〇萬。 本發明之内-以-L-岩藻糖甞酶之確認,可藉由測定脱乙 酿化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻聚糖之分解活性 而進行。再者,將硫酸化葡糖醛酸化岩藻寡聚糖以本發明 之以-D·岩藻糖答酶處理而得到之寡聚糖且其還原末端用 2 -胺基ρ比淀勞光標識之化合物亦可做爲本酵素之基質,以 及藉由使用此等螢光標識之寡聚糖可構築微量、高感度之 活性測定系統。舉例而言,將8Fuc-4S-PA (下述)用於基質 使其反應後’若將反應生成物以HPLC分析,可測定内·以· L _岩藻糖苷酶之活性。本發明之内-以-L _岩藻糖嘗酶之活 性,亦可用生產菌之無細胞萃取液,或用各種管柱層析法 精製後之酵素液來進行測定。 -33- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 ____B7 五、發明説明(31 ) 於一實施態樣中,本發明之内_ L -岩藻糖甞酶可於氯 化鈉、鈣離子及/或蛋白質存在下活性化。此等因子無論單 獨或藉由兩種或三種組合均具有活性化作用。首先,對於 ,化鈉加以説明,試藥之氣化鈉、食鹽、海水及人工海水 等八要含有氣化鈉,無論任何物質均可使用。添加於本 發明内-從-L-岩藻糖苷酶反應液中之氯化鈉濃度以在〇^ mM〜1 Μ〈範圍内爲較佳,而以在i mM〜6〇〇 mM之範圍内 爲更佳。 繼而,對於鈣離子加以説明,只要可使鈣離子產生,無 論1何物質均可使用。較佳之可溶性鈣鹽例如爲氣化鈣及 醋酸鈣等。再者,即使爲難溶性鈣鹽例如碳酸鈣、磷酸 鈣、檸檬酸鈣、硫酸鈣等,在硫酸化葡糖醛酸化岩藻聚糖 等之硫酸化多糖爲溶解狀態下,會慢慢地產生鈣離子,因 此可被用於本發明内_ “ · L -岩藻糖甞酶之活性化。再者, 硫酸化葡糖醛酸化岩藻聚糖之硫酸基及羧基之平衡離子含 有鈣鹽之情況,由於基質成爲鈣離子之產生來源,因此爲 活性化而添加之鈣離子源可予以減少。視情況,在不添加 約鹽下本酵素亦可作用。添加於本發明内-“-乙-岩藻糖菩 酶反應液中之鈣離子濃度以在〇1 〜2〇〇 之範圍内爲 較佳,而以在1 mM〜100 mM之範圍内爲更佳。 繼而,對於蛋白質加以敘述,以使本發明之内_ α 藻糖甞酶活性化爲目的而於反應液中添加之蛋白質,只要 既不分~本發明之内-沒-L-岩漠糖答酶,亦不抑制其反 應’任何蛋白質均可。其中以使用牛血清白蛋白等爲車六 -34- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 _B7__ 五、發明説明(32 ) 佳。再者,舉例而言,亦可使用從本發明岩藻依聚糖分解 嗜岩藻菌SI- 1234菌株之菌體萃取而來之蛋白質。添加於 本發明内-a -L-岩藻糖苷酶反應液之蛋白質濃度以在 0.001〜10毫克/毫升之範圍内爲較佳,而以在〇.〇1〜1毫克/ 毫升之範圍内爲更佳。 在本發明中用於製造岩藻依聚糖脱乙醯酶、π-D -葡糖 甞酸酶及内- α- L·岩藻糖甞酶之微生物,只要爲能生產將 上述硫酸化多糖溶份或硫酸化葡糖醛酸化岩藻聚糖低分子 化之酵素之微生物即可,並無特別限定,例如適合使用嗜 岩藻菌屬細菌。上述之嗜岩藻菌屬細菌,包含從細菌學性 質被分類爲同屬者或依據與16S rDNA之鹼基序列之相同性 而被分類爲同屬者之全部微生物,亦包含能生產,與本發 明之岩藻依聚糖脱乙醯酶、以-D-葡糖甞酸酶及内- a- L-岩蕩糖#酶同樣,可將硫酸化葡糖趁酸化岩蕩聚糖分解之 酵素之全部微生物。 適合培養生產本發明之岩藻依聚糖脱乙醯酶、π-D -葡 糖甞酸酶及内- π- L-岩藻糖甞酶之微生物而添加於培養基 中之營養源,只要能被使用之微生物利用,且於其存在下 可以生產該酵素即可;碳源,可利用例如硫酸化葡糖醛酸 化岩藻聚糖、沖繩海蘊藻等海藻,褐藻酸、昆布多糖、岩 藻糖、葡萄糖、甘露醇、甘油、蔗糖、麥芽糖及澱粉等; 適合作爲氮源者,例如爲酵母萃取液、蛋白腺、酶蛋白胺 基酸、玉米浸潰液、肉萃取液、脱脂大豆、硫酸銨、氯化 铵、尿素及尿酸等。亦可添加其他納、钾、鍰及#5等之氣 -35- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(33 化物、磷酸鹽或硫酸鹽等。再者,該微生物之培養基可爲 海水或市售之人工海水培養基。 再者,培養條件及培養基組成,當然應根據所使用之微 生物而設定成能使本發明之岩藻依聚糖脱乙醯酶、以_ D _ 匍糖甞酸酶及内-從-L -岩藻糖苷酶之生產量達到最大者。 例如,以培養溫度爲15〜3〇1,培養基之卩{^爲5〜9以及進 行5〜72小時之通氣攪拌培養爲較佳,在前述條件下,本發 明〈石藻依聚糖脱乙醯酶、a_D-葡糖甞酸酶及内以_l_ 岩漢糖㈣之生產量可達到最大。培養終了後,藉由離心 γ將菌體與培養上清液分開,從其中可分別得到本發明之 岩澡依聚糖脱乙酿酶U-葡糖苷酸酶及内_以彳_岩 糖苷酶。 雖無特別限定’但舉例而言’可藉由將本發明之岩藻依 聚糖分解嗜岩藻菌SI_ 1234菌株在適當之培養基中培養, 收集其菌體’然後藉習用之細胞破碎手段(例如超音波處理) 將菌體弄碎,可得到無細胞萃取液。繼而藉由習用之精製 手段:可從此萃取液中得到精製的酵素樣品。藉由鹽析、 離子人換&amp;柱層析法、疏水管柱層析法及凝膠過遽等進 精製’可得到實質上不包含其他含硫酸化岩藻财糖之分 解酵素之純化本發明岩隸聚糖脱乙㈣、^D·葡 酸酶及内m藥㈣酶。再者’若使用將硫酸 趁酸化岩藻聚糖固定化之樹脂,可輕易地將本發明之: D-葡糖純酶與本發明之内·a_L•岩_麵分離。· 再者,上述之培養上清液中,由於亦存在本發明之岩藻 -36- 1243853 A7 _____B7 五、發明説明(35 ) 比從4 : 1至4 : 0之各種葡糖醛酸含量之脱乙醯化脱葡糖醛 酸化硫酸化葡糖醛酸化岩藻聚糖。 爲了獲得本發明脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸 化岩藻聚糖,使a - D -葡糖甞酸酶作用於脱乙醯化硫酸化 葡糖趁酸化岩藻聚糖,然後將游離之D -葡糖醛酸藉由例如 超遽法、凝膠過滤及陰離子交換管柱處理等除去即可。視 需要可進行脱鹽及凍結乾燥等處理。進行脱葡糖醛酸化處 理時,若預先將硫酸化葡糖醛酸化岩藻聚糖用岩藻依聚糖 脫乙酿酶處理及鹼處理以脱去乙醯,可使脱葡糖醛酸化有 效率地進行。 舉例而言,將來自沖繩海蘊藻之硫酸化葡糖醛酸化岩藻 聚糖予以脱乙醯化得到之脱乙醯化硫酸化葡糖醛酸化岩藻 聚糖中’約每4分子岩藻糖有1分子D -葡糖趁酸,但藉由以 -D -葡糖:y:酸酶將D -葡糖醛酸除去,可調製成具各種葡糖 趁酸含量之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻 聚糖。藉由調整脱葡糖醛酸反應所用之酵素量及基質量、 反應時間、反應溫度及P Η値等之條件,例如(但非限於此) 將適量之氣化鈉、牛血清白蛋白及500 mlJ之本發明α - D-葡糖荅酸酶混入1公克之脱乙醯化硫酸化葡糖醛酸化岩藻 聚糖中,並使其於20 °C及约ρΗ7下反應歷各種時間,可製 造出岩藻糖與葡糖遂酸之莫耳比爲4 : 1至4 : 0之具各種葡 糖遂酸含量之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩 藻聚糖。 脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻聚糖雖可 -38· 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(36 ) 以原樣做爲糖鏈工學用試藥,但除做爲本發明内-泛-L _岩 藻糖苷酶之基質而用於活性測定之外,爲其反應生成物之 本發明硫酸化葡糖醛酸化岩藻寡聚糖,亦可做爲糖鏈工學 用試藥。 當調製本發明之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸 化岩藻聚糖時,脱乙醯化硫酸化葡糖醛酸化岩藻聚糖或脱 乙醯化硫酸化葡糖醛酸化岩藻聚糖含有物之溶解,可藉通 常之方法進行,而溶解液中之脱乙醯化硫酸化葡糖醛酸化 岩藻聚糖或脱乙醯化硫酸化葡糖醛酸化岩藻聚糖含有物之 濃度,雖可爲其最高溶解濃度,但通常以考量其之操作性 及酵素活性値而選定爲較佳。作爲脱乙醯化硫酸化葡糖醛 酸化岩藻聚糖之溶解液者,可按照目的從水及緩衝液等中 選擇。溶解液之pH通常在中性附近,酵素反應通常在20°C 附近進行。藉由調整酵素量、反應液之組成及反應時間 等,可調整脱葡糖醛酸之程度。脱乙醯化脱葡糖醛酸化硫 酸化葡糖醛酸化岩藻聚糖,視需要可進一步進行離子交換 樹脂處理及超濾法等精製操作,視需要亦可進行脱鹽處 理、無菌處理及凍結乾燥處理。 本發明之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻 聚糖於分子中具有硫酸基及/或羧基,該基與各種鹼反應形 成鹽。本發明之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化 岩藻聚糖形成之鹽狀態安定,通常以鈉及/或鉀及/或鈣等 鹽之形態被提供。此等物質之鹽,可利用陶亦克斯(Dowex) 50W等陽離子交換樹脂,導入游離之本發明脱乙酸化脱葡 -39- 本纸張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 B7 五、發明説明(37 ) 糖醛酸化硫酸化葡糖醛酸化岩藻聚糖中。再者,彼等視需 要可進行公知之鹽交換法,以變換成各種期望之鹽。 本發明之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻 聚糖之鹽,可使用醫藥上容許之鹽,例如鈉及鉀等鹼金 屬、鈣、鎂及鋅等鹼土金屬及銨等之鹽。 本説明書中硫酸化葡糖醛酸化岩藻寡聚糖,係指藉由本 發明之岩藻依聚糖脱乙醯酶作用於上述硫酸化葡糖醛酸化 岩藻聚糖,或者進行鹼處理以脱乙醯化後,以a - D -葡糖 甞酸酶及内-a - L -岩藻糖苷酶作用而得到之還原性末端糖 爲L -岩藻糖之寡聚糖。例如具有從下列通式(I)〜(111)選出 之化學構造之糖化合物,但.非僅限於此。 -40- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 Α7 Β7 五、發明説明( 38DESCRIPTION OF THE INVENTION (29) For the purpose of activating a sugar a enzyme, adding "· D-glucosaminidase protein ..." to the reaction solution does not decompose the invention. Any protein may be used. Among them, bovine serum = its reaction, Another example is 1. It is expected that the Shiming-D-glucopurinase reaction solution from the 1234 strain of the present invention is extracted from the bacterial cell of the present invention: 2. Added to this hairpin ancient / ancient 1, It is better to be in the range of 0.001 ~ 10 gram / stroke &lt; from Bei / Chen degree, and more preferably in the range. Normalization in the range of 0.01 ~ g / ml:!: Within the month ... L- Fucose enzymes, which can act on deacetylated glutamate. Acidified sulfated glucuronidated fucose and sulfated glucosamine fossil bath oligomers Shoutang, while -fucosyl group The bond is hydrolyzed in an inward manner so that the reducing end has [• fucose oligosaccharide-producing enzyme: within the present invention ... fucose I enzyme, a natural sulfated glucoside acidified diatom I Glycosides function, but for sulfated glucuronidated fucans previously treated with fucoidan deacetylase and pan-D-glucosidase, or The sulfated glucuronidated fucoidan with co-existence of enan deacetylase and "_D.glucosidase has a good effect. However, even if it is a natural sulfated glucuronidated fucoidan, if you borrow Removal of acetamyl and glucose by acid groups from any reason such as enzymes from other marine bacteria or physical or chemical factors is suitable as a substrate for the endo-fucosidase of the present invention. Within the present invention-to- The physical and chemical properties of L-Langangsufenfen enzyme are as follows: 0 (I) Action: It acts on deacetylated deglucuronidated sulfated glucuronic acid-32- This paper size applies to Chinese national standards (CNS ) A4 specification (210X 297 mm) 1243853 A7 ___B7 V. Description of the invention (3Q &quot; &quot;) ^ &quot; Fossil algal and gadolinated glucuronidated fuctooligosaccharides will act as -L- Fucosyl bond is hydrolyzed inward to generate oligosaccharides with L-fucose at the reducing end. (II) Optimum pH 値: The optimal pH of this enzyme is about 4 5 ~ 7 4 (Figure 5). That is, Figure 5 is a graph showing the relationship between pH 値 and relative activity during the reaction of this enzyme. The vertical axis indicates relative activity (%), and the horizontal axis indicates pH 値. (III) Optimum temperature: The optimal temperature of the enzyme is in the range of about 23 to 42Ό (Figure 6). That is, Figure 6 shows the The relationship between temperature and relative activity during enzyme reaction, where the vertical axis represents relative activity (%) and the horizontal axis represents temperature (...). (Iv) Molecular weight: When measured by gel filtration, it is about 150,000 ~ 200,000. The confirmation of the -L-fucosinase in the present invention can be carried out by measuring the degradation activity of deacetylation, deglucouration, sulfated glucuronidation, and fucoidan. Furthermore, the sulfated glucuronidated fucoid oligosaccharide is treated with -D · fucosylase in the present invention, and its reducing end is labeled with 2-aminopyridine. The compounds can also be used as a substrate for this enzyme, and trace and high-sensitivity activity measurement systems can be constructed by using these fluorescently labeled oligosaccharides. For example, after using 8Fuc-4S-PA (described below) for a substrate and reacting it, if the reaction product is analyzed by HPLC, the activity of endo-L · fucosidase can be measured. In the present invention, the activity of the enzyme can be measured with -L_fucose, and the cell-free extract of the producing bacteria or the enzyme solution purified by various column chromatography can be used for measurement. -33- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 ____B7 V. Description of the invention (31) In an embodiment, the present invention is within the scope of the present invention. L-Fucoidan Enzymes can be activated in the presence of sodium chloride, calcium ions and / or proteins. These factors have activation effects either alone or by a combination of two or three. First of all, for the explanation of sodium sulfide, sodium hydride, common salt, seawater and artificial seawater of the test drug must contain sodium fumes, and any substance can be used. The concentration of sodium chloride added in the -L-fucosidase reaction solution of the present invention is preferably within a range of 0 mM to 1 M <, and within a range of 1 mM to 600 mM. For the better. Next, as for calcium ions, any substance can be used as long as calcium ions can be generated. Preferred soluble calcium salts are, for example, calcium carbonate and calcium acetate. Furthermore, even in the case of poorly soluble calcium salts such as calcium carbonate, calcium phosphate, calcium citrate, and calcium sulfate, calcium is slowly produced when sulfated polysaccharides such as sulfated glucuronidated fucoidan are dissolved. Therefore, it can be used in the present invention. "·-L-fucosinase activation. Furthermore, the sulfate ion and the carboxyl group of sulfated glucuronide contain calcium salt when the counter ion contains calcium salt. Since the matrix becomes the source of calcium ions, the calcium ion source added for activation can be reduced. Depending on the situation, the enzyme can also be used without adding about salt. Added in the present invention-"-B-rock The calcium ion concentration in the fucose enzyme reaction solution is preferably in the range of 0-1 to 200, and more preferably in the range of 1 mM to 100 mM. Next, the protein will be described, and the protein added to the reaction solution for the purpose of activating the α-fucosinase in the present invention, as long as it does not distinguish ~ within the present invention-not-L-rock desert sugar answer Enzymes do not inhibit their reactions' Any protein is fine. Among them, the use of bovine serum albumin as the car six -34- This paper size applies the Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1243853 A7 _B7__ 5. The invention description (32) is good. Furthermore, for example, a protein extracted from the fucoidan strain SI-1234 strain decomposed by the fucoidan of the present invention can also be used. The protein concentration of the -a-L-fucosidase reaction solution added in the present invention is preferably in the range of 0.001 to 10 mg / ml, and in the range of 0.01 to 1 mg / ml. Better. Microorganisms used in the present invention for the production of fucoidan deacetylase, π-D-glucosidase, and endo-α-L · fucosidase, as long as they are capable of producing the above sulfated polysaccharides There are no particular restrictions on the amount of the dissolved or sulfated glucuronidated fucoidan enzyme, and for example, it is suitable to use a fucobacterium. The above-mentioned fucobacteria bacteria include all microorganisms that are classified as homologous from the bacteriological nature or are classified as homologous based on the same sequence as the base sequence of 16S rDNA. Invented Fucoidan Deacetylase, -D-Glucosidase and Endo-a-L-yandose #enzyme, the same enzyme that can decompose sulfated glucose while acidifying fucoidan Of all microorganisms. It is suitable for culturing and producing microorganisms of fucoidan deacetylase, π-D-glucosidase and endo-π-L-fucosidase of the present invention, and the nutrient source added to the culture medium, as long as it can It can be used by the used microorganisms, and the enzyme can be produced in the presence of it. The carbon source can be seaweeds such as sulfated glucuronide, fucoidan, Okinawa algae, alginic acid, kumbu polysaccharide, fucoidan Sugar, glucose, mannitol, glycerol, sucrose, maltose, and starch; suitable as nitrogen source, such as yeast extract, protein gland, enzyme protein amino acid, corn extract, meat extract, defatted soybean, sulfuric acid Ammonium, ammonium chloride, urea and uric acid. Other gases such as sodium, potassium, thorium, and # 5 can also be added -35- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (33 compounds, phosphates Or sulphate, etc. Moreover, the culture medium of the microorganism may be seawater or a commercially available artificial seawater culture medium. Furthermore, the culture conditions and the composition of the medium should of course be set according to the microorganisms used to enable the fucoid of the present invention Glycan deacetylase, _ D _ glucuronidase and endo-from-L-fucosidase produced the largest amount. For example, at a culture temperature of 15 ~ 301, the culture medium { ^ Is 5 to 9 and aeration and agitation culture is preferably performed for 5 to 72 hours. Under the aforementioned conditions, the present invention <fucoidan deacetylase, a_D-glucosidase, and internal _l_ rock The production amount of glycosaminoglycan can reach the maximum. After the end of the culture, the bacterial cells are separated from the culture supernatant by centrifugation γ, and the rock bath glycosaminoglycan deethyl brewing enzyme U-glucuronide of the present invention can be obtained from them respectively. Enzyme and endo_yase_fucosidase. Although not particularly limited, but by way of example, The fucoidan of the invention decomposes Fucoidophila SI 1234 and cultivated in an appropriate culture medium. Then collect the bacterial cells' and then use conventional cell disruption methods (such as ultrasonic treatment) to break the bacterial cells to obtain cell-free cells. Extraction solution. Then, by the conventional refining method: a refined enzyme sample can be obtained from this extraction solution. It can be extracted by salting out, ion exchange &amp; column chromatography, hydrophobic column chromatography, and gel filtration. Refined 'can obtain a purification that does not substantially contain other sulfated fucose-containing degrading enzymes of the present invention. The fucoidan deacetylase, ^ D · glucanase, and endogenous medicinal enzymes can be obtained. Furthermore,' if used, the Sulfuric acid while acidifying fucoidan-immobilized resin can easily separate the D-glucose pure enzyme from the a.L. rock surface of the present invention. Furthermore, in the above culture supernatant Since there are also fucoids of the present invention-36-1243853 A7 _____B7 V. Description of the invention (35) Deacetylation degluconization desulfurization and sulfation of various glucuronic acid ratios from 4: 1 to 4: 0 Glucuronidated fucoidan. In order to obtain the deacetylated deglucose of the present invention Alkylated sulfated glucuronide fucose, a-D-glucuronidase acts on deacetylated sulfated glucose while acidifying fucose, and then free D-glucuronide It can be removed by, for example, ultrathorium method, gel filtration, anion exchange column treatment, etc. If necessary, treatments such as desalting and freeze-drying can be performed. In the case of deglucose acidification treatment, if sulfated glucoaldehyde is used in advance, Acidified fucoidan treatment with fucoidan deacetylation enzyme and alkaline treatment to remove acetamidine can efficiently deglucose acidification. For example, sulfation of algae from Okinawa Deacetylated sulfated glucuronidated fucose obtained by deacetylation of glucuronidated fucoidan 'about 1 molecule of D-glucose per 4 molecules of fucose while acid, but borrowed By removing D-glucuronic acid with -D -glucose: y: acidase, it can be adjusted to deacetylated degluconated sulfated glucuronidated fucoid with various glucose content and acid content. sugar. By adjusting conditions such as the amount of enzymes and base mass, reaction time, reaction temperature, and P Η 値 used in the de-glucuronic acid reaction, for example (but not limited to), appropriate amounts of sodium gasification, bovine serum albumin, and 500 The α-D-glucuronidase of the present invention in mlJ is mixed into 1 g of deacetylated sulfated glucuronidated fucose and allowed to react at 20 ° C and about ρΗ7 for various times. Production of deacetylated degluconated degluconated sulfated glucuronidated fucose with various glucosinic acid content of fucose and glucosinolate from 4: 1 to 4: 0 . Deacetylated, de-glucuronidated, sulfated, glucuronidated, fucoidan -38 · This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (36) It is used as a sugar chain engineering reagent as it is, but in addition to being used as the substrate of the endo-pan-L_fucosidase of the present invention and used for the activity measurement, the sulfuric acid of the present invention as a reaction product thereof Glucuronidated fuco-oligosaccharide can also be used as a test reagent for sugar chain engineering. When the deacetylated degluconated sulfated glucuronidated fucose of the present invention is prepared, the deacetylated sulfated glucuronidated fuctan or deacetylated sulfated glucan The dissolution of the acidified fucoidan can be carried out by a common method, and the deacetylated sulfated glucuronidated fucoidan or the deacetylated sulfated glucuronidated fucoidan in the solution is dissolved. Although the concentration of the sugar-containing substance can be its highest dissolved concentration, it is usually better to select it in consideration of its operability and enzyme activity. As the dissolving solution of the deacetylated sulfated glucuronidated fucoidan, it can be selected from water, a buffer solution, and the like according to the purpose. The pH of the dissolving solution is usually around neutral, and the enzyme reaction is usually carried out around 20 ° C. By adjusting the amount of enzyme, the composition of the reaction solution, and the reaction time, the degree of de-glucuronic acid can be adjusted. Deacetylated, de-glucuronidated, sulfated-glucuronidated fucoidan can be further purified by ion exchange resin treatment and ultrafiltration if necessary, and desalted, aseptically treated, and frozen if necessary Drying. The deacetylated de-glucuronidated sulfated glucuronidated fucoidan of the present invention has a sulfate group and / or a carboxyl group in the molecule, and the group reacts with various bases to form a salt. The state of the salt formed by the deacetylation, deglucouration, sulfated glucuronidation, and fucoidan of the present invention is usually provided in the form of salts such as sodium and / or potassium and / or calcium. The salts of these substances can be introduced by using cation exchange resins such as Dowex 50W to introduce the free deacetation and deglucose of the present invention-39- This paper size applies to China National Standard (CNS) A4 (210X297) (%) 1243853 A7 B7 V. Description of the invention (37) Uronic acid sulfated glucuronidated fucose. Furthermore, they can carry out well-known salt exchange methods as needed to transform into various desired salts. In the present invention, the salts of deacetylated deglucouronated sulfated glucuronidated fucoidan can use pharmaceutically acceptable salts, such as alkali metals such as sodium and potassium, alkaline earth metals such as calcium, magnesium, and zinc, and Ammonium and other salts. In this specification, the sulfated glucuronidated fucoidan refers to the action of the fucoidan deacetylase of the present invention on the sulfated glucuronidated fucoidan, or an alkali treatment to After deacetylation, the reducing terminal sugar obtained by the action of a-D-glucosidase and endo-a-L-fucosidase is an oligosaccharide of L-fucose. For example, a sugar compound having a chemical structure selected from the following general formulae (I) to (111) is not limited thereto. -40- This paper size applies to Chinese National Standard (CNS) Α4 size (210 X 297 mm) 1243853 Α7 Β7 V. Description of invention (38

(式中,R爲Η,S03H或CH3CO ; η爲0以上之整數)。 -41 -(In the formula, R is Η, S03H or CH3CO; η is an integer of 0 or more). -41-

本纸張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(39This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of invention (39

〇 X X〇 X X

J (式中,R爲Η,S03H或CH3CO ; η爲0以上之整數) 〇 42J (where R is Η, S03H or CH3CO; η is an integer of 0 or more) 〇 42

本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853This paper size applies to China National Standard (CNS) Α4 size (210 X 297 mm) 1243853

五、發明説明(4Q (\ HH »—ίV. Description of the invention (4Q (\ HH »—ί

XX

〇 X π: (式中,R爲Η,S03H或CH3CO ; η爲0以上之整數) -43-〇 X π: (where R is Η, S03H or CH3CO; η is an integer of 0 or more) -43-

本紙張尺度適用中國國家標準(CNS) Α4規格(210X297公釐) 1243853 A7 B7 五、發明説明(41 ) 本發明之硫酸化葡糖醛酸化岩藻寡聚糖,可藉由使本發 明之岩藻依聚糖脱乙醯酶、π-D -葡糖芬酸酶及内-a-L-岩藻糖甞酶作用於硫酸化葡糖醛酸化岩藻聚糖或硫酸化葡 糖醛酸化岩藻聚糖含有物,而有效率地調製,亦可藉由使 本發明之π-D·葡糖甞酸酶及内- α- L-岩藻糖荅酶作用於 預先經過鹼處理等化學處理之脱乙醯化硫酸化葡糖醛酸化 岩藻聚糖而調製。作爲硫酸化葡糖醛酸化岩藻聚糖含有物 者,適合使用例如硫酸化葡糖醛酸化岩藻聚糖之部份精製 品、來自褐'藻類之含岩藻糖之多糖成分、褐藻類之水性溶 劑萃取物或褐藻類藻體等。再者,使本發明之内- π- L-岩 藻糖苷酶作用於本發明之脱乙醯化脱葡糖醛酸化硫酸化葡 糖醛酸化岩藻聚糖,當然亦可得到本發明之硫酸化葡糖醛 酸化岩藻寡聚糖。例如(但非限於此)藉由將來自沖繩海蘊 藻之硫酸化葡糖醛酸化岩藻聚糖予以脱乙醯化,然後以本 發明之a_D -葡糖甞酸酶及内- α- L-岩藻糖苷酶作用,可 得到具有從上述通式(I)〜(III)選出之化學構造之糖化合物 或其鹽。 當調製本發明之硫酸化葡糖醛酸化岩藻寡聚糖時,硫酸 化葡糖醛酸化岩藻聚糖或硫酸化葡糖醛酸化岩藻聚糖含有 物之溶解可藉通常之方法進行,而溶解液中之本發明硫酸 化葡糖醛酸化岩藻聚糖或該硫酸化葡糖醛酸化岩藻聚糖含 有物之濃度雖可爲其最高溶解濃度,但通常以考慮其操作 性及本發明岩藻依聚糖脱乙醯酶、α-D -葡糖芸酸酶及内-沒-L -岩蕩糖嘗酶之量而選定爲較佳。作爲硫酸化葡糖路 -44- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(42 酸化岩藥聚糖之溶解液者,可視目的而從水及緩衝液等中 選擇。溶解液之pH通常在中性附近,酵素反應通常在25 °C 附近進行。藉由調整反應中所使用之本發明岩藻依聚糖脱 乙酿酶、α-D·葡糖荅酸酶及内-泛-l•岩藻糖甞酶之配合 比率及使用量、反應液之組成及反應時間等,可調整硫酸 化葡糖路酸化岩藻寡聚糖之分子量及葡糖醛酸與乙醯基之 含量。硫酸化葡糖醛酸化岩藻聚糖可藉由3種酵素,亦即 本發明之岩藻依聚糖脱乙醯酶、a_D_葡糖棼酸酶及内-泛 -L-岩蕩糖苷酶而分解,然而此3種酵素之反應可同時進 行’亦可各別進行。亦即,預先將硫酸化葡糖醛酸化岩藻 聚糖藉由本發明之岩藻依聚糖脱乙醯酶、江_;〇_葡糖甞酸 酶予以脱乙醯化及脱葡糖醛酸化,隨後藉由熱處理或酸或 驗處理等使本發明之岩藻依聚糖脱乙醯酶及α-D·葡糖嘗 酸酶失去活性後,以本發明之内岩藻糖苷酶作用, 則所生成之本發明硫酸化葡糖醛酸化岩藻寡聚糖之分子量 分布及葡糖趁酸及乙醯基含量之調整將變得容易。 上述方式所得到之本發明硫酸化葡糖醛酸化岩藻寡聚 糖,藉由分子量分劃或陰離子交換管柱分劃,可進一步調 製分子量更均一或均一電荷分布之本發明硫酸化葡糖醛酸 化岩蕩寡聚糖。分子量分劃適用通常被使用之方法,例如 可使用凝膠過濾或分子量分劃膜。低分子化物視需要可進 一步進行離子交換樹脂處理及活性碳處理等精製操作,視 需要亦可進一步進行脱鹽處理、無菌處理及凍結乾燥處理 等。藉由此等方法,可得到均一構造(以NMR分析決定構 -45- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 1243853 A7 B7 V. Description of the invention (41) The sulfated glucuronide fuco-oligosaccharide of the present invention can be used to make the rock of the present invention Fucoidan deacetylase, π-D-glucosidase and endo-aL-fucosinase act on sulfated glucuronidated fucoidan or sulfated glucuronidated fucoidan The sugar-containing substance can be efficiently prepared, and the π-D · glucosaminidase and endo-α-L-fucosinase of the present invention can also be used to remove chemical substances which have undergone chemical treatment such as alkali treatment in advance. Acetate is prepared by sulfated glucuronidation of fucoidan. As the sulfated glucuronide fucoidan-containing substance, for example, a partially refined product of sulfated glucuronidated fucose, a fucose-containing polysaccharide component derived from brown algae, and brown algae are suitably used. Aqueous solvent extracts or brown algae algae. Furthermore, when the π-L-fucosidase in the present invention is applied to the deacetylation, deglucouration, sulfated glucuronidation, and fucoidan of the present invention, of course, the sulfuric acid of the present invention can also be obtained. Glucuronidated Fucoidan. For example, but not limited to, by deacetylating the sulfated glucuronidated fucoidan from Okinawa algae, and then using the a_D-glucuronidase and endo-α-L of the present invention -Fucosidase acts to obtain a sugar compound or a salt thereof having a chemical structure selected from the above general formulae (I) to (III). When preparing the sulfated glucuronidated fuctooligosaccharide of the present invention, the dissolution of the sulfated glucuronidated fucoidan or the sulfated glucuronidated fucoidan can be performed by a common method. Although the concentration of the sulfated glucuronidated fucoidan of the present invention or the content of the sulfated glucuronidated fucoidan in the dissolving solution can be its highest dissolved concentration, it is generally considered in consideration of its operability and cost. The amount of fucoidan deacetylase, α-D-glucosaccharinase, and endo-me-L-rock dextrose enzymes in the invention is preferably selected. As the sulfated glucose road-44- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (42 Acidified lycoglycan solution, depending on the purpose Choose from water, buffer solution, etc. The pH of the dissolving solution is usually around neutral, and the enzyme reaction is usually carried out around 25 ° C. By adjusting the fucoidan deacetylase, α of the present invention used in the reaction, -D · Glucosidase and Endo-Pan-l · Fucosylase The mixing ratio and usage amount, the composition of the reaction solution and the reaction time, etc. Molecular weight and the content of glucuronic acid and acetamyl group. Sulfated glucuronidated fucoidan can be obtained by 3 kinds of enzymes, namely fucoidan deacetylase, a_D_glucoside of the present invention. Acidase and endo-pan-L-fucosidase are decomposed, however, the reaction of these three enzymes can be performed simultaneously or separately. That is, the sulfated glucuronidation fucoidan is prepared in advance by the present The fucoidan deacetylating enzyme and ___ glucuronidase were invented to deacetylate and deglucose After the fucoidan deacetylase and α-D.glucose acidase of the present invention are deactivated by heat treatment, acid or test treatment, etc., then the fuccosidase of the present invention acts, Then the molecular weight distribution of the sulfated glucuronidated fuctooligosaccharide of the present invention and the adjustment of the glucose and acid and acetamyl content will become easy. The sulfated glucuronide of the present invention obtained in the above manner will be easily acidified. Fucoidan, through molecular weight division or anion exchange column division, can further adjust the molecular weight division or uniform charge distribution of the present invention sulfated glucuronidated oligosaccharide. The molecular weight division is usually applied by The method used can be, for example, gel filtration or molecular weight division membrane. The low-molecular-weight compound can be further subjected to purification operations such as ion exchange resin treatment and activated carbon treatment if necessary, and can be further subjected to desalination treatment, aseptic treatment, and freezing if necessary. Drying, etc. By this method, a uniform structure can be obtained (determined by NMR analysis -45- This paper size applies to China National Standard (CNS) A4 specifications (210 X 297 mm)

装 訂Binding

1243853 A7 B7 五、發明説明(43 ) 造)之本發明硫酸化葡糖醛酸化岩藻寡聚糖。 本發明之硫酸化葡糖醛酸化岩藻寡聚糖於分子中具有硫 酸基及羧墓,該基與各種鹼反應可形成鹽。本發明之硫酸 化葡糖醛酸化岩藻寡聚糖形成之鹽狀態安定,通常以鈉及/ 或鉀及/或鈣等鹽之形態被提供。此等物質之鹽,可利用陶 亦克斯(Dowex)50W等陽離子交換樹脂,導入游離之本發 明硫酸化葡糖醛酸化岩藻寡聚糖中。再者,彼等視需要可 進行已知之鹽交換法,以變換成各種期望之鹽。 本發明之硫酸化葡糖醛酸化岩藻寡聚糖之鹽,可使用醫 藥上容許之鹽,例如鈉及鉀等鹼金屬,鈣、鎂及鋅等鹼土 金屬以及銨等之鹽。 再者,本發明之硫酸化葡糖醛酸化岩藻寡聚糖可做爲糖 鏈工學用試藥使用。舉例而言,若藉由特公平5-65108號 公報記載之方法進行2-胺基吡啶化(PA化),及調整該寡聚 糖之P A -化物,則可做爲本發明之岩藻依聚糖脱乙醯酶、 以-D -葡糖甞酸酶及内-沒-L -岩藻糖苷酶之活性測定用基 質。依此方式,本發明之硫酸化葡糖醛酸化岩藻寡聚糖在 做爲糖鏈工學用試藥上爲極有用之物質。 本發明之岩藻依聚糖脱乙醯酶、α-D -葡糖甞酸酶及内-泛-L -岩藻糖甞酶,可被用於供硫酸化葡糖醛酸化岩藻聚 糖低分子化用之硫酸化葡糖醛酸化岩藻聚糖之構造解析。 再者,由於本發明之岩藻依聚糖脱乙醯酶、α-D -葡糖甞 酸酶及内-α-L-岩藻糖芬酶藉由反應液中有氣化納、蛋白 質及/或鈣離子共存,可提高安定性及反應速度,因而藉由 -46 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 .ΛΛ 、 五、發明説明( ) 此等硫酸化葡糖醛酸化岩藻聚糖分解酵素活性化因子之共 存,可有效率地進行上述之低分子化。再者,本發明之硫 酸化葡糖醛酸化岩藻寡聚糖、脱乙醯化硫酸化葡糖醛酸化 岩藻聚糖及脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸化岩藻 聚糖可被用做糖鏈工學用試藥,亦可被用做本發明之岩藻 依聚糖脱乙醯酶、π-D -葡糖甞酸酶及内- a- L-岩藻糖甞 酶之活性測定用基質。 實例 以下,將藉由實施例具體地説明本發明,然而本發明不 只限定於以下之實施例範圍。 ’ 參考例1 (1 )粗硫酸化葡糖醛酸化岩藻聚糖部份之調製 將市售之鹽腌沖繩海蘊藻625公克懸浮於4375毫升之30 mM磷酸鈉緩衝液(ρΗ6·0)中,藉由均質機進行8000迴轉/ 分鐘之5分鐘處理後,於9 5 °C處理1小時,藉由離心得到上 清液。於所得到之上清液中添加1 0公克之活性碳後攪摔3 0 分鐘,藉由離心得到上清液。將所得到之上清液藉由裝設 有排除分子量爲1 0萬之中空纖維之限外過濾機濃縮爲2公 升後,以20 mM氣化鈉置換溶媒,然後凍結乾燥,得到 10.9公克之粗硫酸化葡糖醛酸化岩藻聚糖部份之乾燥物。 (2 )硫酸化葡糖醛酸化岩藻聚糖分解活性測定方法 以本發明之岩藻依聚糖脱乙醯酶、α - D -葡糖:y:酸酶及 内-a - L -岩藻糖甞酶單獨地對硫酸化葡糖醛酸化岩藻聚糖 作用雖無法效率良好地生成寡聚糖,然而藉由組合可將硫 -47- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 B7 1 45~ 五、發明説明( ) 酸化葡糖醛酸化岩藻聚糖分解,效率良好地使其低分子 化。前述3種酵素共存下將硫酸化葡糖醛酸化岩藻聚糖分 解之活性·,稱爲「硫酸化葡糖醛酸化岩藻聚糖分解活 性」,其可藉由下列之活性測定方法數値化。 亦即,將1 0微升之1 %粗硫酸化葡糖醛酸化岩藻聚糖部份 溶液,52.5微升之50 mM咪唑鹽酸緩衝液(ρΗ6·6),5·5微 升之4Μ氣化鈉,2微升之1Μ氣化鈣及10微升之5毫克/毫 升牛血清白蛋白與20微升共存有本發明岩藻依聚糖脱乙醯 酶、“ -d -葡糖:y:酸酶及内-α - L -岩藻糖茹酶之酵素液混 合,並於30°C反應3小時後,將反應液於l〇〇°C處理1 0分 鐘,離心後以9 0微升進行HPLC分析,以測定低分子化之 程度。做爲對照者,係將共存有本發明岩藻依聚糖脱乙醯 酶、a - D -葡糖苷酸酶及内-a - L -岩藻糖甞酶之酵素液用 溶解該酵素液之緩衝液代替進行反應,粗硫酸化葡糖醛酸 化岩藻聚糖部份係使用水代替進行反應,同樣地進行HPLC 分析。所謂1個單位之硫酸化葡糖醛酸化岩藻聚糖分解活 性係指上述反應系統中1分鐘内將1微莫耳硫酸化葡糖醛酸 化岩、藻聚糖之岩藻糖基鍵結切斷之酵素量。切斷之岩藻糖 基鍵結之量可藉由下列公式求得。 數學式1 {(ΙΟχΙΟΟΟχ l/100)/MG}x{(MG/M)-l}x{ 1/(180x0.02)} =U/ml 1 0 x 1000 x 1/ 100 ··反應系中所添加之粗硫酸化葡糖醛酸化 岩藻聚糖部份(微克) M G :基質粗硫酸化葡糖醛酸化岩藻聚糖之平均分子量 -48- 本紙張尺度適用中國國家標準(CNS) Α4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(46 ) Μ:反應生成物之平均分子量 (MG/M)-1 : 1分子硫酸化葡糖醛酸化岩藻聚糖藉由酵素 切斷之部位數 180 ··反應時間(分鐘) 0.02 :酵素液量(毫升) 再者,HPLC之條件如下述。 裝置:L-6200型(曰立製作所製) 管柱:OHpak SB-806HQ(8 X 300 mm,昭和電工公司製) 溶離液:含有5 mM疊氮化鈉之50 mM氯化鈉 檢涓J :視差曲折率檢測器(Shodex RI-71,昭和電工公司 製)1243853 A7 B7 V. Description of the invention (made by (43)) The sulfated glucuronide fuco-oligosaccharide of the present invention. The sulfated glucuronidated fucoidan oligosaccharide of the present invention has a sulfuric acid group and a carboxymethyl group in the molecule, and the group reacts with various bases to form a salt. The salt state formed by the sulfated glucuronidation of fuco-oligosaccharides of the present invention is stable, and is usually provided in the form of salts such as sodium and / or potassium and / or calcium. The salts of these substances can be introduced into the free sulfonated glucuronidated fucoidan of the present invention using a cation exchange resin such as Dowex 50W. Furthermore, they can perform known salt exchange methods as needed to transform into various desired salts. As the salt of the sulfated glucuronidated fuco-oligosaccharide of the present invention, pharmaceutically acceptable salts such as alkali metals such as sodium and potassium, alkaline earth metals such as calcium, magnesium, and zinc, and ammonium salts can be used. Furthermore, the sulfated glucuronidated fucoidigosaccharides of the present invention can be used as a test reagent for sugar chain engineering. For example, if 2-aminopyridination (PA) is performed by the method described in Japanese Patent Publication No. 5-65108 and the PA-form of the oligosaccharide is adjusted, it can be used as the fucoidan of the present invention. A substrate for measuring the activity of glycan deacetylase, -D-glucosidase, and endo-me-L-fucosidase. In this way, the sulfated glucuronidated fuco-oligosaccharide of the present invention is extremely useful as a reagent for sugar chain engineering. The fucoidan deacetylase, α-D-glucosaccharase and endo-pan-L-fucosidase of the present invention can be used for sulfated glucuronidation of fucoidan. Structural analysis of sulfated glucuronidated fucoidan used for low molecularization. Furthermore, since the fucoidan deacetylase, α-D-glucosaminidase and endo-α-L-fucose fenase of the present invention have vaporized sodium, protein and Coexistence of calcium ions can improve stability and response speed. Therefore, -46-This paper size applies Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1243853 A7 B7. ΛΛ, V. Description of the invention ( ) The coexistence of these sulfated glucuronidated fucoidan decomposing enzyme activation factors can efficiently perform the above-mentioned low-molecularization. Furthermore, the sulfated glucuronidated fucoid oligosaccharide, deacetylated sulfated glucuronidated fucoidan, and deacetylated deglucuronidated sulfated glucuronidated fucoidan of the present invention Glycan can be used as a sugar chain engineering reagent, and can also be used as the fucoidan deacetylase, π-D-glucuronidase and endo-a-L-fucoid A substrate for measuring the activity of glycosidase. Examples Hereinafter, the present invention will be specifically described by way of examples. However, the present invention is not limited to the scope of the following examples. '' Reference Example 1 (1) Preparation of Crude Sulfated Glucuronidated Fucoidan Fraction 625 g of salted marine algae from Okinawa, suspended in 4375 ml of 30 mM sodium phosphate buffer (ρΗ6.0 ·) After 5 minutes of treatment at 8000 revolutions / minute with a homogenizer, the mixture was treated at 95 ° C for 1 hour, and the supernatant was obtained by centrifugation. 10 g of activated carbon was added to the obtained supernatant, and the mixture was stirred for 30 minutes, and the supernatant was obtained by centrifugation. The obtained supernatant was concentrated to 2 liters by means of an external filter equipped with a hollow fiber exclusion molecular weight of 100,000, and then the solvent was replaced with 20 mM sodium vaporization, and then freeze-dried to obtain a crude of 10.9 grams. Sulfate glucuronidation of dried fucoidan. (2) Method for determination of sulfated glucuronidation fucoidan decomposition activity The fucoidan deacetylase, α-D-glucose: y: acidase and endo-a-L-rock of the present invention Although fucosinase alone acts on sulfated glucuronidated fucoidan, although it cannot produce oligosaccharides efficiently, it can combine sulfur-47 by combining this paper. This paper standard is applicable to China National Standard (CNS) A4 specifications. (210 X 297 mm) 1243853 A7 B7 1 45 ~ V. Description of the invention () Acidified glucuronide fucose decomposes, making it low molecular efficiently. The activity of degrading sulfated glucuronidated fucans in the presence of the three enzymes mentioned above is called "sulfated glucuronidation fucoidan decomposition activity", which can be counted by the following activity measurement methods: Into. That is, 10 microliters of a 1% crude sulfated glucuronidated fucoidan solution, 52.5 microliters of 50 mM imidazole hydrochloride buffer (ρΗ6 · 6), and 5.5 microliters of 4M gas Sodium chloride, 2 microliters of 1M calcium carbonate and 10 microliters of 5 mg / ml bovine serum albumin and 20 microliters coexist with fucoidan deacetylase, "-d-glucose: y : The enzyme solution of acidase and endo-α-L-fucose enzyme was mixed and reacted at 30 ° C for 3 hours, and then the reaction solution was treated at 100 ° C for 10 minutes. HPLC analysis to determine the degree of low-molecularization. As a control, the fucoidan deacetylase, a-D-glucosidase and endo-a-L-rock of the present invention were coexisted. The enzyme solution of trehalase was replaced by a buffer solution to dissolve the enzyme solution, and the crude sulfated glucuronidated fucoidan was reacted by using water instead. The HPLC analysis was performed in the same way. The so-called 1 unit Sulfated glucuronide fucoidan decomposition activity refers to the fucosyl bond of 1 micromolar sulfated glucuronide rock and fucose in 1 minute in the above reaction system The amount of broken enzyme. The amount of fucosyl bond cut can be obtained by the following formula. Mathematical formula 1 {(ΙΟχΙΟΟΟχ l / 100) / MG} x {(MG / M) -l} x {1 /(180x0.02)} = U / ml 1 0 x 1000 x 1/100 ·· Crude sulfated glucuronidated fucoidan added in the reaction system (micrograms) MG: Matrix crude sulfated glucose The average molecular weight of uronic acid fucoidan-48- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 B7 V. Description of the invention (46) M: The average molecular weight of the reaction product ( MG / M) -1: 1 molecule of sulfated glucuronidated fucoidan is cut by enzymes 180 ··· reaction time (minutes) 0.02: amount of enzyme solution (ml) Furthermore, the conditions of HPLC are as follows Device: Model L-6200 (manufactured by Yori Manufacturing Co., Ltd.) Column: OHpak SB-806HQ (8 X 300 mm, manufactured by Showa Denko Corporation) Eluent: 50 mM sodium chloride containing 5 mM sodium azide J: Parallax tortuosity detector (Shodex RI-71, manufactured by Showa Denko Corporation)

流速:1毫升/分鐘 管柱溫度:25°C 爲測定反應生成物之平均分子量,將市售已知分子量之 出芽短梗孢糖(Pullulan) (STANDARD P-82,昭和電工公司 製)藉由上述HPLC分析之相同條件分析,將出芽短梗孢糖 之分子量與保持時間之關係以曲線表示,做爲供上述反應 生成物之分子量測定用之標準曲線。再者,蛋白質之定量 係藉由測定酵素液之280 nm吸光度而進行。此時係以1毫 克/毫升之蛋白質溶液之吸光度當作1.0計算。 實例1 將岩藻依聚糖分解嗜岩藻菌SI - 1234菌株接種於培養基 上,該培養基係將含有以參考例1 ( 1)之方法調製之來自沖 繩海蘊藻粗硫酸化葡糖醛酸化岩藻聚糖部份0.2 %及蛋白腺 -49- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 47 五、發明説明( 1%之人工海水(ρΗ8·0)(加馬林拉勃拉翠公司製)組成之培 養基50毫升於120°C經20分鐘熱壓器處理而得。接種後, 於2 4 °C培養7 2小時做爲菌種培養液。將含有以參考例丨(^ ) 之方法調製之來自沖繩海蘊藻之粗硫酸化葡糖醛酸化岩藻 聚糖部份0.2 %、蛋白腺1 %及消泡劑(KM70,信越化學工 業公司製)之人工海水所組成之PH8.0培養基600毫升加入2 公升之三角燒瓶中,於115。(:經10分鐘熱壓器處理而得培 養基,如此製備7瓶,將上述菌種培養液在每個三角燒瓶 接種5毫升,於每分鐘90迴轉之迴轉速度下,在24t培養 7 2小時。培養終了後,將培養液離心,得到菌體及培養上 清液。 裝 訂 將所得到之菌體懸浮於250毫升之含有1〇〇 mM氣化鈉及 10mM氣化鈣之i〇mM咪唑-鹽酸緩衝液(pH7〇)中,以超 音波破碎後’離心,得到上清液。將所得到之上清液藉由 相同之緩衝液充分透析,離心,將上清液做爲粗酵素液。 將所得到之粗酵素液饋入以相同緩衝液平衡化之3 00毫升 DEAE-赛璐玢A_800管柱中,用相同緩衝液洗淨後,用1〇〇 mM至400 mM之氣化鈉梯度溶析,收集活性溶出部份。以 此種方式得到部份精製酵素液。再者,測定被包含於上述 培養上清液與粗酵素液中之「硫酸化葡糖醛酸化岩藻聚糖 刀解活性j ,結果可確認在任一者中均有活性,於菌體萃 取液中,每1毫升培養基檢測出〇 4 mlJ之活性。 實例2 (1 )使實例1記載之粗酵素液作用於參考例丨(丨)記載之粗 -50- 1243853 A7 _ B7 五、發明説明(48~Γ ' 硫酸化葡糖醛酸化岩藻聚糖部份,以調製本發明之硫酸化 葡糖醛酸化岩藻寡聚糖。亦即,將5公克之粗硫酸化葡糖 醛酸化岩藻聚糖部份溶解於1公升之含有25〇 氯化納及 20 mM氣化鈣之10 mM咪唑-鹽酸緩衝液(pH6.6)中後,添 加35 mU之實例1記載之粗酵素液,使其於3 〇 t反應6日。 將反應液離心,所得到之上清液使用裝設有排除分子量爲 1萬之中芝纖維之限外過遽機處理,回收分子量1萬以下之 寡聚糖部份,做爲硫酸化葡糖醛酸化岩藻聚耱酵素消化物 部份1。 (2 )實例2 ( 1)所得到之硫酸化葡糖醛酸化岩藻聚糖酵素消 化物部份1藉由脱鹽裝置(微阿西來札-G3,旭化成工業公 司製)脱鹽。於脱鹽之硫酸化葡糖醛酸化岩藻聚糖酵素消化 物邵份1中,添加咪唑並使其濃度爲5 m Μ以及添加氣化鈉 並使其濃度爲20 mM,將該混合物饋入預先以含有20 mM 氣化鈉之5 mM咪唑-鹽酸緩衝液(pH 7· 0)平衡化之1公升 DEAE -赛璐玢A - 8 0 0管柱中,用相同緩衝液洗淨後,藉由 20 mM至600 mM之氣化鈉梯度溶析。被溶出之部份,其總 糖量藉由g分-硫酸法測定,總糖趁酸量藉由味峻-硫酸法測 定。其結果,溶出之部份中至少8個有明顯之尖峰存在, 將各個尖峰部份集合,做爲寡聚糖i _ (丨)〜(8 ),分別將其 藉由蒸發器濃縮爲40毫升後,饋入預先以1〇%乙醇平衡化 之赛路玲GCL-25管柱中,然後以10%乙醇溶析及脱鹽。 由此可得到本發明之硫酸化葡糖醛酸化岩藻寡聚糖1-(丨)〜 (8),亦即寡聚糖1-(1)〜(8)。 -51 - 本紙張尺度適财g g家標準(CNS) A4規格(2脳297公爱) 1243853 A7 _____ B7 五、發明説明(49 ) (3)對於實例2(2)得到之寡聚糖卜(1)〜(8),藉由使用2-胺基吨淀之螢光標識法進行還原末端糖及糖組成之分析, 再者’使用UFC測定試藥Takara(寶酒公司造)進行岩藻糖 絕對配置之決定時,發現寡聚糖1_(1)〜(8)之還原性末端 糖全邵爲L -岩藻糖。再者,關於糖組成,寡聚糖I·(丨)爲 只由岩藻糖形成,寡聚糖1-(2)〜(8)爲由岩藻糖與葡糖醛 酸所形成。繼而,測定硫酸含量(藉由使用氯化鋇之比濁法) 及糖路酸含量(藉由咔唑-硫酸法),且藉由質量分析裝置 (API-III,帕金艾瑪-赛克斯公司製)分析質量。再者,使 用JNM_ α500型核磁共振裝置(日本電子公司製)進行nmR 分析。將分析試料藉由固定方法以重水置換後進行構造解 析。構成糖之結合方式,係使用Η Μ B C法(一種1 Η -檢測異 種核檢測法)而進行。1H-NMR之歸屬係使用dqf-COSY法 及ΗΟΗΑΗΑ法,13C-NMR之歸屬係使用HSQC法。以下, 表示寡聚糖1-(1)〜(8)之物性。 (a)寡聚糖1-(1)之物性 質量分析及NMR分析之結果如以下所示,本發明之硫酸 化葡糖趁酸化岩藻寡聚糖1-(1)之- NMR光譜如圖7所 示’ 13 C- NMR光譜如圖8所示,質譜如圖9所示。圖7與圖 8中縱轴表示訊號之強度,橫軸表示化學位移値(ppm)。再 者’圖9中縱軸表示相對強度(〇/〇),橫軸表示m/z値。 分子量·· 762 MS m/z 380.2[M-2H + ]2· 藉由1Η-NMR及13C_NMR分析之結果如表!所示。 -52· 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7Flow rate: 1 ml / min. Column temperature: 25 ° C. In order to measure the average molecular weight of the reaction product, a commercially available pullulan (Pullulan) (STANDARD P-82, manufactured by Showa Denko Corporation) with a known molecular weight was used. In the same condition analysis of the above HPLC analysis, the relationship between the molecular weight and the retention time of the budding spore sugar was expressed as a curve, and it was used as a standard curve for measuring the molecular weight of the reaction product. The protein was quantified by measuring the absorbance at 280 nm of the enzyme solution. In this case, the absorbance of the protein solution at 1 mg / ml was taken as 1.0. Example 1 Fucoidan-degrading Fucoidophile SI-1234 strain was inoculated on a culture medium containing acidified crude sulfated glucuronide from algae from Okinawa, prepared in accordance with the method of Reference Example 1 (1). Fucoidan part 0.2% and protein gland-49- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 B7 47 V. Description of the invention (1% artificial seawater (ρΗ8 · 0 ) (Manufactured by Gamarinly Labradure), 50 ml of the culture medium was prepared at 120 ° C by a 20-minute autoclave. After inoculation, it was cultured at 24 ° C for 7 2 hours as the culture broth. Contains 0.2% of crude sulfated glucuronidated fucoidan from algae in Okinawa, prepared by the method of Reference Example 丨 (^), 1% of protein glands, and an antifoaming agent (KM70, Shin-Etsu Chemical Industry Co., Ltd. 600 ml of pH 8.0 culture medium made of artificial seawater was added to a 2-liter Erlenmeyer flask at 115. (: 10-minute autoclave treatment to obtain the culture medium, 7 bottles were prepared in this way, Inoculate 5 ml per Erlenmeyer flask, at a rotation speed of 90 revolutions per minute, Incubate at 24t for 72 hours. After the end of the culture, the culture solution is centrifuged to obtain the bacterial cells and the culture supernatant. Binding The obtained bacterial cells are suspended in 250 ml of 100 mM sodium vaporized and 10 mM calcium vaporized In 10 mM imidazole-hydrochloric acid buffer solution (pH 70), the solution was centrifuged to obtain a supernatant after ultrasonic disruption. The obtained supernatant was fully dialyzed with the same buffer solution, centrifuged, and the supernatant was processed. It is a crude enzyme solution. The obtained crude enzyme solution is fed into a 300 ml DEAE-cellulose A_800 column equilibrated with the same buffer solution, washed with the same buffer solution, and then washed with 100 mM to 400 mM. Gaseous sodium lysate was used for gradient elution, and the active dissolution fraction was collected. In this way, a part of the purified enzyme solution was obtained. Furthermore, the "sulfated glucuronidation" contained in the above culture supernatant and crude enzyme solution was measured. The fucoidan activity j was confirmed to be active in any of them, and the activity of 0.4 mlJ was detected per 1 ml of the culture medium in the bacterial cell extract. Example 2 (1) The crude value described in Example 1 The enzyme solution acts on the crude -50- 1243853 A7 described in Reference Example 丨 (丨) _ B7 V. Description of the invention (48 ~ Γ 'Sulfated glucuronidated fucoidan to prepare the sulfated glucuronidated fuctooligosaccharide of the present invention. That is, 5 g of crude sulfuric acid The glucuronidated fucoidan was partially dissolved in 1 liter of 10 mM imidazole-hydrochloric acid buffer (pH 6.6) containing 25 ° C sodium chloride and 20 mM calcium carbonate, and then added 35 mU of Example 1 The crude enzyme solution described was allowed to react at 30t for 6 days. The reaction solution was centrifuged, and the resulting supernatant was treated with an external machine equipped with an exclusion limit equipped with a medium molecular weight of 10,000, and the molecular weight was recovered. The oligosaccharide part below 10,000 is used as the sulfated glucuronidated fucolytic enzyme digestion part1. (2) Example 2 (1) The obtained sulfated glucuronidated fucoidan enzyme digestion part 1 was desalted by a desalination apparatus (Micro-Asilaza-G3, manufactured by Asahi Kasei Corporation). In desalted sulfated glucuronide fucoidanase digestion Shao 1, imidazole was added to a concentration of 5 μM and sodium gasification was added to a concentration of 20 mM. The mixture was fed into Equilibrate 1 liter of DEAE-Cellulose A-8 0 0 column with 5 mM imidazole-hydrochloric acid buffer solution (pH 7.0) containing 20 mM sodium vaporization, wash with the same buffer, and borrow Gradient dissolution from 20 mM to 600 mM sodium vaporization. The total sugar content of the eluted portion was measured by the g-sulfuric acid method, and the total sugar content was measured by the Weijun-sulfuric acid method. As a result, at least 8 of the eluted fractions had obvious peaks, and the peaks were collected as oligosaccharides i_ (丨) ~ (8), which were respectively concentrated to 40 ml by an evaporator. After that, it was fed into a celluloid GCL-25 column preliminarily equilibrated with 10% ethanol, and then eluted and desalted with 10% ethanol. Thereby, the sulfated glucuronidated fucoidan oligosaccharides 1- (丨) ~ (8) of the present invention can be obtained, that is, oligosaccharides 1- (1) ~ (8). -51-Standards for this paper: Standards for Financial Standards (CNS) A4 (2 脳 297 public love) 1243853 A7 _____ B7 V. Description of the invention (49) (3) For the oligosaccharide obtained from Example 2 (2) ( 1) ~ (8), analysis of reducing terminal sugar and sugar composition by fluorescent labeling method using 2-aminotitanium, and fucose using UFC measurement reagent Takara (manufactured by Takara Shuzo) When determining the absolute configuration, it was found that the reducing terminal sugars of oligosaccharides 1_ (1) to (8) were L-fucose. Regarding sugar composition, oligosaccharides I · (丨) are formed only from fucose, and oligosaccharides 1- (2) to (8) are formed from fucose and glucuronic acid. Then, the sulfuric acid content (by the turbidimetric method using barium chloride) and the gluconic acid content (by the carbazole-sulfuric acid method) were measured, and the mass analysis device (API-III, Parkin Emma-Sec Company's) analysis quality. Furthermore, nmR analysis was performed using a JNM_α500 nuclear magnetic resonance apparatus (manufactured by Japan Electronics Corporation). The analysis sample was replaced with heavy water by a fixed method, and then the structure was analyzed. The method of combining sugars is performed using the Μ BM B C method (a 1 Η-detection of heteronuclear detection method). 1H-NMR is assigned using the dqf-COSY method and ΗΟΗΑΗΑ method, and 13C-NMR is assigned using the HSQC method. The physical properties of oligosaccharides 1- (1) to (8) are shown below. (a) The physical property quality analysis and NMR analysis results of oligosaccharide 1- (1) are shown below. The NMR spectrum of the sulfated glucose of the present invention while acidifying fucoidan 1- (1) is shown in FIG. The '13 C-NMR spectrum shown in 7 is shown in FIG. 8, and the mass spectrum is shown in FIG. 9. In Figs. 7 and 8, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In Fig. 9, the vertical axis represents the relative intensity (0 / 〇), and the horizontal axis represents m / z 値. Molecular weight · 762 MS m / z 380.2 [M-2H +] 2 · The results of analysis by 1NMR-NMR and 13C_NMR are shown in the table! As shown. -52 · This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7

五、發明説明(5Q 表1 化學位移値(ppm) 13c-nmr 'HNMR 化學位移値、多重度、結合常數 F1-1 97.0 4.48, d, 7.6 F1-2 70.8 3.44, dd, 7.6, 10.1 F1-3 78.4 3.59, dd, 3.7, 10.1 F1-4 68.6 3.86, d, 3.7 F1-5 71.4 3.66, q, 6.8 F1-6 16.5 1.13, d, 6.8 F2-1 96.5 4.98, d,4.0 F2-2 67.5 3.85, dd,4.0, 10.4 F2-3 77.5 3.98, dd, 3.1, 10.4 F2-4 80.5 4.65, d, 3.1 F2-5 67.2 4.30, q,6.8 F2-6 16.5 1.13, d, 6.8 F3-1 99.9 4.99, d, 4.0 F3-2 68.0 3.72, dd, 4.0, 10.6 F3-3 76.1 3.90, dd,3.0, 10.6 F3-4 80.3 4.65, d, 3.0 F3-5 67.4 4.34, q, 6.7 F3-6 16.5 1.11, d, 6.7 F4-1 98.4 4.97, d, 4.0 F4-2 69.3 3.59, dd,4.0, 10.4 F4-3 70.8 3.76, dd, 3.4, 10.4 F4-4 72.8 3.68, d? 3.4 F4-5 68.0 4.21, q, 6.7 F4-6 16.0 1.09, d, 6.7 糖組成只有L -岩藻糖(4分子) -53- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 51 为 1 X Ο ΟV. Description of the invention (5Q Table 1 Chemical shift 値 (ppm) 13c-nmr 'HNMR Chemical shift 値, multiplicity, binding constant F1-1 97.0 4.48, d, 7.6 F1-2 70.8 3.44, dd, 7.6, 10.1 F1- 3 78.4 3.59, dd, 3.7, 10.1 F1-4 68.6 3.86, d, 3.7 F1-5 71.4 3.66, q, 6.8 F1-6 16.5 1.13, d, 6.8 F2-1 96.5 4.98, d, 4.0 F2-2 67.5 3.85 , dd, 4.0, 10.4 F2-3 77.5 3.98, dd, 3.1, 10.4 F2-4 80.5 4.65, d, 3.1 F2-5 67.2 4.30, q, 6.8 F2-6 16.5 1.13, d, 6.8 F3-1 99.9 4.99, d, 4.0 F3-2 68.0 3.72, dd, 4.0, 10.6 F3-3 76.1 3.90, dd, 3.0, 10.6 F3-4 80.3 4.65, d, 3.0 F3-5 67.4 4.34, q, 6.7 F3-6 16.5 1.11, d , 6.7 F4-1 98.4 4.97, d, 4.0 F4-2 69.3 3.59, dd, 4.0, 10.4 F4-3 70.8 3.76, dd, 3.4, 10.4 F4-4 72.8 3.68, d? 3.4 F4-5 68.0 4.21, q, 6.7 F4-6 16.0 1.09, d, 6.7 The sugar composition is only L-fucose (4 molecules) -53- This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) 1243853 51 is 1 X Ο Ο

X 〔IV〕 A7 B7 五、發明説明( 硫酸基2分子 再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式 (IV)所示。 〇 -=X 〔IV〕 A7 B7 V. Description of the invention (sulfate group 2 molecules In addition, the numbers of the peak assignments in iH-NMR and 13C-NMR are shown by the following formula (IV). 〇-=

SrSr

-54- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐)-54- This paper size applies to Chinese National Standard (CNS) A4 (210 x 297 mm)

1243853 A7 B7 五、發明説明(52 ) (b)寡聚糖1-(2)之物性 質量分析之結果如以下所示,本發明之硫酸化葡糖醛酸 化岩藻寡聚糖1-(2)之質譜如圖10所示。圖10中縱軸表示 相對強度(%),以及橫軸表示m/z値。 分子量:1456 MS m/z 484.6[M-3H+]3' 糖組成L-岩藻糖:D-葡糖醛酸=7 : 1 硫酸基3分子 (c )寡聚糖1 - ( 3 )之物性 質量分析及NMR分析歸屬之結果如以下所示,本發明之 硫酸化葡糖醛酸化岩藻寡聚糖1 - ( 3 )之1 Η - NMR光譜如圖 1 1所示,13 C-NMR光譜如圖1 2所示,質譜如圖1 3所示。 圖11與圖12中縱軸表示訊號之強度,橫軸表示化學位移値 (ppm)。再者,圖13中縱軸表示相對強度(%),橫軸表示 m / z 値 0 分子量:1682 MS m/z 873.4[M+3Na+-5H+]2·、862.4[M+2Na+-4H+]2 、 574.4[M+2Na+-5H+]3·、567.2[M+Na+-4H+]3-、425·2 [M+ Na+-5H+]4-、419.8[M-4H+]4·、 藉由1H-NMR及13C-NMR分析結果如表2所示。 -55- 本紙張尺度適用中國國家標準(CNS) A4規格(210x 297公釐) 1243853 A7 B7 五、發明説明( 表2 化學位移値(ppm) 13c_nmr lH-NMR 化學位移値、多重度、結合常數 F1-1 97.1 4.47, d, 7.9 F1-2 70.9 3.44, dd,7.9, 10.1 F1-3 78.6 3.57, dd, 3.2, 10.1 F1-4 68.7 3.85, d, 3.2 F1-5 71.5 3.65, q, 6.7 F1-6 16.6 1.13, d, 6.7 F2-1 96.6 4.98, d,4.0 F2-2 67.6 3.86, dd, 4.0, 8.6 F2-3 77.6 3.97, dd, 2.9, 8.6 F2-4 80.6 4.65, d, 2.9 F2-5 67.4 4.29, q, 6.7 F2-6 16.7 1.11,d,6.7 F3-1 100.1 4.99, d, 4.0 F3-2 68.1 3.74, dd, 4.0, 10.4 F3-3 77.4 3.89, dd,2.8, 10.4 F3-4 80.6 4.62, d, 2.8 F3-5 67.4 4.33 q, 6.7 F3-6 16.6 1.12, d, 6.7 F4-1 99.6 4.95, d,4.0 F4-2 67.7 3.72, dd, 4.0, 10.4 F4-3 74.8 3.86, dd,3.1,10.4 F4-4 69.1 3.95, d, 3.1 F4-5 68.1 4.22, q, 6.8 F4-6 16.2 1.09, d, 6.8 F5-1 95.1 5.00, d, 4.0 -56- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 表2 (續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F5-2 71.4 4.04, dd,4.0, 10.4 F5-3 73.7 4.19, dd,2.8, 10.4 F5-4 68.1 4.00, d,2.8 F5-5 67.4 4.20 q, 6.7 F5-6 16.2 1.11, d, 6.7 F6-1 94.3 5.08, d,4.0 F6-2 67.4 3.89, dd, 4.0, 10.4 F6-3 76.5 3.99, dd,, 10.4 F6-4 80.3 4.58, d, 2.4 F6-5 67.8 4.37, q, 6.7 F6-6 16.7 1.12, d, 6.7 F7-1 99.1 4.99, d, 4.0 F7-2 68.1 3.74, dd, 4.0, 10.4 F7-3 76.4 3.91,dd,3.0, 10.4 F7-4 80.2 4.64, d,3.0 F7_5 67.4 4.37, q,6.7 F7-6 16.7 1.12, d, 6.7 F8-1 98.7 4.96, d,4.0 F8-2 69.4 3.57, dd, 4.0, 10.1 F8-3 70.9 3.76, dd, 3.0, 10.1 F8-4 73.0 3.66, d,3.0 F8-5 68.1 4.23, q, 6.7 F8-6 16.1 1.07, d, 6.7 GA-1 100.4 5.16, d, 4.0 GA-2 72.1 3.48, dd, 4.0, 9.8 -57- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(55 表2(續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 GA-3 74.0 3.59, t, 9.8 GA-4 72.7 3.36, t,9.8 GA-5 73.7 3.81, d, 9.8 GA-6 177.3 糖組成L -岩藻糖·· D -葡糖醛酸=8 ·· 1 硫酸基4分子 再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式(V) 所示。 -58- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 56 〔V〕 GA 11243853 A7 B7 V. Description of the invention (52) (b) The results of the physical quality analysis of oligosaccharides 1- (2) are shown below. The sulfated glucuronide-fucose oligosaccharides 1- (2) The mass spectrum of) is shown in Fig. 10. In Fig. 10, the vertical axis indicates the relative intensity (%), and the horizontal axis indicates m / z 値. Molecular weight: 1456 MS m / z 484.6 [M-3H +] 3 'sugar composition L-fucose: D-glucuronic acid = 7: 1 sulfate group 3 molecules (c) oligosaccharide 1-(3) physical properties The results of mass analysis and NMR analysis are shown below. The sulfated glucuronidated fuctooligosaccharide 1-(3) 1 Η-NMR spectrum of the present invention is shown in Figure 11 and 13 C-NMR spectrum As shown in Figure 12, the mass spectrum is shown in Figure 13. In FIGS. 11 and 12, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In FIG. 13, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値 0 Molecular weight: 1682 MS m / z 873.4 [M + 3Na + -5H +] 2 ·, 862.4 [M + 2Na + -4H +] 2 , 574.4 [M + 2Na + -5H +] 3, 567.2 [M + Na + -4H +] 3-, 425.2 [M + Na + -5H +] 4-, 419.8 [M-4H +] 4 ·, by 1H-NMR and 13C-NMR analysis results are shown in Table 2. -55- This paper size is in accordance with Chinese National Standard (CNS) A4 (210x 297 mm) 1243853 A7 B7 V. Description of the invention (Table 2 Chemical shift 値 (ppm) 13c_nmr lH-NMR Chemical shift 値, multiplicity, binding constant F1-1 97.1 4.47, d, 7.9 F1-2 70.9 3.44, dd, 7.9, 10.1 F1-3 78.6 3.57, dd, 3.2, 10.1 F1-4 68.7 3.85, d, 3.2 F1-5 71.5 3.65, q, 6.7 F1 -6 16.6 1.13, d, 6.7 F2-1 96.6 4.98, d, 4.0 F2-2 67.6 3.86, dd, 4.0, 8.6 F2-3 77.6 3.97, dd, 2.9, 8.6 F2-4 80.6 4.65, d, 2.9 F2- 5 67.4 4.29, q, 6.7 F2-6 16.7 1.11, d, 6.7 F3-1 100.1 4.99, d, 4.0 F3-2 68.1 3.74, dd, 4.0, 10.4 F3-3 77.4 3.89, dd, 2.8, 10.4 F3-4 80.6 4.62, d, 2.8 F3-5 67.4 4.33 q, 6.7 F3-6 16.6 1.12, d, 6.7 F4-1 99.6 4.95, d, 4.0 F4-2 67.7 3.72, dd, 4.0, 10.4 F4-3 74.8 3.86, dd , 3.1, 10.4 F4-4 69.1 3.95, d, 3.1 F4-5 68.1 4.22, q, 6.8 F4-6 16.2 1.09, d, 6.8 F5-1 95.1 5.00, d, 4.0 -56- This paper size applies to Chinese national standards (CNS) A4 size (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (Table 2 (continued) Chemical shift 値(ppm) 13c-nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F5-2 71.4 4.04, dd, 4.0, 10.4 F5-3 73.7 4.19, dd, 2.8, 10.4 F5-4 68.1 4.00, d, 2.8 F5 -5 67.4 4.20 q, 6.7 F5-6 16.2 1.11, d, 6.7 F6-1 94.3 5.08, d, 4.0 F6-2 67.4 3.89, dd, 4.0, 10.4 F6-3 76.5 3.99, dd ,, 10.4 F6-4 80.3 4.58, d, 2.4 F6-5 67.8 4.37, q, 6.7 F6-6 16.7 1.12, d, 6.7 F7-1 99.1 4.99, d, 4.0 F7-2 68.1 3.74, dd, 4.0, 10.4 F7-3 76.4 3.91, dd , 3.0, 10.4 F7-4 80.2 4.64, d, 3.0 F7_5 67.4 4.37, q, 6.7 F7-6 16.7 1.12, d, 6.7 F8-1 98.7 4.96, d, 4.0 F8-2 69.4 3.57, dd, 4.0, 10.1 F8 -3 70.9 3.76, dd, 3.0, 10.1 F8-4 73.0 3.66, d, 3.0 F8-5 68.1 4.23, q, 6.7 F8-6 16.1 1.07, d, 6.7 GA-1 100.4 5.16, d, 4.0 GA-2 72.1 3.48, dd, 4.0, 9.8 -57- This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (55 Table 2 (continued) Chemical shift 値 (ppm) 13c -nmr ^ -NMR Chemical shift 値, multiplicity, binding constant GA-3 74.0 3.59, t, 9.8 GA-4 72.7 3.36, t, 9.8 GA-5 73.7 3 .81, d, 9.8 GA-6 177.3 Sugar composition L-fucose ·· D-glucuronic acid = 8 ·· 1 sulfate group 4 molecules Furthermore, the numbers of the peak assignments in iH-NMR and 13C-NMR are as follows Equation (V) is shown. -58- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (56 〔V] GA 1

Η c F 7 F6 F 5 ΗΗ c F 7 F6 F 5 Η

S 匀1 U *S even 1 U *

OH -59-本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853 A7 B7 五、發明説明( ) (d)寡聚糖1-(4)之物性 質量分析之結果如以下所示,本發明之硫酸化葡糖醛酸 化岩藻寡聚:糖1-(4)之質譜如圖14所示。圖14中縱軸表示 相對強度(%),橫轴表示m/z値。 分子量:2376 MS m/z 598.8[M+Na + -5H + ]4-、474.6[M-5H+]5· 糖組成L·岩藻糖:D_葡糖醛酸=11 : 2 硫酸基5分子 (e )寡聚糖1 - ( 5 )之物性 質量分析之結果如以下所示,本發明之硫酸化葡糖醛酸 化岩藻寡聚糖1-(5)之1H-NMR光譜如圖15所示,13C-NMR光譜如圖16所示,質譜如圖17所示。圖15與圖16中 縱轴表示訊號之強度,橫轴表示化學位移値(ppm )。再 者,圖17中縱軸表示相對強度(%),橫軸表示m/z値。 分子量:2602 MS m/z 666.4[M+3Na+-7H+广、661.0[M+2Na+-6H+]4&quot;、 524.0[M+Na+-6H+]5-、433·0[Μ-6Η+]6-、 藉由1H-NMR及13C-NMR分析結果如表3所示。 -60- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(58 ) 表3 化學位移値(ppm) 13c-nmr iH-NMR 化學位移値、多重度、結合常數 F1-1 96.8 4.48, d, 8.0 F1-2 70.6 3.45, dd, 8.0, 9.5 F1-3 78.3 3.58, m F1-4 68.3 3.85,m F1-5 71.2 3.66, q, 6.7 F1-6 16.2 1.14, d, 6.7 F2-1 96.3 4.99, d, 4.0 F2-2 67.4 3.86, m F2-3 77.1 3.98, m F2-4 80.2 4.65, m F2-5 67.0 4.30, q, 6.7 F2-6 16.3 1.10, d, 6.7 F3-1 99.7 5.00, d, 4.0 F3-2 67.8 3.75, m F3-3 77.0 3.90, m F3-4 80.2 4.63, m F3-5 67.4 4.34, q, 6.7 F3-6 16.3 1.13, d, 6.7 F4_l 99.2 4.96, d, 4.0 F4-2 67.4 3.73, m F4-3 74.5 3.86, m F4-4 68.7 3.96, m F4-5 67.8 4.22, q, 6.7 F4-6 15.8 1.10, d, 6.7 F5-1 94.7 5.01, d, 4.0 -61 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 表3(續) 化學位移値(ppm) 13c-nmr b-NMR 化學位移値、多重度、結合常數 F5-2 71.1 4.05, dd,4.0, 10.0 F5-3 73.4 4.20, m F5-4 67.8 4.01, m F5-5 67.0 4.21, q, 6.7 F5-6 15.8 1.12, d, 6.7 F6-1 94.0 5.09, d, 4.0 F6-2 67.0 3.90, m F6-3 76.2 3.99, m F6-4 79.9 4.60, m F6-5 67.4 4.38, q, 6.7 F6-6 16.4 1.13, d, 6.7 F7-1 98.7 5.00, d,4.0 F7-2 67.8 3.75, m F7-3 76.0 3.91, m F7-4 79.8 4.65,m F7-5 67.4 4.38, q, 6.7 F7-6 16.4 1.13, d, 6.7 F8-1 99.2 4.96, d, 4.0 F8-2 67.4 3.73,m F8-3 74.5 3.86, m F8-4 68.7 3.96, m F8-5 67.8 4.22, q, 6.7 F8-6 15.8 1.10, d, 6.7 F9-1 94.7 5.01, d? 4.0 F9-2 71.1 4.05, dd, 4.0, 10.0 -62- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 表3 (續) 化學位移値(ppm) 13c_nmr ^-NMR 化學位移値、多重度、結合常數 F9-3 73.4 4.20, m F9-4 67.8 4.01, m F9-5 67.0 4.21, q, 6.7 F9-6 15.8 1.12, d, 6.7 F10-1 94.0 5.09, d, 4.0 F10-2 67.0 3.90, m F10-3 76.2 3.99, m F10-4 79.9 4.60, m F10-5 67.4 4.38, q, 6.7 F10-6 16.4 1.13, d, 6.7 F11-1 98.7 5.00, d, 4.0 F11-2 67.8 3.75, m F11-3 76.0 3.91, m F11-4 79.8 4.65, m F11-5 67.4 4.38, q, 6.7 F11-6 16.4 1.13, d, 6.7 F12-1 98.3 4.96, d, 4.0 F12-2 69.1 3.58, m F12-3 70.5 3.77, m F12-4 72.6 3.67, d, 4.0 F12-5 67.8 4.23, q, 6.7 F12-6 15.8 1.08, d,6.7 GA1-1 100.0 5.16, d, 4.0 GA1-2 71.8 3.49, dd, 4.0, 10.0 GA1-3 73.6 3.60, t, 10.0 裝 訂OH -59- This paper size applies Chinese National Standard (CNS) A4 specification (210 x 297 mm) 1243853 A7 B7 V. Description of the invention () (d) Oligosaccharide 1- (4) The results of physical property quality analysis are as follows As shown below, the mass spectrum of the sulfated glucuronidated fucoid: oligosaccharide 1- (4) of the present invention is shown in FIG. 14. In Fig. 14, the vertical axis represents the relative intensity (%), and the horizontal axis represents m / z 値. Molecular weight: 2376 MS m / z 598.8 [M + Na + -5H +] 4-, 474.6 [M-5H +] 5 · Sugar composition L · Fucose: D_glucuronic acid = 11: 2 sulfate group 5 molecules (e) The results of the physical property quality analysis of oligosaccharides 1-(5) are shown below. The 1H-NMR spectrum of the sulfated glucuronidated fucoidan 1- (5) of the present invention is shown in Fig. 15 The 13C-NMR spectrum is shown in FIG. 16 and the mass spectrum is shown in FIG. 17. In Fig. 15 and Fig. 16, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In Fig. 17, the vertical axis represents the relative intensity (%), and the horizontal axis represents m / z 値. Molecular weight: 2602 MS m / z 666.4 [M + 3Na + -7H + wide, 661.0 [M + 2Na + -6H +] 4 &quot;, 524.0 [M + Na + -6H +] 5-, 433 · 0 [Μ-6Η +] 6-, The analysis results by 1H-NMR and 13C-NMR are shown in Table 3. -60- This paper scale is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (58) Table 3 Chemical shift 値 (ppm) 13c-nmr iH-NMR chemical shift 値, Multiplicity, binding constant F1-1 96.8 4.48, d, 8.0 F1-2 70.6 3.45, dd, 8.0, 9.5 F1-3 78.3 3.58, m F1-4 68.3 3.85, m F1-5 71.2 3.66, q, 6.7 F1- 6 16.2 1.14, d, 6.7 F2-1 96.3 4.99, d, 4.0 F2-2 67.4 3.86, m F2-3 77.1 3.98, m F2-4 80.2 4.65, m F2-5 67.0 4.30, q, 6.7 F2-6 16.3 1.10, d, 6.7 F3-1 99.7 5.00, d, 4.0 F3-2 67.8 3.75, m F3-3 77.0 3.90, m F3-4 80.2 4.63, m F3-5 67.4 4.34, q, 6.7 F3-6 16.3 1.13, d, 6.7 F4_l 99.2 4.96, d, 4.0 F4-2 67.4 3.73, m F4-3 74.5 3.86, m F4-4 68.7 3.96, m F4-5 67.8 4.22, q, 6.7 F4-6 15.8 1.10, d, 6.7 F5 -1 94.7 5.01, d, 4.0 -61-This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (Table 3 (continued) Chemical shift 値 (ppm) 13c -nmr b-NMR Chemical shift 値, multiplicity, binding constant F5-2 71.1 4.05, dd, 4.0, 10.0 F5-3 73. 4 4.20, m F5-4 67.8 4.01, m F5-5 67.0 4.21, q, 6.7 F5-6 15.8 1.12, d, 6.7 F6-1 94.0 5.09, d, 4.0 F6-2 67.0 3.90, m F6-3 76.2 3.99 , m F6-4 79.9 4.60, m F6-5 67.4 4.38, q, 6.7 F6-6 16.4 1.13, d, 6.7 F7-1 98.7 5.00, d, 4.0 F7-2 67.8 3.75, m F7-3 76.0 3.91, m F7-4 79.8 4.65, m F7-5 67.4 4.38, q, 6.7 F7-6 16.4 1.13, d, 6.7 F8-1 99.2 4.96, d, 4.0 F8-2 67.4 3.73, m F8-3 74.5 3.86, m F8- 4 68.7 3.96, m F8-5 67.8 4.22, q, 6.7 F8-6 15.8 1.10, d, 6.7 F9-1 94.7 5.01, d? 4.0 F9-2 71.1 4.05, dd, 4.0, 10.0 -62- This paper size applies China National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (Table 3 (continued) Chemical shift 値 (ppm) 13c_nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F9-3 73.4 4.20, m F9-4 67.8 4.01, m F9-5 67.0 4.21, q, 6.7 F9-6 15.8 1.12, d, 6.7 F10-1 94.0 5.09, d, 4.0 F10-2 67.0 3.90, m F10-3 76.2 3.99 , m F10-4 79.9 4.60, m F10-5 67.4 4.38, q, 6.7 F10-6 16.4 1.13, d, 6.7 F11-1 98.7 5.00, d, 4.0 F11-2 67.8 3.75, m F11-3 76 .0 3.91, m F11-4 79.8 4.65, m F11-5 67.4 4.38, q, 6.7 F11-6 16.4 1.13, d, 6.7 F12-1 98.3 4.96, d, 4.0 F12-2 69.1 3.58, m F12-3 70.5 3.77, m F12-4 72.6 3.67, d, 4.0 F12-5 67.8 4.23, q, 6.7 F12-6 15.8 1.08, d, 6.7 GA1-1 100.0 5.16, d, 4.0 GA1-2 71.8 3.49, dd, 4.0, 10.0 GA1-3 73.6 3.60, t, 10.0 binding

-63-本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明( 表3 (續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 GA1-4 72.4 3.37, t, 10.0 GA1-5 73.2 3.82, d, 10.0 GA1-6 176.9 GA2-1 100.0 5.16, d, 4.0 GA2-2 71.8 3.49, dd, 4.0, 10.0 GA2-3 73.6 3.60, t, 10.0 GA2-4 72.4 3.37, t, 10.0 GA2-5 73.2 3.82, d, 10.0 GA2-6 176.9 糖組成L-岩藻糖:D -葡糖醛酸=12 : 2 硫酸基6分子 再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式 (XI)所示。 -64- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7-63- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 B7 V. Description of the invention (Table 3 (continued) Chemical shift 値 (ppm) 13c-nmr ^ -NMR chemical shift 値, Multiplicity, binding constant GA1-4 72.4 3.37, t, 10.0 GA1-5 73.2 3.82, d, 10.0 GA1-6 176.9 GA2-1 100.0 5.16, d, 4.0 GA2-2 71.8 3.49, dd, 4.0, 10.0 GA2-3 73.6 3.60, t, 10.0 GA2-4 72.4 3.37, t, 10.0 GA2-5 73.2 3.82, d, 10.0 GA2-6 176.9 Sugar composition L-fucose: D-glucuronic acid = 12: 2 sulfate group 6 molecules In addition, the numbers of the peak assignments in iH-NMR and 13C-NMR are shown in the following formula (XI).

1243853 A7 B7 五、發明説明(63 ) Η 1F 81243853 A7 B7 V. Description of the invention (63) Η 1F 8

F 1 W F 7 F 1 1F 1 W F 7 F 1 1

F 1 0 F 9 再者,以下將本物質稱爲12Fuc-6S-2GlcUA 〇 (f)寡聚糖1-(6)之物性 -66- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐)F 1 0 F 9 In addition, this substance is hereinafter referred to as 12Fuc-6S-2GlcUA 〇 (f) oligosaccharide 1- (6) -66- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm)

1243853 A7 B7 五、發明説明( ) 質量分析之結果如以下所示,本發明之硫酸化葡糖醛酸 化岩藻寡聚糖1 - ( 6 )之質譜如圖1 8所示。圖1 8中縱軸表示 相對強度(%),橫軸表示Πΐ/ζ値。 分子量:3296 MS m/z 840.0[M+3Na+_7H+]4. 、 672.0[M+3Na+-8H+]5.、 556.0[M+2Na+-8H+]6-、473.2[M+Na+-8H+]7· 糖組成L_岩藻糖:D -葡糖醛酸=15 : 3 硫酸基7分子 (g)寡聚糖1-(7)之物性 質量分析及NMR分析歸屬之結果如以下所示,本發明之 硫酸化葡糖醛酸化岩藻寡聚糖1-(7)之1 H-NMR光譜如圖 1 9所示,13 C- NMR光譜如圖2 0所示,質譜如圖2 1所示。 圖19與圖20中縱軸表示訊號之強度,橫軸表示化學位移値 (ppm)。再者,圖2 1中縱軸表示相對強度(%),橫軸表示 m / z 値 0 分子量:3522 MS m/z 896.6[M+3Na+-7H+]4· 、 712.6[M+2Na+-7H+]5* 、 597.2[M+3Na+-9H十]6·、505.4[M+Na十-8H+]7-、439.6[M-8H+]8· 藉由1Η-NMR及13C-NMR分析結果如表4所示。 -67- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)1243853 A7 B7 V. Description of the invention () The results of the mass analysis are shown below. The mass spectrum of the sulfated glucuronidated fuctooligosaccharide 1-(6) of the present invention is shown in FIG. 18. In Fig. 18, the vertical axis represents relative intensity (%), and the horizontal axis represents Πΐ / ζ 値. Molecular weight: 3296 MS m / z 840.0 [M + 3Na + _7H +] 4, 672.0 [M + 3Na + -8H +] 5, 556.0 [M + 2Na + -8H +] 6-, 473.2 [M + Na + -8H +] 7 · Sugar composition L_fucose: D-glucuronic acid = 15: 3 sulfate group 7 molecules (g) oligosaccharide 1- (7) The physical property quality analysis and NMR analysis result are shown below. The present invention The 1 H-NMR spectrum of the sulfated glucuronidated fuctooligosaccharide 1- (7) is shown in FIG. 19, the 13 C-NMR spectrum is shown in FIG. 20, and the mass spectrum is shown in FIG. 21. In Figs. 19 and 20, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In addition, in FIG. 21, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値 0. Molecular weight: 3522 MS m / z 896.6 [M + 3Na + -7H +] 4, 712.6 [M + 2Na + -7H +] 5 * 、 597.2 [M + 3Na + -9H 十] 6 ·, 505.4 [M + Na 十 -8H +] 7-, 439.6 [M-8H +] 8 · The analysis results by 1Η-NMR and 13C-NMR are shown in Table 4. Show. -67- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)

裝 訂Binding

1243853 A7 B7 五、發明説明(65 ) 表4 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F1-1 96.8 4.46, d? 8.0 F1-2 70.6 3.43, dd, 8.0, 9.5 F1-3 78.3 3.57, m F1-4 68.3 3.83,m F1-5 71.2 3.65, q, 6.7 F1-6 16.2 1.12, d, 6.7 F2-1 96.3 4.98, d, 4.0 F2-2 67.3 3.84, m F2-3 77.1 3.96, m F2-4 79.9 4.65, m F2-5 67.1 4.29, q, 6.7 F2-6 16.3 1.09, d,6.7 F3-1 99.7 4.98, d, 4.0 F3-2 67.8 3.73,m F3-3 77.0 3.88, m F3-4 80.2 4.61, m F3-5 67.1 4.33, q, 6.7 F3-6 16.3 1.11, d, 6.7 F4-1 99.3 4.94, d, 4.0 F4-2 67.3 3.71,m F4-3 74.5 3.84, m F4-4 68.7 3.93, m F4-5 67.8 4.20, q, 6.7 F4-6 15.9 1.07, d, 6.7 F5-1 94.7 4.99, d,4.0 -68- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 表4(續) 化學位移値(ppm) 13c-nmr bNMR 化學位移値、多重度、結合常數 F5-2 71.2 4.03,m F5-3 73.4 4.18, m F5-4 67.8 3.99, m F5-5 67.1 4.19, q, 6.7 F5-6 15.9 1.09, d, 6.7 F6-1 94.0 5.07, d, 4.0 F6-2 67.1 3.88, m F6-3 76.2 3.98, m F6-4 79.8 4.58, m F6-5 67.4 4.36, q, 6.7 F6-6 16.4 1.11, d, 6.7 F7-1 98.7 4.98, d,4.0 F7-2 67.8 3.73,m F7-3 76.0 3.90, m F7-4 79.8 4.64, m F7-5 67.1 4.36, q, 6.7 F7-6 16.4 1.11, d, 6.7 F8-1 99.3 4.94, d, 4.0 F8-2 67.3 3.71, m F8-3 74.5 3.84, m F8-4 68.7 3.93, m F8-5 67.8 4.20, q, 6.7 F8-6 15.9 1.07, d, 6.7 F9-1 94.7 4.99, d,4.0 F9-2 71.2 4.03,m -69- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(67 表4(續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F9-3 73.4 4.18, m F9-4 67.8 3.99, m F9-5 67.1 4.19, q, 6.7 F9-6 15.9 1.09, d, 6.7 F10-1 94.0 5.07, d, 4.0 F10-2 67.1 3.88, m F10-3 76.2 3.98, m F10-4 79.8 4.58, m F10-5 67.4 4.36, q, 6.7 F10-6 16.4 1.11, d, 6.7 F11-1 98.7 4.98, d, 4.0 F11-2 67.8 3.73, m F11-3 76.0 3.90, m F11-4 79.8 4.64, m F11-5 67.1 4.36, q, 6.7 F11-6 16.4 1.11, d, 6.7 F12-1 99.3 4.94, d, 4.0 F12-2 67.3 3.71, m F12-3 74.5 3.84, m F12-4 68.7 3.93, m F12-5 67.8 4.20, q, 6.7 F12-6 15.9 1.07, d, 6.7 F13-1 94.7 4.99, d,4.0 F13-2 71.2 4.03,m F13-3 73.4 4.18, m -70- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 B7 五、發明説明(68 ) 表4(續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F13-4 67.8 3.99, m F13-5 67.1 4.19, q, 6.7 F13-6 15.9 1.09, d, 6.7 F14-1 94.0 5.07, d, 4.0 F14-2 67.1 3.88, m F14-3 76.2 3.98, m F14-4 79.8 4.58, m F14-5 67.4 4.36, q, 6.7 F14-6 16.4 1.11, d, 6.7 F15-1 98.7 4.98, d, 4.0 F15-2 67.8 3.73, m F15-3 76.0 3.90, m F15-4 79.8 4.64, m F15-5 67.1 4.36, q, 6.7 F15-6 16.4 1.11, d, 6.7 F16-1 98.3 4.97, d, 4.0 F16-2 69.1 3.57, m F16-3 70.6 3.75, m F16-4 72.6 3.66, m F16-5 67.8 4.23, q, 6.7 F16-6 15.8 1.06, d, 6.7 GA1-1 100.1 5.15, d,4.0 GA1-2 71.8 3.47, dd, 4.0, 10.0 GA1-3 73.6 3.58, t, 10.0 GA1-4 72.4 3.36, t, 10.0 -71 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(69 ) 表4(續) 化學位移値(ppm) 13c_nmr ^-NMR 化學位移値、多重度、結合常數 GA1-5 73.2 3.81, d, 10.0 GA1-6 177.0 GA2-1 100.1 5.15, d, 4.0 GA2-2 71.8 3.47, dd,4.0, 10.0 GA2-3 73.6 3.58, t, 10.0 GA2-4 72.4 3.36, t, 10.0 GA2-5 73.2 3.81, d, 10.0 GA2-6 177.0 GA3-1 100.1 5.15, d,4.0 GA3-2 71.8 3.47, dd, 4.0, 10.0 GA3-3 73.6 3.58, t, 10.0 GA3-4 72.4 3.36, t, 10.0 GA3-5 73.2 3.81, d, 10.0 GA3-6 177.0 糖組成L -岩藻糖·· D -葡糖醛酸=1 6 ·· 3 硫酸基8分子 再者,1 Η - NMR及13 C- NMR中尖峰歸屬之編號如下式 (X11)所示。 -72- 本紙張尺度適用中國國家標準(CNS) Α4規格(210X 297公釐) 1243853 A7 B71243853 A7 B7 V. Description of the invention (65) Table 4 Chemical shift 値 (ppm) 13c-nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F1-1 96.8 4.46, d? 8.0 F1-2 70.6 3.43, dd, 8.0, 9.5 F1-3 78.3 3.57, m F1-4 68.3 3.83, m F1-5 71.2 3.65, q, 6.7 F1-6 16.2 1.12, d, 6.7 F2-1 96.3 4.98, d, 4.0 F2-2 67.3 3.84, m F2-3 77.1 3.96, m F2-4 79.9 4.65, m F2-5 67.1 4.29, q, 6.7 F2-6 16.3 1.09, d, 6.7 F3-1 99.7 4.98, d, 4.0 F3-2 67.8 3.73, m F3 -3 77.0 3.88, m F3-4 80.2 4.61, m F3-5 67.1 4.33, q, 6.7 F3-6 16.3 1.11, d, 6.7 F4-1 99.3 4.94, d, 4.0 F4-2 67.3 3.71, m F4-3 74.5 3.84, m F4-4 68.7 3.93, m F4-5 67.8 4.20, q, 6.7 F4-6 15.9 1.07, d, 6.7 F5-1 94.7 4.99, d, 4.0 -68- This paper size applies to the Chinese National Standard (CNS ) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (Table 4 (continued) Chemical shift 値 (ppm) 13c-nmr bNMR Chemical shift 値, multiplicity, binding constant F5-2 71.2 4.03, m F5 -3 73.4 4.18, m F5-4 67.8 3.99, m F5-5 67.1 4.19, q, 6.7 F5-6 15.9 1.09, d, 6.7 F6-1 94.0 5.07, d , 4.0 F6-2 67.1 3.88, m F6-3 76.2 3.98, m F6-4 79.8 4.58, m F6-5 67.4 4.36, q, 6.7 F6-6 16.4 1.11, d, 6.7 F7-1 98.7 4.98, d, 4.0 F7-2 67.8 3.73, m F7-3 76.0 3.90, m F7-4 79.8 4.64, m F7-5 67.1 4.36, q, 6.7 F7-6 16.4 1.11, d, 6.7 F8-1 99.3 4.94, d, 4.0 F8- 2 67.3 3.71, m F8-3 74.5 3.84, m F8-4 68.7 3.93, m F8-5 67.8 4.20, q, 6.7 F8-6 15.9 1.07, d, 6.7 F9-1 94.7 4.99, d, 4.0 F9-2 71.2 4.03, m -69- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (67 Table 4 (continued) Chemical shift 値 (ppm) 13c-nmr ^- NMR chemical shift 値, multiplicity, binding constant F9-3 73.4 4.18, m F9-4 67.8 3.99, m F9-5 67.1 4.19, q, 6.7 F9-6 15.9 1.09, d, 6.7 F10-1 94.0 5.07, d, 4.0 F10-2 67.1 3.88, m F10-3 76.2 3.98, m F10-4 79.8 4.58, m F10-5 67.4 4.36, q, 6.7 F10-6 16.4 1.11, d, 6.7 F11-1 98.7 4.98, d, 4.0 F11 -2 67.8 3.73, m F11-3 76.0 3.90, m F11-4 79.8 4.64, m F11-5 67.1 4.36, q, 6.7 F11-6 16.4 1.11, d, 6.7 F12-1 99.3 4.94, d, 4.0 F12-2 67.3 3.71, m F12-3 74.5 3.84, m F12-4 68.7 3.93, m F12-5 67.8 4.20, q, 6.7 F12-6 15.9 1.07, d, 6.7 F13-1 94.7 4.99, d, 4.0 F13- 2 71.2 4.03, m F13-3 73.4 4.18, m -70- This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) 1243853 A7 B7 V. Description of the invention (68) Table 4 (continued) Chemical shift 値(ppm) 13c-nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F13-4 67.8 3.99, m F13-5 67.1 4.19, q, 6.7 F13-6 15.9 1.09, d, 6.7 F14-1 94.0 5.07, d , 4.0 F14-2 67.1 3.88, m F14-3 76.2 3.98, m F14-4 79.8 4.58, m F14-5 67.4 4.36, q, 6.7 F14-6 16.4 1.11, d, 6.7 F15-1 98.7 4.98, d, 4.0 F15-2 67.8 3.73, m F15-3 76.0 3.90, m F15-4 79.8 4.64, m F15-5 67.1 4.36, q, 6.7 F15-6 16.4 1.11, d, 6.7 F16-1 98.3 4.97, d, 4.0 F16- 2 69.1 3.57, m F16-3 70.6 3.75, m F16-4 72.6 3.66, m F16-5 67.8 4.23, q, 6.7 F16-6 15.8 1.06, d, 6.7 GA1-1 100.1 5.15, d, 4.0 GA1-2 71.8 3.47, dd, 4.0, 10.0 GA1-3 73.6 3.58, t, 10.0 GA1-4 72.4 3.36, t, 10.0 -71-This paper size applies to China Standard (CNS) A4 (210X 297 mm) 1243853 A7 B7 V. Description of the invention (69) Table 4 (continued) Chemical shift 値 (ppm) 13c_nmr ^ -NMR chemical shift 値, multiplicity, binding constant GA1-5 73.2 3.81, d, 10.0 GA1-6 177.0 GA2-1 100.1 5.15, d, 4.0 GA2-2 71.8 3.47, dd, 4.0, 10.0 GA2-3 73.6 3.58, t, 10.0 GA2-4 72.4 3.36, t, 10.0 GA2- 5 73.2 3.81, d, 10.0 GA2-6 177.0 GA3-1 100.1 5.15, d, 4.0 GA3-2 71.8 3.47, dd, 4.0, 10.0 GA3-3 73.6 3.58, t, 10.0 GA3-4 72.4 3.36, t, 10.0 GA3 -5 73.2 3.81, d, 10.0 GA3-6 177.0 Sugar composition L-fucose ·· D-glucuronic acid = 1 6 ·· 3 sulfate group 8 molecules, 1 再-NMR and 13 C-NMR The number of the spike assignment is shown in the following formula (X11). -72- This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 1243853 A7 B7

1243853 A7 B7 五、發明説明(711243853 A7 B7 V. Description of the invention (71

F 1 4: F 1 3 -74-F 1 4: F 1 3 -74-

本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853 五、發明説明(72 A7 B7This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 1243853 V. Description of the invention (72 A7 B7

再者,以下將本物質稱爲16Fuc_8S-3GlcUA。 (h)寡聚糖1-(8)之物性 質量分析之結果如以下所示’本發明之硫酸化葡糖駿酸 化岩藻寡聚糖1-(8)之質讀如圖22所示。圖22中縱轴表示 相對強度(% ),橫轴表示m / z値。 分子量:4216 MS m/z 1092.0[M+7Na+-llH+]4_、869.0[M+6Na+_llH+]5.、 713.0[M+3Na+-9H+]6' 、 611.0[M+3Na+-10H+]7' &gt; 529 2 [M+Na、9H+]8·、470.2[M+Na、10H+]9-糖組成L-岩藻糖:D -葡糖趁酸=19 : 4 硫酸基9分子 實例3 (1)使實例1記載之部份粗酵素液作用於參考例1 (i )記載 之粗硫酸化葡糖路酸化岩藻聚糖部份中,調製本發明之硫 酸化葡糖醛酸化岩藻寡聚糖。亦即,將3公克之粗硫酸化 葡糖趁酸化岩藻聚糖部份溶解於1公升之含有250 mM氯化 納、20 mM氣化爹弓及1公克牛血清白蛋白之1〇 mM味也-鹽 酸緩衝液(ρΗ6·6)中後,添加29 mU之實例1記載之部份精 製酵素,使其於3 0 °C反應3日。將反應液離心,所得之上 清液用裝設有排除分子量爲1萬之中空纖維之限外過濾 機,回收分子量1萬以下之寡聚糖部份,做爲硫酸化葡糖 醛酸化岩藻聚糖酵素消化物部份2。 (2 )將實例3 ( 1)所得到之硫酸化葡糖醛酸化岩藻聚糖酵素 消化物部份2藉由脱鹽裝置(微阿西來札-G3,旭化成工業 -75- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐)The substance is hereinafter referred to as 16Fuc_8S-3GlcUA. (h) Physical properties of oligosaccharide 1- (8) The results of the mass analysis are shown below. 'The quality of the sulfated glucosamine acidified fucoidigosaccharide 1- (8) of the present invention is shown in FIG. 22. In Fig. 22, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値. Molecular weight: 4216 MS m / z 1092.0 [M + 7Na + -llH +] 4_, 869.0 [M + 6Na + _llH +] 5, 713.0 [M + 3Na + -9H +] 6 ', 611.0 [M + 3Na + -10H +] 7' &gt; 529 2 [M + Na, 9H +] 8 ·, 470.2 [M + Na, 10H +] 9-sugar composition L-fucose: D-glucose while acid = 19: 4 sulfate 9 molecular example 3 (1) A part of the crude enzyme solution described in Example 1 was applied to the crude sulfated gluconate acidified fucoidan portion described in Reference Example 1 (i) to prepare the sulfated glucuronidated fucoidan of the present invention. . That is, 3 grams of crude sulfated gluconate was partially dissolved in 1 liter of 250 mM sodium chloride, 20 mM vaporized dextrose, and 1 gram of bovine serum albumin at 10 mM. Also, after adding hydrochloric acid buffer solution (ρΗ6.6) to 29 mU, a part of the purified enzyme described in Example 1 was added and allowed to react at 30 ° C for 3 days. The reaction solution was centrifuged, and the resulting supernatant was equipped with an outer limit filter for removing hollow fiber with a molecular weight of 10,000, and an oligosaccharide part with a molecular weight of less than 10,000 was recovered as sulfated glucuronidated fucoid Glycanase digestion part 2. (2) The sulfated glucuronide fucoidanase digested part 2 obtained in Example 3 (1) was passed through a desalination device (micro-Asilaza-G3, Asahi Kasei Industries-75-) Applicable to China National Standard (CNS) A4 (210X 297mm)

裝 訂Binding

線 1243853 A7 B7 五、發明説明(73 ) 公司製)脱鹽。於脱鹽之硫酸化葡糖醛酸化岩藻聚糖酵素消 化物部份2中,添加咪唑並使其濃度爲5 m Μ,以及添加氯 化鈉並使莫濃度爲1 〇 mM,饋入預先以含有10 mM氯化鋼 之5mM咪唑-鹽酸緩衝液(PH7.0)平衡化之1公升DEAE -赛 璐玢A-800管柱中,用相同緩衝液洗淨後,藉由10 mM至 600 mM之氯化鈉梯度溶析。被溶出之部份,其總糖量藉由 酚-硫酸法測定,總糖醛酸量藉由咔唑-硫酸法測定。其結 果,溶出之部份中至少5個有明顯之尖峰存在,將各個尖 峰部份集合,做爲寡聚糖2-(1)〜(5),分別將其藉由蒸發 器濃縮爲4 0毫升後,饋入預先以1 〇 %乙醇平衡化之赛璐玢 GCL-25管柱中,以10%乙醇溶析及脱鹽。由此可得到寡聚 糖2-(1)〜(5)。 (3)寡聚糖之構造解析 對於實例3 ( 2 )所得到之寡聚糖2 - ( 1 )〜(5 )之脱鹽物,使 用2 -胺基吡啶之螢光標識法進行還原末端糖及糖組成之分 析時,發現該寡聚糖之還原性末端糖全部爲L-岩藻糖。再 者,關於糖組成,寡聚糖2-(1)只由岩藻糖形成,而寡聚 糖2 - (2 )〜(5 )則係由岩藻糖與葡糖趁酸形成。繼而,測定 硫酸含量(藉由使用氣化鋇之比濁法)及糖醛酸含量(藉由咔 峻-硫酸法),且藉由質量分析裝置(API _〗Π,帕金野如馬 赛也克斯公司製)分析質量。再者,使用JNM-泛500型核磁 共振裝置(日本電子公司製)進行NMR分析。將分析試料藉 由固定方法以重水置換後進行構造解析。構成糖之結合方 式,係使用HMBC法(爲一種1 Η -檢測異種核檢測法)而進 -76- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1243853 A7 ____B7__ 五、發明説明(74 ) 行。1H-NMR之歸屬係使用DQF-COSY法及HOHAHA法, 13C-NMR之歸屬係使用HSQC法。 以下,表示寡聚糖2-(1)〜(5)之物性。 (a) 寡聚糖2-(1)之物性 上述分析之結果,判定本物質爲與寡聚糖1-(1)相同之物 質。 (b) 寡聚糖2-(2)之物性 上述分析之結果,判定本物質爲與寡聚糖1-(3)相同之物 質。 (c) 寡聚糖2-(3)之物性 質量分析及NMR分析歸屬之結果如以下所示,本發明之 硫酸化葡糖醛酸化岩藻寡聚糖2-(3)之1 H-NMR光譜如圖 23所示,13C-NMR光譜如圖24所示,質譜如圖25所示。 圖23與圖24中縱軸表示訊號之強度,橫軸表示化學位移値 (ppm)。再者,圖25中縱軸表示相對強度(%),橫抽表示 m / z 値0 分子量:1536 MS m/z 800.2[M+3Na+-5H+]2_、789.2[M+2Na+-4H+]2-、526.0 [M+2Na+-5H+]3-、518.6[M+Na+-4H+]3·、388.8 [M+Na+-5H+]4. 、383.2[M-4H+]4· 藉由1H-NMR及13C-NMR分析之結果如表5所示。 •77- 本紙張尺度適用中國國家榡準(CNS) A4規格(210 x 297公釐) 1243853 A7 B7 五、發明説明( 表5 化學位移値(ppm) 13c_nmr ^-NMR 化學位移値、多重度、結合常數 F1 -1 97.1 4.47, d, 7.9 F1-2 70.9 3.44, d-d, 7.9, 9.8 F1-3 78.6 3.58, d-d, 2.8, 9.8 F1-4 68.7 3.85, d, 2.8 F1-5 71.5 3.66, q, 6.8 F1-6 16.6 1.13, d, 6.8 F2-1 96.6 4.99, d, 4.0 F2-2 67.7 3.85, d-d, 4.0, 8.6 F2-3 77.6 3.98, d-d, 3.1, 8.6 F2-4 80.6 4.65, d, 3.1 F2-5 67.3 4.30, q, 6.8 F2-6 16.6 1.13, d, 6.8 F3-1 100.1 4.99, d,4.0 F3-2 68.2 3.75, d-d, 4.0, 11.3 F3-3 77.4 3.90, d-d, 2.7, 11.3 F3-4 80.6 4.62, d, 2.7 F3-5 67.4 4.34, q,6.8 F3-6 16.7 1.12, d, 6.8 F4-1 99.6 4.96, d, 4.0 F4-2 67.8 3.73, d-d, 4.0, 10.4 F4-3 74.9 3.86, d-d, 3.1, 10.4 F4-4 69.1 3.95, d, 3.1 F4-5 68.1 4.21,q,6.8 F4-6 16.2 1.09, d, 6.8 F5-1 95.1 5.01, d, 4.0 -78- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 表5 (續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F5-2 71.4 4.05, d-d,4.0, 10.4 F5-3 73.7 4.18, d-d,3.1,10.4 F5-4 68.1 4.00, d, 3.1 F5-5 67.3 4.19, q, 6.4 F5-6 16.2 1.13, d, 6.4 F6-1 94.2 5.08, d, 4.0 F6-2 67.6 3.85, m F6-3 75.8 4.00, m F6-4 80.0 4.59, d, 2.4 F6-5 67.4 4.37, q, 6.8 F6-6 16.8 1.14, d, 6.8 F7-1 98.3 5.01, d, 4.0 F7-2 69.5 3.66, d-d, 4.0, 10.7 F7-3 70.0 3.87, d-d, 2.5, 10.7 F7-4 81.6 4.48, d,2.5 F7-5 67.4 4.37, q, 6.8 F7-6 16.8 1.11, d, 6.8 GA1-1 100.3 5.16, d,4.0 GA1-2 72.1 3.47, d-d, 4.0, 9.8 GA1-3 74.0 3.59, t,9.8 GA1-4 72.7 3.37, d-d,9.8, 10.4 GA1-5 73.6 3.81, d, 10.4 GA1-6 177.3 - -79- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7五、發明説明(77 )糖組成L-岩藻糖·· D-葡糖醛酸=7 ·· 1 硫酸基4分子再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式 (VI)所示。 GA1Line 1243853 A7 B7 V. Description of Invention (73) Company) Desalination. In the desalted sulfated glucuronide fucoidan digest part 2, add imidazole to a concentration of 5 μM, and add sodium chloride to a concentration of 10 mM. A 1 liter DEAE-cellulose A-800 column equilibrated with 5 mM imidazole-hydrochloric acid buffer (pH 7.0) containing 10 mM steel chloride, washed with the same buffer, and passed 10 mM to 600 mM sodium chloride gradient elution. The total sugar content of the eluted portion was measured by the phenol-sulfuric acid method, and the total uronic acid content was measured by the carbazole-sulfuric acid method. As a result, at least 5 of the eluted portions had obvious peaks, and the peaks were collected as oligosaccharides 2- (1) to (5), which were respectively concentrated by an evaporator to 40. After milliliters, it was fed into a celluloid GCL-25 column preliminarily equilibrated with 10% ethanol, and eluted and desalted with 10% ethanol. Thus, oligosaccharides 2- (1) to (5) can be obtained. (3) Structural analysis of oligosaccharides For the desalted products of oligosaccharides 2-(1) to (5) obtained in Example 3 (2), the terminal sugar was reduced by the fluorescent labeling method of 2-aminopyridine. When analyzing the sugar composition, it was found that all the reducing terminal sugars of the oligosaccharide were L-fucose. In addition, as for the sugar composition, oligosaccharide 2- (1) is formed only from fucose, while oligosaccharides 2- (2) to (5) are formed from fucose and glucose while the acid is present. Then, the sulfuric acid content (by the turbidimetric method using barium vaporization) and the uronic acid content (by the Cajun-sulfuric acid method) were measured. (Manufactured by Max Cox) Analytical quality. Furthermore, NMR analysis was performed using a JNM-Pan 500 type nuclear magnetic resonance device (manufactured by Japan Electronics Co., Ltd.). The analysis sample was replaced with heavy water by a fixed method, and the structure was analyzed. The method of combining sugar is based on the use of HMBC method (for a 1 Η-detection of heterogeneous nuclear detection method) -76- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 ____B7__ 5 The invention description (74) line. 1H-NMR is assigned using the DQF-COSY method and HOHAHA method, and 13C-NMR is assigned using the HSQC method. The physical properties of oligosaccharides 2- (1) to (5) are shown below. (a) Physical properties of oligosaccharide 2- (1) As a result of the above analysis, the substance was determined to be the same substance as oligosaccharide 1- (1). (b) Physical properties of oligosaccharide 2- (2) As a result of the above analysis, it was determined that this substance was the same substance as oligosaccharide 1- (3). (c) The physical property quality analysis and NMR analysis results of oligosaccharide 2- (3) are shown below. The 1 H-NMR of the sulfated glucuronidated fucoidan 2- (3) of the present invention is shown below. The spectrum is shown in Fig. 23, the 13C-NMR spectrum is shown in Fig. 24, and the mass spectrum is shown in Fig. 25. In Figs. 23 and 24, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In addition, the vertical axis in FIG. 25 indicates the relative strength (%), and the horizontal extraction indicates m / z 値 0. Molecular weight: 1536 MS m / z 800.2 [M + 3Na + -5H +] 2_, 789.2 [M + 2Na + -4H +] 2- , 526.0 [M + 2Na + -5H +] 3-, 518.6 [M + Na + -4H +] 3 ·, 388.8 [M + Na + -5H +] 4, 383.2 [M-4H +] 4 · By 1H-NMR and 13C- The results of the NMR analysis are shown in Table 5. • 77- This paper size applies to the Chinese National Standard (CNS) A4 (210 x 297 mm) 1243853 A7 B7 V. Description of the invention (Table 5 Chemical shift 値 (ppm) 13c_nmr ^ -NMR chemical shift 値, multiplicity, Bonding constant F1 -1 97.1 4.47, d, 7.9 F1-2 70.9 3.44, dd, 7.9, 9.8 F1-3 78.6 3.58, dd, 2.8, 9.8 F1-4 68.7 3.85, d, 2.8 F1-5 71.5 3.66, q, 6.8 F1-6 16.6 1.13, d, 6.8 F2-1 96.6 4.99, d, 4.0 F2-2 67.7 3.85, dd, 4.0, 8.6 F2-3 77.6 3.98, dd, 3.1, 8.6 F2-4 80.6 4.65, d, 3.1 F2-5 67.3 4.30, q, 6.8 F2-6 16.6 1.13, d, 6.8 F3-1 100.1 4.99, d, 4.0 F3-2 68.2 3.75, dd, 4.0, 11.3 F3-3 77.4 3.90, dd, 2.7, 11.3 F3 -4 80.6 4.62, d, 2.7 F3-5 67.4 4.34, q, 6.8 F3-6 16.7 1.12, d, 6.8 F4-1 99.6 4.96, d, 4.0 F4-2 67.8 3.73, dd, 4.0, 10.4 F4-3 74.9 3.86, dd, 3.1, 10.4 F4-4 69.1 3.95, d, 3.1 F4-5 68.1 4.21, q, 6.8 F4-6 16.2 1.09, d, 6.8 F5-1 95.1 5.01, d, 4.0 -78- This paper size applies China National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of invention (Table 5 (continued) Chemical position Shift (ppm) 13c-nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F5-2 71.4 4.05, dd, 4.0, 10.4 F5-3 73.7 4.18, dd, 3.1, 10.4 F5-4 68.1 4.00, d, 3.1 F5-5 67.3 4.19, q, 6.4 F5-6 16.2 1.13, d, 6.4 F6-1 94.2 5.08, d, 4.0 F6-2 67.6 3.85, m F6-3 75.8 4.00, m F6-4 80.0 4.59, d, 2.4 F6-5 67.4 4.37, q, 6.8 F6-6 16.8 1.14, d, 6.8 F7-1 98.3 5.01, d, 4.0 F7-2 69.5 3.66, dd, 4.0, 10.7 F7-3 70.0 3.87, dd, 2.5, 10.7 F7-4 81.6 4.48, d, 2.5 F7-5 67.4 4.37, q, 6.8 F7-6 16.8 1.11, d, 6.8 GA1-1 100.3 5.16, d, 4.0 GA1-2 72.1 3.47, dd, 4.0, 9.8 GA1-3 74.0 3.59, t, 9.8 GA1-4 72.7 3.37, dd, 9.8, 10.4 GA1-5 73.6 3.81, d, 10.4 GA1-6 177.3--79- This paper size applies to China National Standard (CNS) A4 (210X 297 male) 1243853 A7 B7 V. Description of the invention (77) Sugar composition L-fucose · D-glucuronic acid = 7 · 1 1 molecule of sulfate The numbers are shown in the following formula (VI). GA1

3 2 H F 7 X H H F 6 F 5 ^3 2 H F 7 X H H F 6 F 5 ^

Η Η H -oyo/ H % 〔VI〕Η Η H -oyo / H% 〔VI〕

HH

啕3 F 2 匀1 -80-啕 3 F 2 even 1 -80-

本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853 A7 B7 五、發明説明(78 ) (d) 寡聚糖2-(4)之物性 上述分析之結果,判定本物質爲與寡聚糖1 - ( 5 )相同之物 質。 (e) 寡聚糖2-(5)之物性 質量分析之結果如以下所示,本發明之硫酸化葡糖醛酸 化岩藻寡聚糖2-(5)之1H-NMR光譜如圖26所示,13C-NMR光譜如圖2 7所示,質譜如圖28所示。圖26與圖27中 縱軸表示訊號之強度,橫軸表示化學位移値(ppm)。再 者,圖28中縱軸表示相對強度(%),橫軸表示m/z値。 分子量·· 2456 MS m/z 854.8[M+5Na+_8H+]3、847.2[M+4Na+-7H + ]3·、840.4 [M+3Na+-6H+]3- 、63 5.4[M+4Na+-8H+广、630.0[M+3Na+-7H+]4·、624.4[M+2Na+_6H+]4·、503.6[M+3Na+-8H + ]5·、499.4 [M+2Na+-7H+]5· 、 495.0[M+Na+-6H + ]6' 、 416.0[M+2Na+- 8H+]6、412.4[M+Na+-7H+]6-、408·8[Μ·6Η + ]6· 藉由1H-NMR及13C_NMR分析之結果如表6所示。 -81 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(79 表6 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F1-1 97.1 4.48, d,8.0 F1-2 70.9 3.45, dd, 8.0, 9.5 F1-3 78.6 3.59, m F1-4 68.7 3.87, m F1-5 71.5 3.67, q, 6.7 F1-6 16.6 1.15, d, 6.7 F2-1 96.6 4.99, d, 4.0 F2-2 67.6 3.87, m F2-3 77.5 3.99, m F2-4 80.6 4.66, m F2 - 5 67.4 4.30, q, 6.7 F2-6 16.6 1.10, d, 6.7 F3-1 100.1 5.00, d, 4.0 F3-2 68.1 3.78, m F3-3 77.5 3.88, m F3-4 80.6 4.63, m F3-5 67.6 4.35, q, 6.7 F3-6 16.7 1.13, d, 6.7 F4-1 99.6 4.97, d, 4.0 F4-2 67.8 3.73, m F4-3 74.8 3.87, m F4-4 69.1 3.96, m F4-5 68.1 4.22, q, 6.7 F4-6 16.2 1.10, d, 6.7 F5-1 95.1 5.02, d, 4.0 -82- 本纸張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(8Q ) 表6(續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F5-2 71.4 4.06, dd,4.0, 10.0 F5-3 73.7 4.20, m F5-4 68.1 4.01,m F5-5 67.4 4.21, q, 6.7 F5-6 16.2 1.12, d, 6.7 F6-1 94.3 5.09, d, 4.0 F6-2 67.4 3.88, m F6-3 75.8 4.00, m F6-4 80.0 4.60, m F6-5 67.6 4.38, q, 6.7 F6-6 16.8 1.13, d, 6.7 F7-1 99.1 5.02, d, 4.0 F7-2 68.2 3.76, m F7-3 76.4 4.00, m F7-4 80.5 4.66, m F7-5 67.6 4.38, q, 6.7 F7-6 16.7 1.13, d, 6.7 F8_l 99.6 4.97, d, 4.0 F8-2 67.8 3.73,m F8-3 74.8 3.87, m F8-4 69.1 3.96, m F8-5 68.1 4.22, q, 6.7 F8-6 16.2 1.10, d, 6.7 F9-1 95.0 5.02, d, 4.0 F9-2 71·4 4.06, dd, 4.0, 10.0 -83- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(81 表6(續) 化學位移値(ppm) 13C-NMR ^-NMR 化學位移値、多重度、結合常數 F9-3 73.7 4.20, m F9-4 68.1 4.01, m F9-5 67.4 4.21, q, 6.7 F9-6 16.2 1.12, d5 6.7 F10-1 94.2 5.09, d? 4.0 F10-2 67.4 3.88, m F10-3 75.8 4.00, m F10-4 80.0 4.60, m F10-5 67.6 4.38, q, 6.7 F10-6 16.8 1.13, d, 6.7 F11-1 98.3 5.02, d, 4.0 F11-2 69.5 3.67, m F11-3 70.0 3.88, m F11-4 81.6 4.49, m F11-5 67.6 4.38, q,6.7 F11-6 16.7 1.12, d, 6.7 GA1-L 100.4 5.17, d, 4.0 GA1-2 72.1 3.49, dd,4.0, 10.0 GA1-3 74.0 3.60, t, 10.0 GA1-4 72.7 3.37, t, 10.0 GA1-5 73.6 3.82, d, 10.0 GA1-6 177.3 GA2-1 100.3 5.17, d, 4.0 GA2-2 72.1 3.49, dd, 4.0, 10.0 GA2-3 74.0 3.60, t,10.0 -84- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(82 ) 表6(續) 化學位移値(ppm) 13c-nmr !h-nmr 化學位移値、多重度、結合常數 GA2-4 72.7 3.37, t, 10.0 GA2-5 73.6 3.82, d, 10.0 GA2-6 177.3 糖組成L -岩藻糖·· D -葡糖醛酸=1 1 : 2 硫酸基6分子 再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式 (XIII)所示。 -85- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 Α7 Β7 五、發明説明( 83 GA 1This paper size applies Chinese National Standard (CNS) A4 specification (210 x 297 mm) 1243853 A7 B7 V. Description of the invention (78) (d) Properties of oligosaccharide 2- (4) The results of the above analysis determine the substance It is the same substance as oligosaccharides 1-(5). (e) The results of the physical quality analysis of oligosaccharide 2- (5) are shown below. The 1H-NMR spectrum of the sulfated glucuronidated fuco-oligosaccharide 2- (5) of the present invention is shown in Fig. 26 The 13C-NMR spectrum is shown in Figure 27 and the mass spectrum is shown in Figure 28. In Figs. 26 and 27, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In Fig. 28, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値. Molecular weight 2456 MS m / z 854.8 [M + 5Na + _8H +] 3, 847.2 [M + 4Na + -7H +] 3, 840.4 [M + 3Na + -6H +] 3-, 63 5.4 [M + 4Na + -8H + 广, 630.0 [M + 3Na + -7H +] 4 ·, 624.4 [M + 2Na + _6H +] 4 ·, 503.6 [M + 3Na + -8H +] 5 ·, 499.4 [M + 2Na + -7H +] 5 ·, 495.0 [M + Na + -6H +] 6 ', 416.0 [M + 2Na +-8H +] 6, 412.4 [M + Na + -7H +] 6-, 408 · 8 [Μ · 6Η +] 6 · Results of analysis by 1H-NMR and 13C_NMR As shown in Table 6. -81-This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (79 Table 6 Chemical shift 値 (ppm) 13c-nmr ^ -NMR Chemical shift 値, more Severity, binding constant F1-1 97.1 4.48, d, 8.0 F1-2 70.9 3.45, dd, 8.0, 9.5 F1-3 78.6 3.59, m F1-4 68.7 3.87, m F1-5 71.5 3.67, q, 6.7 F1-6 16.6 1.15, d, 6.7 F2-1 96.6 4.99, d, 4.0 F2-2 67.6 3.87, m F2-3 77.5 3.99, m F2-4 80.6 4.66, m F2-5 67.4 4.30, q, 6.7 F2-6 16.6 1.10 , d, 6.7 F3-1 100.1 5.00, d, 4.0 F3-2 68.1 3.78, m F3-3 77.5 3.88, m F3-4 80.6 4.63, m F3-5 67.6 4.35, q, 6.7 F3-6 16.7 1.13, d , 6.7 F4-1 99.6 4.97, d, 4.0 F4-2 67.8 3.73, m F4-3 74.8 3.87, m F4-4 69.1 3.96, m F4-5 68.1 4.22, q, 6.7 F4-6 16.2 1.10, d, 6.7 F5-1 95.1 5.02, d, 4.0 -82- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (8Q) Table 6 (continued) Chemical shift 値(ppm) 13c-nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F5-2 71.4 4.06, dd, 4.0, 10.0 F5-3 7 3.7 4.20, m F5-4 68.1 4.01, m F5-5 67.4 4.21, q, 6.7 F5-6 16.2 1.12, d, 6.7 F6-1 94.3 5.09, d, 4.0 F6-2 67.4 3.88, m F6-3 75.8 4.00 , m F6-4 80.0 4.60, m F6-5 67.6 4.38, q, 6.7 F6-6 16.8 1.13, d, 6.7 F7-1 99.1 5.02, d, 4.0 F7-2 68.2 3.76, m F7-3 76.4 4.00, m F7-4 80.5 4.66, m F7-5 67.6 4.38, q, 6.7 F7-6 16.7 1.13, d, 6.7 F8_l 99.6 4.97, d, 4.0 F8-2 67.8 3.73, m F8-3 74.8 3.87, m F8-4 69.1 3.96, m F8-5 68.1 4.22, q, 6.7 F8-6 16.2 1.10, d, 6.7 F9-1 95.0 5.02, d, 4.0 F9-2 71 · 4 4.06, dd, 4.0, 10.0 -83- Applicable for this paper size China National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (81 Table 6 (continued) Chemical shift 値 (ppm) 13C-NMR ^ -NMR chemical shift 値, multiplicity, binding constant F9-3 73.7 4.20, m F9-4 68.1 4.01, m F9-5 67.4 4.21, q, 6.7 F9-6 16.2 1.12, d5 6.7 F10-1 94.2 5.09, d? 4.0 F10-2 67.4 3.88, m F10-3 75.8 4.00, m F10-4 80.0 4.60, m F10-5 67.6 4.38, q, 6.7 F10-6 16.8 1.13, d, 6.7 F11-1 98.3 5.02, d, 4.0 F11-2 69.5 3.67, m F11-3 70 .0 3.88, m F11-4 81.6 4.49, m F11-5 67.6 4.38, q, 6.7 F11-6 16.7 1.12, d, 6.7 GA1-L 100.4 5.17, d, 4.0 GA1-2 72.1 3.49, dd, 4.0, 10.0 GA1-3 74.0 3.60, t, 10.0 GA1-4 72.7 3.37, t, 10.0 GA1-5 73.6 3.82, d, 10.0 GA1-6 177.3 GA2-1 100.3 5.17, d, 4.0 GA2-2 72.1 3.49, dd, 4.0, 10.0 GA2-3 74.0 3.60, t, 10.0 -84- This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 1243853 A7 B7 V. Description of the invention (82) Table 6 (continued) Chemical shift 値 ( ppm) 13c-nmr! h-nmr Chemical shift 値, multiplicity, binding constant GA2-4 72.7 3.37, t, 10.0 GA2-5 73.6 3.82, d, 10.0 GA2-6 177.3 Sugar composition L-fucose · D -Glucuronic acid = 1 1: 2 sulfate group 6 molecules Furthermore, the number of the peak assignment in iH-NMR and 13C-NMR is shown by the following formula (XIII). -85- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 Α7 Β7 V. Description of the invention (83 GA 1

F4 F3 F2 Fl ο π:F4 F3 F2 Fl ο π:

X -86- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)X -86- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm)

^ § X 1243853 A7 B7 五、發明説明(84 ) Ο H J——Ο-Ϊ &amp; X οχGA2^ § X 1243853 A7 B7 V. Description of the invention (84) 〇 H J——〇-Ϊ &amp; X οχGA2

Η *Η *

再者’以下將本物質稱爲11Fuc-6S-2(Hcl;A 〇 由上述實例2及實例3得到之酵素反應生成物所見,舉例 而各’寡聚糖1-(1)、、1气5)及1-(7)間之質量差, 相當於岩蓮糖4分子、硫酸基2分子與葡糖醛酸1分子之質 量。寡聚糖1-(2)、1_(4)、1-(6)及1-(8)間之質量差、寡 聚糖2-(1)、2-(2)及2-(4)間之質量差及寡聚糖2-(3)與2-(5 )間之質量差亦相同。因此,認爲在實例1得到之粗酵素 液及部份精製酵素液中,包含在硫酸化葡糖醛酸化岩藻聚 糖之重覆單位{亦即岩藻糖4分子、硫酸基2分子及葡糖遂 酸 1 分子之單位((-3F-3(4S)Fl-3(4S)Fl-3(GUl-2)Fl-),其中 泛-L -岩藻糖簡稱F,硫酸基簡杈S,π - D -葡糖醛酸簡稱 GU)}間切斷之酵素。不過,反應生成物中不存在由岩藻 -87- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 χ 297公董) 1243853 A7 B7 五、發明説明(85 ) 糖4分子、硫酸基2分子及葡糖醛酸1分子形成之寡聚糖, 近似其構造者’爲岩藻糖4分子及硫酸基2分子形成之春聚 糖。亦即’隱約表示實例1 ( 1)所得到之粗酵素液及部份精 製酵素液中,至少爲葡糖酸甞酶及岩藻糖甞酶之混合物。 實例4 (1 )硫酸化葡糖醛酸化岩藻聚糖赛璐玢之調製 爲調製供分離實例1 ( 1)得到之部份精製酵素液中所含之 酵素用之親和性樹脂,將參考例i (丨)記載之粗硫酸化葡糖 酸酸化岩藻聚糖部份固定於胺基赛璐玢(生化學工業製) 上。該固定化之方法係依據生化學工業之説明書。亦即, 將1 · 5公克之粗硫酸化葡糖趁酸化岩蕩聚糖部份溶於$ 〇毫 升水中後’用鹽酸調成ρΗ4·5,添加50毫升之胺基赛璐玢 與3公克之1-乙基·3-(二甲胺丙基)碳化二亞胺鹽酸鹽,於 4 C攪摔2 0小時,過濾後,用水充分洗淨,得到硫酸化葡 糖醛酸化岩藻聚糖-赛璐紛。 (2)藉由硫酸化葡糖醛酸化岩藻聚糖·赛璐玢將α-D -葡糖 菩酸酶及内-a - L-岩藻糖荅酶分離 將實例1 ( 1)所得到之部份精製酵素液,用含有5〇 氣 化鈉及10 mM氣化鈣之1〇 mM咪唑_鹽酸緩衝液(pH7 5)充 分透析後,债入以相同緩衝液平衡化之5〇毫升硫酸化葡糖 醛酸化岩藻聚糖赛璐玢中,用相同緩衝液洗淨後,用5〇 mM至1M之氣化鈉梯度溶析。若測定溶出部份之「硫酸化 葡糖醛酸化岩藻聚糖分解活性」―,活性之回收率約爲2%, 仁疋方知僅具些微「硫酸化葡糖醛酸化岩藻聚糖分解活 -88 -Furthermore, this substance is hereinafter referred to as 11Fuc-6S-2 (Hcl; A), which is seen from the enzyme reaction products obtained in the above Examples 2 and 3. For example, the respective oligosaccharides 1- (1), 1 The mass difference between 5) and 1- (7) is equivalent to the mass of 4 molecules of rock lotus, 2 molecules of sulfate group and 1 molecule of glucuronic acid. Mass difference between oligosaccharides 1- (2), 1_ (4), 1- (6) and 1- (8), oligosaccharides 2- (1), 2- (2) and 2- (4) The mass difference between the two and the mass difference between the oligosaccharides 2- (3) and 2- (5) are also the same. Therefore, it is considered that the crude enzyme solution obtained in Example 1 and the partially purified enzyme solution include the repeating unit {that is, 4 molecules of fucose, 2 molecules of sulfate group and 1 unit of glucosinolic acid ((-3F-3 (4S) Fl-3 (4S) Fl-3 (GUl-2) Fl-), where pan-L-fucose is abbreviated as F, sulfate group is simple S, π-D-glucuronic acid is abbreviated as GU)}. However, there is no fucoidan-87 in the reaction product. This paper is in accordance with Chinese National Standards (CNS) A4 specifications (210 x 297). 1243853 A7 B7 V. Description of the invention (85) Sugar 4 molecules, sulfate groups 2 The oligosaccharide formed by the molecule and one glucuronic acid molecule is similar to the structure of the oligosaccharide, which is formed by four fucose molecules and two sulfate group molecules. That is, "'vaguely shows that the crude enzyme solution and part of the purified enzyme solution obtained in Example 1 (1) are at least a mixture of glucosidase and fucosidase. Example 4 (1) The preparation of sulfated glucuronidated fucoidan celluloid is prepared as an affinity resin for the enzyme contained in the partially purified enzyme solution obtained in Example 1 (1). The crude sulfated gluconate-acidified fucoidan described in i (丨) is partially fixed to aminocellulose (manufactured by Biochemical Industry). The method of immobilization is based on the instructions of the biochemical industry. That is, 1.5 g of crude sulfated glucose was dissolved in $ 00 ml of water while the acidified rock glycan was partially dissolved in hydrochloric acid to make pH 4.5, and 50 ml of aminocellulose and 3 g were added. 1-ethyl · 3- (dimethylaminopropyl) carbodiimide hydrochloride, stirred at 4 C for 20 hours, filtered, and thoroughly washed with water to obtain sulfated glucuronidated fucoidan Sugar-Celluloid. (2) Separation of α-D-glucosidase and endo-a-L-fucosinase by sulfated glucuronidation fucoidan · Celluloid Obtained from Example 1 (1) Part of the purified enzyme solution was thoroughly dialyzed with 10 mM imidazole-hydrochloric acid buffer solution (pH 75) containing 50% of sodium gas and 10 mM of calcium gas, and then 50 ml of sulfuric acid equilibrated with the same buffer solution was used. The glucuronidated fucoidan celluloid was washed with the same buffer solution, and then eluted with a gradient of 50 mM to 1M sodium gaseous sodium. If the "sulfated glucuronidated fucoidan decomposition activity" of the dissolution part is measured, the recovery rate of the activity is about 2%. Renxifang only has a slight "sulphated glucuronidated fucoidan decomposition" Live-88-

1243853 A7 B7 五、發明説明 性」之殘餘溶出邵份與硫酸化葡糖醛酸化岩藻聚糖赛路纷 未吸著部份之混合,則「硫酸化葡糖醛酸化岩藻聚糖分解 活性」變得約略與加至管柱之活性相等。 由於上述未吸著部份單獨使用時完全不會將硫酸化葡糖 醛酸化岩藻聚糖低分子化,以及僅具有些微「硫酸化葡糖 醛酸化岩藻聚糖分解活性」之溶出部份單獨使用時亦完全 不會將硫酸化葡糖醛酸化岩藻聚糖低分子化,可以判定未 吸著部份及溶出部份分別藉由不同作用將硫酸化葡糖醛酸 化岩藻聚糖分解,以及若未使溶出部份預先作用於硫酸化 葡糖路酸化岩藻聚糖作用,未吸著部份亦不會作用。由此 暗示溶出部份係切斷硫酸化.葡糖醛酸化岩藻聚糖之側鏈(亦 即a - D -葡糖醛酸基鍵結或硫酸酯鍵結等使硫酸化葡糖醛 酸化岩藻聚糖之分子量變化不太大之部份),而未吸著部份 則係切斷其主鏈(亦即a - L -岩藻糖基键結)。 實例5 (1)藉由2 -胺基吡啶螢光標識(ρ Α化)法標識寡聚糖 爲確認實例4 ( 2 ) I己載之非吸著部份及溶出部份之作用機 構,進行以下之實驗。 取硫酸化葡糖醛酸化岩藻聚糖1-(1)〜(8)及2-(3)及2-(5) 之乾燥物各50毫微莫耳,使用糖基標示劑及糖基標示試劑 套組(均爲寶酒造公司製)將還原性末端用2 ·胺基吡啶進行 勞光標識(P A化),以調製該寡聚糖之P A化物。 (2 )藉由下述反應系調查實例4 ( 2 )記載之未吸著部份及溶 出部份對實例5 ( 1)記載之1 0種寡聚糖P A化物之作用。 -89 本紙張尺度適用中S S家標準(CNS) A4規格(210 X 297公釐)1243853 A7 B7 V. "Illustrative Invention" Residual dissolution content and sulfated glucuronide fucoidan mixed with unabsorbed part of the mixture, then "sulfated glucuronidation fucoidan decomposition activity Becomes approximately equal to the activity added to the column. Because the above non-adsorbed part is used alone, it will not reduce the molecular weight of sulfated glucuronidated fucoidan, and it has only a little "dissolved activity of sulfated glucuronidated fucoidan" When used alone, it will not reduce the molecular weight of sulfated glucuronidated fucoidan at all. It can be determined that the unadsorbed and dissolved parts of the sulfated glucuronidated fucoidan are decomposed by different actions. And, if the dissolving part is not caused to act in advance on the sulfated gluconate acidified fucoidan, the unabsorbed part will not act. This suggests that the dissolution part is to cut off the sulfate. The side chain of glucuronidated fucoidan (that is, a-D -glucuronyl bond or sulfate ester bond, etc.) The part of the fucoidan whose molecular weight does not change much), and the non-adsorbed part is to cut off its main chain (that is, a-L -fucosyl bond). Example 5 (1) Identification of oligosaccharides by 2-aminopyridine fluorescent labeling (ρ Αβ) method was performed to confirm the function mechanism of the non-adsorbed portion and dissolved portion contained in Example 4 (2) I. The following experiments. Take 50 mol of each of the dried 1- (1) ~ (8) and 2- (3) and 2- (5) sulfated glucuronidated fucoidan, using a glycosyl marker and a glycosyl group The labeling reagent kits (both manufactured by Takara Shuzo Co., Ltd.) are labeled (PA) with a reducing amino group using 2-aminopyridine to prepare a PA compound of the oligosaccharide. (2) The effects of the non-adsorbed portion and the eluted portion described in Example 4 (2) on the 10 types of oligosaccharide PA compounds described in Example 5 (1) were investigated by the following reactions. -89 This paper size applies to Chinese Standard (CNS) A4 (210 X 297 mm)

裝 訂Binding

線 1243853 A7 B7 五、發明説明(87 反應系 50微升50mM咪唑鹽酸緩衝液(ρίί6.6) 2 3微升水 5微升4Μ氣化鈉 2微升1 Μ氣化鈣 5微升5¾克/ ¾升牛血清白蛋白 10微升2微微莫耳/微升寡聚糖之pa化物 5微升水或實例4(2)記載之未吸著部份或實例4(2)記 載之溶出部份 將上述所有成分混合後,於3crc反應3小時,於1〇〇1處 理10分鐘後進行離心,將上清液以下列條件進行HpLC* 析’然後確認對各個寡聚糖PA化物之作用。 裝置:L - 6200型(日立製作所製) 管柱:OHpak SB-803(8x300 mm,昭和電工公司製) 溶析液:含有5mM疊氮化鈉及1〇%甲基亞砜之〇·2Μ氯化 鈉。 檢測:螢光檢測器F-1150(曰立製作所製),激發波長320 nm ’螢光波長400 nm。Line 1243853 A7 B7 V. Description of the invention (87 reaction system 50 microliters 50 mM imidazole hydrochloride buffer (ρίί6.6) 2 3 microliters of water 5 microliters 4M sodium gasification 2 microliters 1M calcium gasification 5 microliters 5¾ g / ¾ liters of bovine serum albumin 10 microliters 2 picomoles / microliters of oligosaccharide palate 5 microliters of water or the non-adsorbed portion described in Example 4 (2) or the dissolved portion described in Example 4 (2) After all the above components were mixed, they were reacted at 3crc for 3 hours, and then centrifuged at 10000 for 10 minutes, and the supernatant was subjected to HpLC * analysis under the following conditions, and then the effect on each oligosaccharide PA compound was confirmed. Device: L-6200 (manufactured by Hitachi, Ltd.) Column: OHpak SB-803 (8x300 mm, manufactured by Showa Denko Corporation) Eluent: 0.2mM sodium chloride containing 5mM sodium azide and 10% methylsulfoxide Detection: Fluorescence Detector F-1150 (manufactured by Yuri Seisakusho), excitation wavelength 320 nm 'fluorescence wavelength 400 nm.

流速·· 1毫升/分鐘 管柱溫度:50°C k上述分析之結果判定,實例4 ( 2 )記載之未吸著部份及 溶出部份對各種硫酸化葡糖醛酸化岩藻寡聚糖p A化物作用 之有無,及作用前後SB803管柱中之保持時間,如表7所 示。 -90-Flow rate · 1ml / min column temperature: 50 ° C k The results of the above analysis are determined. The unabsorbed portion and dissolved portion described in Example 4 (2) are used for various sulfated glucuronidated fucoidan. The presence or absence of p A compound action, and the retention time in the SB803 column before and after the action, are shown in Table 7. -90-

1243853 A7 B7 五、發明説明(88 ) 表7 寡聚糖之PA化物 作用之有無 未吸著部份 溶出部份 使溶出部份作用前後之保持時間 作用前 作用後 K1) 無 無 9.74 9.72 1-⑵ 無 有 9.09 9.22 H3) 無 有 8.94 9.06 H4) 無 有 8.76 8.91 H5) 無 有 8.56 8.65 H6) 無 有 8.50 8.60 1_⑺ 無 有 8.40 8.48 H8) 無 有 8.31 8.40 2-⑶ 無 有 8.92 9.04 2-⑶ 無 有 8.56 8.68 如表7所示之方式,實例4 ( 2 )之未吸著部份對上述寡聚 糖之PA化物全無作用。另一方面,實例4(2)之溶出部份雖 對硫酸化葡糖醛酸化岩藻寡聚糖1 - ( 1 )無作用,但對其他 硫酸化葡糖醛酸化岩藻寡聚糖有作用。藉由此結果,強烈 顯示4 ( 2 )之溶出部份爲切斷硫酸化葡糖醛酸化岩藻寡聚糖 之葡糖醛酸之酵素。舉例而言,若從寡聚糖1-(3)將岩藻 糖1分子切斯,可生成寡聚糖2 - ( 3 )。此時之保持時間變化 被認定係從8.94分鐘變成8.92分鐘。然而實例4(2)之溶出 部份對寡聚糖1-(3)之反應中,保持時間係從8.94分鐘變 化成9.06分鐘。因此,可以認定此反應並非爲切斷岩藻糖 -91 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 _______B7 五、發明説明Γ89~~) ^ &quot;~ 之反應。同樣地藉由比較寡聚糖2_(5)與1-(4)及2-(3)與 1 - ( 2 )’可以認定實例4 ( 2 )溶出部份之反應並非爲切斷硫 酸酯之反應。再者,藉由比較寡聚糖丨气”與卜㈠)、1·(7) 與1-(6)及1-(3)與1-(2),暗示實例4(2)溶出部份之反應 並非切斷硫酸化岩藻糖之反應。 (3 )爲確認實例4 (2 )記載之溶出部份具有從-〇 -葡糖甞酸 酶活性’使實例4 ( 2 )記載之溶出部份作用於實例2記載之 石荒酸化葡糖酸化岩藥寡聚糖1 - ( 3 ),然後分析其質量變 化。首先,構築下列之反應系。 反應系 32.1毫升50mM咪唑鹽酸緩衝液(ρΗ6·6) 2.0毫升4Μ氣化鈉 0.8毫升1Μ氣化鈣 4.0毫升5毫克/毫升牛血清白蛋白 10毫克實例2記載之硫酸化葡糖醛酸化岩藻寡聚糖b(3 ) 1·〇毫升實例4(2)記載之溶出部份 將上述所有成分混合後,於3 〇 °C使其反應5日,爲了脱 鹽,饋入以10%乙醇平衡化之赛璐玢GCL-25管柱(4 X 90 公分)中,以每一溶份9 · 1毫升之方式分取溶份,對於被分 取之溶份’測定總糖量(-硫酸法)及總糖趁酸量(叶峻-硫 酸法)。其結果,藉由酚·硫酸法之顯色爲強陽性之部份, 藉由咔吐-硫酸法之顯色爲陰性。亦即,強烈顯示將含有葡 糖醛酸之硫酸化葡糖醛酸化岩藻寡聚糖1-(3)中之葡糖醛 酸切斷。更且,爲確認葡糖醛酸之切斷,對藉由酚-硫酸法 -92- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(9Q ) 之顯色爲強陽性之部份進行質量分析。結果此等部份質量 爲1506,亦即存在與從硫酸化葡糖醛酸化岩藻寡聚糖1-(3) 中切除葡糖醛酸後之質量(1506)—致之物質。再者,由於 無法測出與硫酸化葡糖醛酸化岩藻寡聚糖1 - ( 3 )質量(1682 ) 一致之物質,可知脱葡糖醛酸化反應進行得很完全。 藉由以上之結果,判定實例4 ( 2 )記載之溶出部份中有以-D -葡糖甞酸酶存在。與從硫酸化葡糖醛酸化岩藻寡聚糖1-(3)切除葡糖醛酸後之質量( 1506)—致之物質,被認定具有 下式(VII)之構造。 -93- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 91 〔VII〕1243853 A7 B7 V. Description of the invention (88) Table 7 Whether the PA compound of the oligosaccharide acts on the dissolution part of the non-adsorbed part so that the retention time before and after the action of the dissolution part K1) None 9.74 9.72 1-有 None 9.09 9.22 H3) None 8.94 9.06 H4) None 8.76 8.91 H5) None 8.56 8.65 H6) None 8.50 8.60 1_⑺ None 8.40 8.48 H8) None 8.31 8.40 2-⑶ None 8.92 9.04 2-⑶ No 8.56 8.68 As shown in Table 7, the unadsorbed portion of Example 4 (2) had no effect on the PA compound of the oligosaccharide. On the other hand, although the dissolution portion of Example 4 (2) had no effect on sulfated glucuronidated fuctooligosaccharides 1-(1), it had effects on other sulfated glucuronidated fuctooligosaccharides. . From this result, it is strongly shown that the dissolution part of 4 (2) is an enzyme that cuts off the glucuronic acid of the sulfated glucuronidated fuctooligosaccharide. For example, if one fucose molecule is Chess from oligosaccharide 1- (3), oligosaccharide 2-(3) can be generated. The change in the holding time at this time was considered to have changed from 8.94 minutes to 8.92 minutes. However, in the reaction of the dissolution part of Example 4 (2) to the oligosaccharide 1- (3), the holding time was changed from 8.94 minutes to 9.06 minutes. Therefore, it can be concluded that this reaction is not for cutting fucose-91-This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 _______B7 V. Description of the invention Γ89 ~~) ^ &quot; ~ of reaction. Similarly, by comparing the oligosaccharides 2_ (5) and 1- (4) and 2- (3) and 1- (2) ', it can be concluded that the reaction of the dissolution part of Example 4 (2) is not to cut off the sulfate. reaction. In addition, by comparing the oligosaccharides and qi ”, and bu㈠), 1 · (7) and 1- (6) and 1- (3) and 1- (2), it is suggested that the dissolution part of Example 4 (2) The reaction is not a reaction to cut off the sulfated fucose. (3) In order to confirm that the elution portion described in Example 4 (2) has a -0-glucosidase activity, the elution portion described in Example 4 (2) The reaction was performed on the stone wild acidified gluconate oligosaccharides 1-(3) described in Example 2, and the mass change was analyzed. First, the following reaction system was constructed. The reaction system was 32.1 ml of 50 mM imidazole hydrochloric acid buffer solution (ρΗ6 · 6) 2.0 ml of 4M sodium gasification, 0.8 ml of 1M calcium gasification, 4.0 ml of 5 mg / ml of bovine serum albumin, 10 mg of sulfated glucuronide fuco-oligosaccharide b (3) as described in Example 2 The dissolution part described in 4 (2) After mixing all the above components, it was reacted at 30 ° C for 5 days. For desalting, a celluloid GCL-25 column equilibrated with 10% ethanol (4 X 90 cm), aliquot each 9.1 ml of the solution, and measure the total sugar content (-sulfuric acid method) and the total sugar content (Ye Jun-sulfuric acid) law As a result, the color development by the phenol-sulfuric acid method was strongly positive, and the color development by the katu-sulfuric acid method was negative. That is, it was strongly shown that sulfated glucuronide containing glucuronic acid Glucuronic acid cleaving in acidified fucoidan oligosaccharide 1- (3). Furthermore, in order to confirm the cleaving of glucuronic acid, the phenol-sulfuric acid method-92- Chinese paper standard applies to this paper size (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 5. The quality of the part of the invention description (9Q) which is strongly positive is analyzed by mass. Results The quality of these parts is 1506, which means that it is present and the content of sulfuric acid The mass (1506) caused by the removal of glucuronic acid in the modified glucuronidated fuco-oligosaccharide 1- (3). Furthermore, the oligomerization with sulfated glucuronidated fucoid cannot be detected because The sugars 1-(3) were consistent in mass (1682), and it was found that the degluconation reaction proceeded completely. Based on the above results, it was determined that the elution part described in Example 4 (2) had -D-glucose Glycosidase is present. It is the same substance as the mass after excision of glucuronic acid from sulfated glucuronidated fuco-oligosaccharide 1- (3) (1506). Having the structure of formula (VII) of. This paper -93- applies China National Standard Scale (CNS) A4 size (210 X 297 mm) 1243853 A7 B7 V. invention is described in (91 [VII]

句8 F7 F6 P5Sentence 8 F7 F6 P5

F 3 F 2 F 1 -94-本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 ----------_ . 五、發明説明(92 ) 再者’以下將本物質稱爲8Fuc-4S 0 藉此,檢纣本發明“ _ D -葡糖甞酸酶對於實例5 (丨)所得 到硫酸化葡糖醛酸化岩藻寡聚糖b (3 )之p A化物之最佳反 應條件。再者,於求取本發明之々-D_葡糖甞酸酶活性 時’係藉由下列反應系測定活性。 反應系 5 0微升含有1〇〇 mM氣化鈉之5〇 咪唑-鹽酸緩衝液 (PH7.0) 2 1微升水 4微升1μ氣化鈣 10微升3毫克/毫升牛血清白蛋白 1 0微升4微微莫耳/微升實例5 ( 1 )所得到之硫酸化葡糖 路酸化岩藻寡聚糖1-(3)之ΡΑ化物 5微升α-D-葡糖甞酸酶溶液 將上述所有成分混合後,於2 2 °C反應3小時,於1〇〇。(:處 理1 0分鐘後進行離心,將上清液以下列條件進行Hplc分 析0 裝置:L_ 6200型(日立製作所製) 管柱:L·管柱(4.6x250 mm,財團法人化學品檢查協會 製) 溶析液:含有0.3 % 丁醇之50 mM醋酸-三乙胺緩衝液 (ρΗ5·0) 檢測:螢光檢測器F-1150(日立製作所製),激發波長320 nm,螢光波長400 nm。 -95- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 _____B7 五發明説明(93^) 一 ' &quot;F 3 F 2 F 1 -94- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 ----------_. V. Description of the invention (92) This substance is hereinafter referred to as 8Fuc-4S 0, thereby detecting the present invention "__D-Glucosidase For sulfated glucuronidated fuctooligosaccharide b (3) obtained in Example 5 (丨) The best reaction conditions of p A compound. In addition, when determining the 々-D-glucosidase activity of the present invention, the activity was measured by the following reaction system. 50 microliters of the reaction system contains 1〇. 50 mM sodium gasified 50 imidazole-hydrochloric acid buffer (PH7.0) 2 1 microliter of water 4 microliters 1 micrometer of calcium vaporized 10 microliters 3 mg / ml bovine serum albumin 10 microliters 4 picomolars / micro 5 microliters of α-D-glucosidase solution after mixing all the above components with 5 μl of α-D-glucuronidase solution. The reaction was performed at 2 ° C for 3 hours at 100 ° C. (Centrifuge after 10 minutes of treatment. The supernatant was subjected to Hplc analysis under the following conditions. 0 Device: L_ 6200 (manufactured by Hitachi). Column: L · Column (4.6x250 mm, corporate foundation Product inspection association) Eluate: 50 mM acetic acid-triethylamine buffer (ρΗ5.0 · 0) containing 0.3% butanol Detection: Fluorescence detector F-1150 (manufactured by Hitachi), excitation wavelength 320 nm, fluorescence The light wavelength is 400 nm. -95- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 _____B7 Five invention instructions (93 ^) a '&quot;

流速:1毫升/分鐘 管柱溫1 : 4(TC 1單位之本發明α _ D -葡糖:y:酸酶,係指上述反應系中以 1分鐘時間將1微莫耳實例5 ( 1 )得到之硫酸化葡糖醛酸化岩 漢暴聚糖1-(3)PA化物之葡糖酸酸基鍵結切斷之酵素量。 所切斷之葡糖醛酸基鍵結之量係藉由下式求得。 數學式2 DGA/18〇x〇.〇〇5=U/ml DGA :被切斷之實例5 ( 1)得到之硫酸化葡糖遂酸化岩藻寡 聚糖1-(3)PA化物之量(微莫耳) 180 :反應時間(分鐘) 0.005 :酵素液量(毫升) (4) 將實例5 (3 )記載之8FUC-4S藉由2 -胺基吡啶勞光標識 (PA 化) 取50毫微莫耳之實例5(3)記載之8FUC-4S,使用糖基標 示劑及糖基標示試劑套組(均爲寶酒造公司製)將還原性末 端用2-胺基峨症進行螢光標識(PA化),調製該寡聚糖之 PA化物。以下將本物質稱爲8Fuc-4S-PA 〇 (5) 使用8Fuc-4S-PA之實例4(2)記載之未吸著部份及溶出 部份之作用之檢討 實例4(2 )記載之未吸著部份及溶出部份對實例5 (4)記載 之8Fuc-4S-PA之作用,藉由下列反應系調查。 反應系 50微升50mM咪唑·鹽酸緩衝液(PH6.6) -96-Flow rate: 1 ml / min column temperature 1: 4 (TC 1 unit of the present invention α_D-glucose: y: acidase, which refers to the reaction system in which 1 micromolar of Example 5 (1 ) The amount of the enzyme that cleaves the glucuronic acid group of the sulfated glucuronidated glutamate 1- (3) PA compound. The amount of the glucuronide group that is cut off is borrowed It is calculated from the following formula: Mathematical formula 2 DGA / 18 × 0.05 = U / ml DGA: Example 5 (1) which was cut off Sulfated glucose obtained from acidified fuctooligosaccharide 1- ( 3) Amount of PA compound (micromolar) 180: reaction time (minutes) 0.005: amount of enzyme solution (ml) (4) 8FUC-4S described in Example 5 (3) is identified by 2-aminopyridine (PA conversion) Take 50 nanomolar of 8FUC-4S as described in Example 5 (3), and use a glycosyl labeling agent and a glycosyl labeling reagent kit (both manufactured by Takara Shuzo Co., Ltd.). Emei is fluorescently labeled (PA-based) to modulate the PA compound of the oligosaccharide. This substance is hereinafter referred to as 8Fuc-4S-PA 〇 (5) As described in Example 4 (2) using 8Fuc-4S-PA Review of the role of the absorbing and dissolving parts Example 4 (2) The effects of the non-adsorbed portion and the eluted portion on 8Fuc-4S-PA described in Example 5 (4) were investigated by the following reaction system: 50 microliters of 50 mM imidazole · hydrochloric acid buffer (PH6.6) -96 -

本紙張尺度適用中國國家標準(CNS) Α4规格(210 X 297公爱) 1243853This paper size applies to China National Standard (CNS) Α4 size (210 X 297 public love) 1243853

2 3微升水 5微升4M氣化鈉 2微升1 Μ氣化_ 5微升5毫克/毫升牛血清白蛋白2 3 microliters of water 5 microliters of 4M sodium gasification 2 microliters of 1M gasification_ 5 microliters 5 mg / ml bovine serum albumin

1〇微升2微微莫耳/微升8Fuc-4S_pA 5微升水或實例4(2)記載之未吸著部份或實例4(2)記载 之溶出部份 將上述所有成分混合後,於3〇。〇反應3小時,於10(rc處 理10分鐘後進行離心,將上清液以5(3)記載之條件進行 HPLC分析。 上述分析之結果,實例4(2)記載之未吸著部份可將8Fm_ 4S-PA,解,而實例4(2)記載之溶出部份無法將盱叫_4孓 PA分解。再者,藉由實例4(2)記載之未吸著部份將aw 4S-PA分解所得到之分解物,與實例5(1)所得到之硫酸化 葡糖醛酸化岩藻寡聚糖丨^丨泞八化物在相同位置溶出。此 ,況與實例2及實例3中大量得到與硫酸化葡糖醛酸化岩藻 寡聚糖1-( 1)相同物質之情況並無矛盾。亦即,實例 記載之未吸著部份,可判定爲對脱乙醯化脱葡糖醛酸化硫 酸化葡糖醛酸化岩藻聚糖及硫酸化葡糖醛酸化岩藻寡聚糖 等作用之内-α-L-岩藻糖甞酶。 藉由此結果,可判定實例4所調製之硫酸化葡糖醛酸化岩 藥聚糖赛路纷爲可將本發明之-葡糖苷酸酶及本發明 之内-從-L -岩藻糖荅酶分離之有用樹脂。 (6)再者’檢讨本發明之内-沒-l·岩藻糖答酶對8Fuc_4S_ -97-10 microliters 2 picomoles / microliters 8Fuc-4S_pA 5 microliters of water or the unadsorbed portion described in Example 4 (2) or the dissolved portion described in Example 4 (2). 3〇. The reaction was performed for 3 hours, and the mixture was centrifuged at 10 ° C for 10 minutes. The supernatant was subjected to HPLC analysis under the conditions described in 5 (3). As a result of the above analysis, the non-adsorbed portion described in Example 4 (2) may be 8Fm_ 4S-PA was solved, and the dissolution part described in Example 4 (2) could not dissolve 盱 4_PA. Furthermore, aw 4S- The decomposed product obtained by PA decomposition is dissolved at the same position as the sulfated glucuronidated fucoidan obtained in Example 5 (1) at the same position. In this case, a large number of compounds are dissolved in Example 2 and Example 3. There is no contradiction in obtaining the same substance as sulfated glucuronidated fuctooligosaccharide 1- (1). That is, the non-adsorbed portion described in the example can be judged to be deacetylated degluconated. Within the action of sulfated glucuronidated fucoidan and sulfated glucuronidated fuctooligosaccharide-α-L-fucosinase. Based on this result, the sulfuric acid prepared in Example 4 can be determined. Glucuronidated fucosides are useful resins for separating the glucuronidase of the present invention and the -L-fucosidase from within the present invention. (6) Who 'review by the present invention - no -l · A enzyme for fucose 8Fuc_4S_ -97-

1243853 A7 B7 五、發明説明(95 ) PA之最佳反應條件。再者,於求取本發明之内-沒-L-岩藻 糖苷酶活性時,係藉由下列反應系測定活性。 反應系 5 0微升含有40 mM氣化鈉之50 mM醋酸緩衝液(ρΗ5·5) 23微升水 2微升1 Μ氣化鈣 10微升3毫克/毫升牛血清白蛋白 10微升4微微莫耳/微升8Fuc-4S-PA 5微升内-a - L -岩藻糖苷酶溶液 在3 0 °C反應3小時,反應液之分析以與上述同樣之方式 進行。 1單位之本發明内-α - L -岩藻糖甞酶,係指上述反應系中 以1分鐘時間將1微莫耳8Fuc-4S-PA之切斷之酵素量。所切 斷之岩藻糖基鍵結之量係藉由下式求得。 數學式3 DPA/180x0.005=U/ml DPA :所切斷之8Fuc-4S-PA之量(微莫耳) 180 :反應時間(分鐘) 0.005 ··酵素液量(毫升) 實例6 將實例4 ( 2 )記載之未吸著部份及溶出部份分別藉由預先 以含有100 mM氣化鈉、10 mM氣化#5及5 m Μ疊氮化納之 10 mM咪吐-鹽酸緩衝液(ρΗ7·5 )平衡化之Sephacryl S-200 管柱(4.4 X 100 cm)凝膠過濾,以每溶份13.5毫升之方式分 -98- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)1243853 A7 B7 V. Invention description (95) Optimum reaction conditions of PA. In addition, when the endo-me-L-fucosidase activity of the present invention is determined, the activity is measured by the following reaction system. 50 microliters of 50 mM acetic acid buffer solution (ρΗ5 · 5) containing 40 mM sodium vaporization 23 microliters of water 2 microliters 1 M calcium vaporization 10 microliters 3 mg / ml bovine serum albumin 10 microliters 4 pico Moore / microliter 8Fuc-4S-PA 5 microliters of endo-a-L-fucosidase was reacted at 30 ° C for 3 hours, and the reaction solution was analyzed in the same manner as above. One unit of the in-α-L-fucosinase of the present invention refers to the amount of enzyme that cuts 1 micromole of 8Fuc-4S-PA in one minute in the above reaction system. The amount of the fucosyl bond that was cut was obtained by the following formula. Mathematical formula 3 DPA / 180x0.005 = U / ml DPA: the amount of 8Fuc-4S-PA cut off (micromolar) 180: reaction time (minutes) 0.005 ·· enzyme volume (ml) Example 6 Example The non-adsorbed portion and the eluted portion described in 4 (2) were prepared by pre-treatment with a 10 mM imidazole-hydrochloric acid buffer solution containing 100 mM sodium vaporization, 10 mM vaporization # 5, and 5 μM sodium azide. (ΡΗ7.5) Equilibrium gel filtration with Sephacryl S-200 column (4.4 X 100 cm), divided into 13.5 ml per solution -98- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm)

裝 訂Binding

線 1243853 A7 B7 五、發明説明(96 ) 取溶份。對於溶出部份,分別測定其中本發明之π _ D -葡 糖菩酸酶及本發明之内-以-L -岩藻糖答酶之活性,其中實 例4 ( 2 )記載之未吸著部份藉由實例5 ( 2 )記載之方法,基質 係使用硫酸化葡糖醛酸化岩藻寡聚糖i 3 )之ρ Α化物,以 及實例4 ( 2 )記載之溶出部份藉由實例5 ( 5 )記載之方法測 定。測定本發明a - D -葡糖甞酸酶及α - L _岩藻糖苷酶之活 性。藉由上述凝膠過濾法所測得之本發明以-D -葡糖苷酸 酶之分子量約爲12萬〜18萬,而本發明内-α-L-岩藻糖答 酶之分子量約爲15萬〜20萬。 實例7 將參考例1 ( 1)記載之粗硫酸化葡糖醛酸化岩藻聚糖部份 用DEAE -赛路纷Α·800精製。亦即,於預先以含有50mM 氣化鈉及1 0 %乙醇之20 mM咪嗅-鹽酸緩衝液(ρΗ8.0 )平衡 化之5公升DEAE -赛路紛A - 800之管柱中,積入溶於相同緩 衝液中之5公克參考例1 ( 1 )記載之粗硫酸化葡糖醛酸化岩 藻聚糖部份,用相同緩衝液洗淨後,再用含有1 〇〇 mM氯化 鈉及10%乙醇之20 mM咪唑-鹽酸緩衝液(pH8.0)洗淨,用 1Q0 mM至2 Μ之氯化鈉梯度溶析。將被溶出之溶份分劃爲 每份500毫升,然後藉由驗·硫酸法測定總糖量。將溶出鹽 濃度500 mM附近所溶出之硫酸化葡糖醛酸化岩藻聚糖認定 爲主成分部份而加以收集,藉由裝設有排除分子量爲1〇萬 之中空纖維之限外過濾裝置予以脱鹽,然後凍結乾燥,得 到精製硫酸化葡糖醛酸化岩藻聚糖部份0.9公克。檢討上述 精製硫酸化葡糖醛酸化岩藻聚糖部份之葡糖醛酸含量之調 -99- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(97 ) 整。首先,構築下列之反應系。 反應系 5微升50mM咪唑-鹽酸緩衝液(pH6.6) 0.5微升4M氯化鈉 0.5微升1 Μ氣化鈣 0.25微升5毫克/毫升牛血清白蛋白 3.35微升實例4(2)記載之溶出部份 2.4毫升1.25 %精製硫酸化葡糖醛酸化岩藻聚糖部份水溶 液 將上述所有成分混合後,於2 5 °C使其反應,經不同時間 取樣,將樣品充分透析,以及除去切斷之葡糖醛酸。表8 中係記載各樣品中所含之岩藻糖量、葡糖醛酸量及彼等之 比率。 表8 反應時間 (小時) 岩藻糖含量 (mM) 葡糖醛酸含量 (mM) 岩藻糖與葡糖醛酸 之莫耳比 0 6.1 1.4 4.4 : 1 1 6.3 1·3 4.9 : 1 2 6.9 1.2 5.8 : 1 5 6.5 0.90 7.2 : 1 10 6.9 0.70 9.9 : 1 20 6.3 一 0.65 9.7 : 1 -100- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(98 ) 藉由上述結果,判定若使用實例4(2)記載之溶出部份, 可以藉由將硫酸化葡糖醛酸化岩藻聚糖之葡糖醛酸切除, 而調整岩藻糖與葡糖醛酸之莫耳比。 實例8 (1) 鈣鹽濃度對於酵素反應之影響 在測定本發明之Γ硫酸化葡糖醛酸化岩藻聚糖分解活 性」之時,若將反應系中所含有之氣化鈣濃度降低,則見 到活性降低。因此,對於本發明之α-D-葡糖苷酸酶及本 發明之内-a - L -岩藻糖苷酶,亦調查反應系中所含氣化鈣 之濃度與酶相對活性之關係。結果,判定該二酵素皆會被 氣化鈣活性化。再者,發現該二酵素亦被醋酸鈣同樣地活 性化。 (2) 蛋白質對於酵素反應之影響 當測定本發明之「硫酸化葡糖醛酸化岩藻聚糖分解活 性」時,若將牛血清白蛋白從反應系中除去,則見到活性 降低。因此,對於本發明之《·〇-葡糖荅酸酶及本發明之 内_ a _ L -岩藻糖甞酶,亦調查反應系中所含之牛血清白蛋 白濃度與酶相對活性之關係。結果,判定該二酵素$會被 牛血清白蛋白活性化。再者,發現亦可被本發明之岩^依 聚糖分解嗜岩藥菌SI- 1234菌株生產之蛋白質同樣地活 化。 (3) 氣化鈉對於酵素反應之影響 當測足本發明之「硫酸化葡糖醛酸化岩藻聚糖分解活 性」時,若將氣化鈉從反應系中除去,則見到活性;低'。 101 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853Line 1243853 A7 B7 V. Description of the invention (96) Take the solvent. For the eluted fraction, the activity of the π_D-glucosaccharinase of the present invention and the -L-fucosylase within the present invention was measured separately, and the unadsorbed portion described in Example 4 (2) In the method described in Example 5 (2), the substrate was a sulfated glucuronidated fucoidan i 3), and the elution portion described in Example 4 (2) was used in Example 5 (2). 5) The method described in the measurement. The a-D-glucosidase and α-L_fucosidase activities of the present invention were measured. The molecular weight of the -D-glucuronidase of the present invention measured by the above-mentioned gel filtration method is about 120,000 to 180,000, and the molecular weight of the endo-α-L-fucosylase of the present invention is about 15 Million to 200,000. Example 7 The crude sulfated glucuronidated fucoidan portion described in Reference Example 1 (1) was purified by DEAE-Servin A · 800. That is, a column of 5 liters of DEAE-Serupine A-800 equilibrated with a 20 mM olfactory-hydrochloric acid buffer solution (ρΗ8.0) containing 50 mM sodium gas and 10% ethanol was deposited in advance, 5 g of the crude sulfated glucuronidated fucoidan described in Reference Example 1 (1) dissolved in the same buffer solution, washed with the same buffer solution, and then washed with 100 mM sodium chloride and Wash with 10% ethanol in 20 mM imidazole-hydrochloric acid buffer (pH 8.0) and elute with a gradient of 1Q0 mM to 2M sodium chloride. The dissolved fractions were divided into 500 ml portions, and the total sugar content was measured by a sulfuric acid test. The sulfated glucuronidated fucoid dissolved in the vicinity of 500 mM of dissolved salt concentration was collected as the main component, and was collected by an out-of-limit filtering device equipped with a hollow fiber with a molecular weight of 100,000. Desalted and freeze-dried to obtain 0.9 g of refined sulfated glucuronidated fucoidan. Review the adjustment of the glucuronic acid content of the above-mentioned refined sulfated glucuronidated fucoidan -99- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Invention Description (97) whole. First, construct the following reaction system. Reaction system 5 μl 50 mM imidazole-hydrochloric acid buffer (pH 6.6) 0.5 μl 4M sodium chloride 0.5 μl 1 M calcium vaporized 0.25 μl 5 mg / ml bovine serum albumin 3.35 μl Example 4 (2) 2.4 ml of the 1.25% refined sulfated glucuronidated fucoidan aqueous solution was mixed with all the above components and reacted at 25 ° C. The samples were taken at different times and the samples were fully dialyzed. Remove the cut-off glucuronic acid. Table 8 shows the amount of fucose, glucuronic acid, and their ratios contained in each sample. Table 8 Reaction time (hours) Fucose content (mM) Glucuronic acid content (mM) Molar ratio of fucose to glucuronic acid 0 6.1 1.4 4.4: 1 1 6.3 1.3 4.9: 1 2 6.9 1.2 5.8: 1 5 6.5 0.90 7.2: 1 10 6.9 0.70 9.9: 1 20 6.3-0.65 9.7: 1 -100- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the Invention (98) Based on the above results, it is determined that if the dissolution portion described in Example 4 (2) is used, the fucose can be adjusted by removing the glucuronic acid from the sulfated glucuronidated fucose. Molar ratio with glucuronic acid. Example 8 (1) Effect of calcium salt concentration on enzyme reaction When measuring the Γ sulfated glucuronidation fucoidan decomposition activity of the present invention ", if the concentration of gasified calcium contained in the reaction system is reduced, then A decrease in activity was seen. Therefore, for the α-D-glucosidase of the present invention and the -a-L-fucosidase of the present invention, the relationship between the concentration of calcium carbonate contained in the reaction system and the relative activity of the enzyme was also investigated. As a result, it was determined that both of these enzymes would be activated by calcium carbonate. Furthermore, it was found that this dienzyme was similarly activated by calcium acetate. (2) Effect of protein on enzyme reaction When the "sulfated glucuronidated fucoidan decomposition activity" of the present invention is measured, if bovine serum albumin is removed from the reaction system, the activity is reduced. Therefore, the relationship between the concentration of bovine serum albumin and the relative activity of the enzyme in the reaction system was also investigated for the "· -glucosidase" and "a_L-fucosidase" of the present invention. . As a result, it was determined that the second enzyme $ would be activated by bovine serum albumin. Furthermore, it was found that the protein produced by the fusarium SI-1234 strain degraded by the rock glycosaminoglycan of the present invention can be similarly activated. (3) Effect of sodium gasification on enzyme reaction When measuring the "sulfated glucuronidated fucoidan decomposition activity" of the present invention, if sodium gasification is removed from the reaction system, the activity is seen; low '. 101-This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 1243853

因此,對於本發明之a_D•葡糖苷酸酶及本發明之内-江· L -石深糖菩酶’亦調查反應系中所含之氣化鈉濃度與酶相 對活性之關係。結果,判定該二酵素在以低分子之寡聚糖 做爲基貧時,並未被氣化鈉活性化。由此,可確認氣化鈉 係在酵素之基質爲高分子之硫酸化葡糖醛酸化岩藻聚糖 時’將兩酵素活性化。 實例9 將石藥依聚糖分解嗜岩藻菌SI - 1234菌株接種於培養基 上’孩培養基係將含有以參考例丨(丨)之方法調製之來自沖 繩海級藻之粗硫酸化葡糖醛酸化岩藻聚糖部份〇.2 %及蛋白 腺1 /〇之人工每水(pH8.0 )(加馬林拉勃拉翠公司製)組成之 培養基600毫升於12〇。(:經20分鐘熱壓器處理而得。接種 後’於24 X:培養72小時做爲菌種培養液。於30公升之搖 瓶發酵器中,將含有蛋白腺2〇〇公克及消泡劑(Κλ17〇,信 越化學工業公司製)之人工海水形成之ρΗ8·0培養基18公升 於120°C進行20分鐘熱壓器處理所得之培養基,與以參考 例1 ( 1)之方法調製之來自沖繩海蘊藻之粗硫酸化葡糖醛酸 化岩藻聚糖部份4 0公克溶於2公升之人工海水並於9 5 °C處 理1小時而得者加以混合,然後接種上述菌種培養液,並 於每分鐘125迴轉之迴轉速度下,在24 °C培養72小時。再 者’於培養中將培養基之pH値自動控制在7以上。培養終 了後’將培養液離心’得到菌體及培養上清液。 如上述之方法,對於添加在本培養之培養基中之硫酸化 葡糖醛酸化岩藻聚糖,將加熱溫度爲約9 5 Ό之情況與於約 -102- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(1Q1 )Therefore, the relationship between the concentration of aerated sodium contained in the reaction system and the relative activity of the enzyme was also investigated for the a_D glucuronidase of the present invention and Nai-Jiang · L-shishensubo enzyme of the present invention. As a result, it was determined that the dienzyme was not activated by sodium vaporization when the low-molecular oligosaccharide was used as the base. From this, it can be confirmed that when sodium carbonate is a substrate in which the substrate of the enzyme is a polymerized sulfated glucuronide fucoidan ', both enzymes are activated. Example 9 Inoculation of the fucoidan strain SI-1234, which is a glycococcus lycoside, into the culture medium, the culture medium system will contain crude sulfated glucoaldehyde from Okinawa sea-grade algae prepared by the method of Reference Example 丨 (丨). 600 ml of culture medium consisting of acidified fucoidan fraction 0.2% and protein gland 1/0 artificial per water (pH 8.0) (manufactured by Gabriel Labradle) was prepared at 120. (: Obtained by 20-minute autoclave treatment. After inoculation, 'at 24 X: cultured for 72 hours as the culture broth. In a 30-liter shake flask fermenter, 200 g of protein gland and defoaming are included. Agent (Κλ17〇, manufactured by Shin-Etsu Chemical Industry Co., Ltd.) 18 liters of ρΗ8.0 culture medium formed by artificial seawater and 120 ° C 20-minute autoclave culture medium, and prepared from the method of Reference Example 1 (1) 40 grams of crude sulfated glucuronidated fucoidan from Okinawa seaweed was dissolved in 2 liters of artificial seawater and treated at 95 ° C for 1 hour, mixed, and then inoculated with the above culture medium And, at a rotation speed of 125 revolutions per minute, culture at 24 ° C for 72 hours. Furthermore, 'the pH value of the culture medium is automatically controlled to more than 7 in the culture. After the culture is complete,' the culture solution is centrifuged 'to obtain bacterial cells and Culture the supernatant. As described above, for the sulfated glucuronidated fucoidan added to the culture medium, the heating temperature is about 9 5 Ό and about -102- this paper size applies China National Standard (CNS) A4 Specification (210 X 297 PCT) 1243853 A7 B7 V. invention is described (1Q1)

Invest. Dermatol.,103: 306-309,1994)之方法,於顯微鏡下 在玻璃培養m中將鬍鬚與毛囊分離。從一隻鼠採取大約 1 4〜1 6根鬍鬚。繼而,將參考例1 ( 1)記載之來自沖繩海蘊 藻之粗硫酸化葡糖醛酸化岩藻聚糖部份溶解於RPMI-1640 培養基中,調製成所設定濃度2 0倍之濃度液,然後於培養 系中添加二十分之一之量。對照組中添加同量之培養基。 鬍鬚之培養,使用組織培養用培養孤Falcon 3037(Becton Dickinson Labware公司製),於中央穴中加入添加0.7毫升 20%FCS之RPMI- 1 640培養基,於其上舖上滅菌之不銹鋼 網(池田理化股份有限公司製)及拭透鏡紙(提西凱斯股份有 限公司製)。 將毛髮加載於其上培養。將來自沖繩海龜蕩之硫酸化葡 糖趁酸化岩藻聚糖部份預先添加於培養基中。培養係在3 5 °(:及5%(:02存在下進行6曰。毛髮之長度,於培養開始前 及終了後在顯微鏡下使用卡尺測定至0 . 1毫米之位數。對 於各種樣品濃度,同一組使用3〜5根毛髮測定,伸長之長 度藉由平均値土標準誤差表示。再者,有意義差檢定係進 行學生之t檢定,並求出相對於對照組之P値。將其結果示 於表9中。 -104- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(1Q2 表9 添加樣品 濃度 (毫克/毫升) 檢體數 毛髮伸長度(平均値 土標準誤差)(毫米) P値 沖繩海蘊藻 0.01 5 0.9 土 0.25 0.17 對照 0 6 0.38土0.23 如表9中所示,來自沖繩海蘊藻之硫酸化葡糖醛酸化岩藻 聚糖部份,與對照組相較,可確認有使老鼠之毛髮伸長之 效果。 實例1 1 (1)酵素之調製 將藉由實例9之方法調製之岩藻依聚糖分解嗜岩藻菌S I -1234菌株之菌體萃取液,用含有10 mM氣化鈣之10 mM咪 唑-鹽酸緩衝液(pH7.5)充分透析,離心後,得到上清液, 亦即本發明之泛-D-葡糖甞酸酶及内- π- L-岩藻糖甞酶共 存之粗酵素液。將所得到之粗酵素液饋入以相同緩衝液平 衡化之5 00毫升DEAE-赛璐玢A-800管柱中,用相同緩衝 液洗淨後,藉由100 mM至40 OmM之氣化鈉梯度溶析,以 每瓶6 7毫升之方式分取溶出部份,收集硫酸化葡糖醛酸化 岩藻聚糖分解活性部份。將所得到硫酸化葡糖醛酸化岩藻 聚糖分解活性部份,藉由裝設有分劃分子量爲1萬之中空 纖維之限外過濾機濃縮,然後用含有50 mM氣化鈉及10 mM氣化鈣之10 mM咪唑-鹽酸緩衝液(pH7.5)將緩衝液置 換。將所得到之酵素液饋入以相同緩衝液平衡化之實例 -105- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明( 4 ( 1)記載之5 0毫升硫酸化葡糖醛酸化岩藻聚糖-赛璐玢管 柱中,用相同緩衝液洗淨後,用50 mM至600 mM之氣化鈉 梯度溶析。以每瓶1 0毫升之方式分取溶出部份,測定各部 份之硫酸化葡糖醛酸化岩藻聚糖分解活性。結果,僅僅只 有溶出部份可檢測出活性,未吸著部份並未發現活性。但 是,若將未吸著部份與溶出部份混合,硫酸化葡糖醛酸化 岩藻聚糖分解活性將與加至管柱中之活性約略相等。 收集未吸著部份,藉由限外過濾機濃縮成1〇〇毫升,而得 到未吸著部份濃縮液。另一方面,使用濃縮之未吸著部份 測定硫酸化葡糖醛酸化岩藻聚糖分解活性,其活性部份, 藉由限外過濾機濃縮成200毫升,得到溶出部份濃縮液。 將此等酵素進一步精製,以嘗試調製硫酸化葡糖醛酸化岩 藻寡聚糖。首先,構築爲測定各個部份之活性之反應系。 上述之溶出部份及未吸著部份單獨使用時,無法對硫酸 化葡糖备故化石澡聚糖作用’因而無法有效地生成寡聚 糖,但若共存,則可將硫酸化葡糖醛酸化岩藻聚糖分解, 而效率良好地使其低分子化。兩酵素共存之狀態下,將分 解硫酸化葡糖路酸化岩蕩聚糖之活性藉由下列之活性測定 方法數値化。 未吸著邵份之活性測定方法如以下之方式進行。亦即, 將1 0微升之1 %粗硫酸化葡糖趁酸化岩藻聚糖部份溶液, 5 3微升之50 mM咪咬-鹽酸緩衝液(ρΗ6·6 ),5微升之4 Μ氯 化鈉,2微升之1Μ氣化鈣,10微升之5毫克/毫升牛血清白 蛋白,1微升之溶出部份濃縮液與1 9微升之供測定活性用 -106- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 裝 訂Invest. Dermatol., 103: 306-309, 1994), the beard is separated from the hair follicle in a glass culture under a microscope. Take about 1 to 16 beards from one rat. Next, partially dissolve the crude sulfated glucuronidated fucoidan from the seaweed algae of Okinawa described in Reference Example 1 (1) in RPMI-1640 medium to prepare a concentration solution of 20 times the set concentration. Then add one-twentieth to the culture line. The same amount of medium was added to the control group. For beard culture, Falcon 3037 (manufactured by Becton Dickinson Labware) for tissue culture was used. 0.7 ml of 20% FCS RPMI-1 640 medium was added to the central acupoint, and a sterilized stainless steel mesh (Ikeda R & D) was placed on it. Co., Ltd.) and lens cleaning paper (made by Tishikesi Co., Ltd.). Hair was loaded thereon and cultivated. The sulfated glucose from the Okinawa Turtle was added to the culture medium in advance while the acidic fucoidan portion was added. The culture line was performed in the presence of 35 ° (: and 5% (: 02). The length of hair was measured under the microscope to a digit of 0.1 mm before and after the culture was started. For various sample concentrations The same group was measured using 3 to 5 hairs, and the length of elongation was expressed by the standard error of average soil. Furthermore, the significant difference test was performed by the student's t test, and the P 値 relative to the control group was determined. The results were compared. Shown in Table 9. -104- This paper size is in accordance with China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (1Q2 Table 9 Add sample concentration (mg / ml) Number of samples Hair elongation (standard mean soil error) (mm) P 値 Okinawa sea algae 0.01 5 0.9 soil 0.25 0.17 control 0 6 0.38 soil 0.23 As shown in Table 9, the sulfated glucuronidation of sea algae from Okinawa Compared to the control group, the fucoidan portion was confirmed to have the effect of elongating the hair of mice. Example 1 1 (1) Modulation of Enzymes The fucoidan prepared by the method of Example 9 will decompose the rock. Algae strain SI-1234 strain cell extract A 10 mM imidazole-hydrochloric acid buffer solution (pH 7.5) with 10 mM calcium carbonate was fully dialyzed, and the supernatant was obtained after centrifugation, that is, the pan-D-glucosaminidase and endo-π-L of the present invention. -A crude enzyme solution coexisting with fucosidase. The obtained crude enzyme solution was fed into a 500 ml DEAE-cellulose A-800 column equilibrated with the same buffer solution, and washed with the same buffer solution. With a gradient of 100 mM to 40 OmM sodium gaseous leaching, dissolve the dissolving fraction in 67 ml per bottle, and collect the sulfated glucuronidated fucoidan decomposing active fraction. The obtained sulfuric acid The glucuronidated fucoidan-decomposing active fraction was concentrated by an out-of-limit filter equipped with a hollow fiber with a molecular weight of 10,000, and then concentrated with a solution containing 50 mM sodium gas and 10 mM calcium gas. 10 mM imidazole-hydrochloric acid buffer solution (pH 7.5) was used to replace the buffer solution. The obtained enzyme solution was fed to an example of equilibration with the same buffer solution. -105- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (4 (1) 50 ml of sulfated glucuronidated fucoidan-celluloid After washing in the column with the same buffer solution, dissolve it in a gradient of 50 mM to 600 mM sodium gaseous solution. Dissolve the dissolution fraction in 10 ml per bottle, and measure the sulfated glucosyl in each fraction. Decomposition activity of acidified fucoidan. As a result, only the eluted portion could detect the activity, and no activity was found on the non-adsorbed portion. However, if the non-adsorbed portion was mixed with the eluted portion, the glucosyl sulfate was sulfated The acidified fucoidan decomposition activity will be approximately equal to the activity added to the column. The non-adsorbed portion was collected and concentrated to 100 ml by an external filter to obtain a non-adsorbed portion concentrate. On the other hand, the concentrated non-adsorbed portion was used to measure the sulfated glucuronidated fucoidan decomposition activity, and the active portion was concentrated to 200 ml by means of an out-of-limit filter to obtain a concentrated solution of the eluted portion. These enzymes were further refined in an attempt to prepare sulfated glucuronidated fuctooligosaccharides. First, a reaction system was constructed to measure the activity of each part. When the dissolving part and the non-adsorbing part mentioned above are used alone, they cannot act on the sulfated glucose fossil bath glycan 'and therefore cannot effectively generate oligosaccharides. However, if they coexist, the sulfated glucoaldehyde can be used. The acidified fucoid is decomposed, and it is efficiently made low molecular. In the state where the two enzymes coexist, the activity of decomposing sulfated glucoside acidified rock glycan is determined by the following activity measurement method. The method for measuring the activity of the non-adsorbed fraction was performed in the following manner. That is, 10 microliters of 1% crude sulfated glucose while acidifying a portion of the fucoidan solution, 5 3 microliters of 50 mM mimic-hydrochloric acid buffer (ρΗ6 · 6), 5 microliters of 4 M sodium chloride, 2 microliters of 1M calcium carbonate, 10 microliters of 5 mg / ml bovine serum albumin, 1 microliter of the dissolution portion concentrate and 19 microliters for measuring activity Paper size applies to China National Standard (CNS) A4 (210 X 297 mm) binding

線 1243853 A7 B7 五、發明説明(1Q4 ) 之來自未吸著部份之酵素液混合,於3 0 °C反應3小時後, 於100 °C處理10分鐘,進行離心後,用90微升進行HPLC分 析,以測定低分子化之程度。做爲對照者,係將來自未吸 著部份之酵素液用溶解該酵素液之緩衝液代替而反應,並 且粗硫酸化葡糖醛酸化岩藻聚糖部份,使用水代替而反 應,然後同樣地藉由HPLC進行分析。 1單位之硫酸化葡糖醛酸化岩藻聚糖分解活性,係指在上 述反應系中於1分鐘時間將1微莫耳硫酸化葡糖醛酸化岩藻 聚糖之岩藻糖基鍵結切斷之酵素量。所切斷之岩藻糖基鍵 結之量係藉由下式求得。 數學式4 {(10xl000xl/100)/MG}x{(MG/M)-l}x{l/(180x0.019)}=U/ml 10x1000x1/100 :添加於反應系中之粗硫酸化葡糖醛酸化岩 藻聚糖部份(微克) M G ··對照反應液之硫酸化葡糖醛酸化岩藻聚糖之平均分 子量 Μ:反應生成物之平均分子量 (MG/M)-1 : 1分子硫酸化葡糖醛酸化岩藻聚糖藉由酵素 切斷之部位數 180 :反應時間(分鐘) 0.019 :酵素液量(毫升) 再者,HPLC之條件係如以下所述。 裝置·· L-6200型(日立製作所製) 管柱:OHpak SB-806HQ(8 x 3 00mm,昭和電工社製) -107- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(1Q5 )Line 1243853 A7 B7 V. Description of the invention (1Q4) The enzyme solution from the non-adsorbed part is mixed, reacted at 30 ° C for 3 hours, and then treated at 100 ° C for 10 minutes. After centrifugation, use 90 microliters. HPLC analysis to determine the extent of low molecularization. As a control, the enzyme solution from the non-adsorbed portion was replaced by a buffer solution in which the enzyme solution was dissolved and reacted, and the crude sulfated glucuronidated fucoidan portion was reacted with water instead, and then The analysis was similarly performed by HPLC. 1 unit of sulfated glucuronidated fucoidan decomposition activity refers to the cleavage of the fucose bond of 1 micromole of sulfated glucuronidated fuctan in the above reaction system in 1 minute Amount of broken enzyme. The amount of the fucosyl bond that was cut off was obtained by the following formula. Mathematical formula 4 {(10xl000xl / 100) / MG} x {(MG / M) -l} x {l / (180x0.019)} = U / ml 10x1000x1 / 100: Crude sulfated glucose added to the reaction system Uronic acid fucoidan fraction (micrograms) MG ·· The average molecular weight of the sulfated glucuronidated fucoidan of the control reaction solution M: the average molecular weight of the reaction product (MG / M) -1: 1 molecule Number of sites where sulfated glucuronidated fucoidan is cut by enzyme 180: reaction time (minutes) 0.019: amount of enzyme solution (ml) Furthermore, the conditions of HPLC are as described below. Device · · L-6200 (manufactured by Hitachi) Column: OHpak SB-806HQ (8 x 3 00mm, manufactured by Showa Denko Corporation) -107- This paper size is in accordance with China National Standard (CNS) A4 (210 X 297) 1243853 A7 B7 V. Description of the invention (1Q5)

溶析液:含有5 m Μ疊氮化鈉之5 0 mM氯化鋼 檢測:視差曲折率檢測器(ShodexRI-71,昭和電工社製) 流速:1毫升/分鐘 管柱溫度:25°C 爲測定反應生成物之平均分子量,將市售已知分子量之 出芽短梗孢糖(Pullulan)(STANDARD P-82,昭和電工社製) 用與上述HPLC分析之相同條件分析,將出芽短梗孢糖之分 子量與保持時間之關係以曲線表示,做爲供測定上述反應 生成物之分子量用之標準曲線。 另一方面,溶出部份之活性測定方法如以下之方式進 行。亦即,將1 0微升之1 %粗硫酸化葡糖醛酸化岩藻聚糖 部份溶液,53微升之50 mM咪唑-鹽酸緩衝液(pH6.6),5 微升之4M氯化鈉,2微升之1M氣化鈣,10微升之5毫克/ 毫升牛血清白蛋白,1 9微升之未吸著部份濃縮液與1微升 之供測定活性用之來自溶出部份之酵素液混合,於3 0 °C反 應3小時後,於1 0 0 °C處理1 0分鐘,進行離心後,將9 0微 升進行HPLC分析,以測定低分子化之程度。做爲對照者, 係將從溶出部份而來之酵素液,使用溶解該酵素液之緩衝 液代替而反應,並且粗硫酸化葡糖醛酸化岩藻聚糖部份, 使用水代替而反應,然後同樣地藉由HPLC進行分析。 1單位之硫酸化葡糖醛酸化岩藻聚糖分解活性,係指上述 反應系中於1分鐘時間將1微莫耳硫酸化葡糖醛酸化岩藻聚 糖之岩藻糖基鍵結切斷之酵素量。所切斷之岩藻糖基键結 之量係藉由下式求得。 -108- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(1Q6 ) 數學式5 {(ΙΟχΙΟΟΟχ 1/100)/MG}x{(MG/M)-l}x{ 1/(18〇χ〇. 00 l)}=U/ml 10x1000x1/100 :添加於反應系中之粗硫酸化葡糖醛酸化岩 藻聚糖部份(微克) M G :對照反應液之硫酸化葡糖醛酸化岩藻聚糖之平均分 子量 Μ :反應生成物之平均分子量 (MG/M)-1 : 1分子硫酸化葡糖醛酸化岩藻聚糖藉由酵素 切斷之部位數 180 ··反應時間(分鐘) 0.001 :酵素液量(毫升) 未吸著部份濃縮液之精製,以下述之方式進行。亦即, 於上述未吸著部份濃縮液中添加4 Μ氣化鈉,並調成濃度爲 250 mM,然後饋入以相同緩衝液平衡化3 0毫升之苯基-赛 璐玢管柱中。用相同緩衝液洗淨後,用250 mM至0 mM之 氯化鈉梯度溶析,然後,用含有10 mM氣化鈣之10 mM咪 唑-鹽酸緩衝液(pH7.5)溶析,繼而用含有1 0%乙醇與10 mM氣化鈣之10 mM咪唑-鹽酸緩衝液(pH7.5)溶析,並以 每瓶1 0毫升之方式分取溶出部份,收集藉由上述方法測定 之硫酸化葡糖醛酸化岩藻聚糖分解活性部份。 將得到之硫酸化葡糖醛酸化岩藻聚糖分解活性部份,用 含有100 mM氣化鈉、10 mM氯化鈣及5 mM疊氮化鈉之10 mM咪也-鹽酸緩衝液(pH7.5 )做爲溶析液,經由Sephacryl S-200管柱(4.4 X 100cm)分離。以每瓶13.5毫升之方式分取 -109- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(1Q7 ) 溶出部份。將藉由上述方法測定之硫酸化葡糖遂酸化岩藻 聚糖分解活性部份做爲精製未吸著部份。 再者,溶出部份濃縮液之精製以下述之方式進行。亦 即,將上述溶出部份濃縮液,藉由裝設有分劃分子量爲1 萬之中空纖維之限外過濾裝置,以含有100 mM氣化鈉及10 mM氣化鈣之10mM咪唑-鹽酸緩衝液(pH7.5)置換,然後饋 入以相同緩衝液平衡化之4 5毫升DEAE -赛璐玢管柱中,用 相同緩衝液洗淨後,用100 mM至400 mM之氣化鈉梯度溶 析,以每瓶1 0毫升之方式分取溶出部份,收集藉由上述方 法測定之硫酸化葡糖醛酸化岩藻聚糖分解活性部份。 將得到之硫酸化葡糖醛酸化岩藻聚糖分解活性部份,用 含有100 mM氣化鈉、10 mM氣化鈣及5 mM疊氮化鈉之10 mM咪峻-鹽酸緩衝液(ρΗ7·5 )做爲溶析液,經由Sephacryl S-200管柱(4·4 X 100cm)分離。以每瓶13.5毫升之方式分取 溶出部份。將藉由上述方法測定之硫酸化葡糖醛酸化岩藻 聚糖分解活性部份做爲精製溶出部份。 (2 )硫酸化葡糖醛酸化岩藻寡聚糖之調製 使用上述精製未吸著部份及精製溶出部份進行硫酸化葡 糖醛酸化岩藻寡聚糖之調製。 亦即,將1 0公克之粗硫酸化葡糖醛酸化岩藻聚糖部份溶 解於1公升之含有250 mM氣化鈉、20 mM氯化#5、5 mM疊 氮化鈉及1公克牛血清白蛋白之10 mM咪峻-鹽酸緩衝液 (ρΗ6·6)後,添加100 mU之精製溶出部份及600 mU之精製 未吸著部份,使其於3 0 °C反應1 0日。將反應液離心,所得 -110- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(1Q8 ) &quot; ^' 到之上清液用裝設有排除分子量爲1萬之中空纖維之限外 過/慮裝置’回收分子量1萬以下之暴聚糖部份,做爲硫酸 化葡糖醛酸化岩藻聚糖酵素消化物部份3。 (3 )硫酸化葡糖醛酸化岩藻寡聚糖之精製 將上述之硫酸化葡糖醛酸化岩藻聚糖酵素消化物部份3藉 由脱鹽裝置(微阿西來札-G3,旭化成工業公司製)脱鹽。 於脱鹽之硫酸化葡糖酸酸化岩藻聚糖酵素消化物部份3, 添加咪咬並使其濃度成爲5 m Μ,以及添加氣化鈉並使其濃 度成爲10 mM,然後饋入預先以含有10 氣化鈉之5 mM 咪也-鹽酸緩衝液(ρΗ7·0)平衡化之i公升dEaE-赛璐纷A-800管柱中,用相同緩衝液洗淨後,用1〇 至4〇〇 mM&lt; 氣化鈉梯度溶析。被溶出之部份,其總糖量藉由酚·硫酸法 測定,以及總糖醛酸量藉由咔唑-硫酸法測定。結果,溶出 之溶份中有至少5個明顯之尖峰存在,將各個尖峰部份集 合’做爲暴聚糖3-(1)〜(5) ’分別將其藉由蒸發器濃縮爲 4〇毫升後,饋入預先以10%乙醇平衡化之赛璐玢GCL-25 管柱中,以1 〇 %乙醇溶出脱鹽。由此可得到本發明之硫酸 化葡糖醛酸化岩藻寡聚糖3-(1)〜(5),即寡糖3_(1)〜(5)。 (4)寡聚糖之構造解析 對於上述之春聚糖3-(1)〜(5)之脱鹽物,藉由使用2 -胺 基批呢之螢光標識法進行還原末端糖及糖組成之分析時, 發現該寡聚糖之還原性末端糖全部爲岩藻糖。再者,關於 糖組成,寡聚糖3-(2)只由岩藻糖形成,寡聚糖3-(1)及3_ (3)〜(5)由岩藻糖與葡糖醛酸所形成者。繼而,測定硫酸 -111 - 本紙張尺度適用中@ g家標準(CNS) A4規格(⑽x297公爱) 1243853 A7 B7 五、發明説明(1Q9 ) 含量(藉由使用氯化鋇之比濁法)及糖醛酸含量(藉由咔唑-硫酸法),且藉由質量分析裝置(API-III,帕金野如馬赛也 克斯公司製)分析質量。再者,使用JNM- α 500型核磁共振 裝置(日本電子公司製)進行NMR分析。將分析試料藉由固 定方法以重水置換後進行構造解析。構成糖之結合方式, 係使用HMBC法(爲一種1 Η -檢測異種核檢測法)而進行。 iH-NMR之歸屬係使用DQF-COSY法及ΗΟΗΑΗΑ法,13C-NMR之歸屬係使用HSQC法。以下,表示寡聚糖3-(2)〜(5) 之物性〇 (a) 寡聚糖3-(2)之物性 上述分析之結果,判定本物質爲與寡聚糖1 - ( 1 )相同之物 質。 (b) 寡聚糖3-(3)之物性 質量分析及NMR分析之歸屬結果如以下所示,本發明之 硫酸化葡糖醛酸化岩藻寡聚糖3 - (3 )之1 Η - NMR光譜如圖 2 9所示,13 C- NMR光譜如圖3 0所示,質譜如圖3 1所示。 圖29與圖30中縱軸表示訊號之強度,橫軸表示化學位移値 (ppm)。再者,圖3 1中縱軸表示相對強度(%),橫軸表示 m / z 値0 分子量:1230 MS m/z 1273.4[M+2Na+-3H+]- 、 625.2[M+Na+-3H+]2·、 409.2[M-3H+]3· 藉由1H-NMR及13C-NMR分析之結果如表10所示。 -112- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 B7Eluate: 50 mM steel chloride containing 5 μM sodium azide. Detection: Parallax tortuosity detector (ShodexRI-71, manufactured by Showa Denko). Flow rate: 1 ml / min. Column temperature: 25 ° C. The average molecular weight of the reaction product was measured, and commercially available pullulan (Pullulan) (STANDARD P-82, manufactured by Showa Denko Co., Ltd.) having a known molecular weight was analyzed under the same conditions as the HPLC analysis described above, and the buds The relationship between the molecular weight and the retention time is represented by a curve, which is used as a standard curve for measuring the molecular weight of the reaction product. On the other hand, the method for measuring the activity of the eluted portion was performed as follows. That is, 10 microliters of a 1% crude sulfated glucuronidated fucoidan partial solution, 53 microliters of 50 mM imidazole-hydrochloric acid buffer (pH 6.6), and 5 microliters of 4M chlorination Sodium, 2 microliters of 1M calcium carbonate, 10 microliters of 5 mg / ml bovine serum albumin, 19 microliters of non-adsorbed fraction concentrate and 1 microliter of activity from the dissolution fraction The enzyme solution was mixed, reacted at 30 ° C for 3 hours, and then treated at 100 ° C for 10 minutes. After centrifugation, 90 microliters were analyzed by HPLC to determine the degree of low molecularization. As a control, the enzyme solution from the eluted portion was replaced with a buffer solution to dissolve the enzyme solution, and the crude sulfated glucuronidated fucoidan portion was reacted with water instead. It was then analyzed by HPLC in the same manner. 1 unit of sulfated glucuronidated fucoidan decomposition activity refers to the above reaction system which cuts off the fucose bond of 1 micromole of sulfated glucuronidated fuctan in 1 minute. The amount of enzyme. The amount of the fucosyl bond that was cut off was obtained by the following formula. -108- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (1Q6) Mathematical formula 5 {(ΙΟχΙΟΟΟχ 1/100) / MG} x {(MG / M) -l} x {1 / (18〇χ〇. 00 l)} = U / ml 10x1000x1 / 100: Crude sulfated glucuronidated fucose part (micrograms) added to the reaction system MG : Average molecular weight of sulfated glucuronidated fucoidan of the control reaction solution M: average molecular weight of reaction product (MG / M) -1: 1 molecule of sulfated glucuronidated fucoidan cut by enzyme Number of broken parts: 180. Response time (minutes) 0.001: Enzyme solution volume (ml) Purification of the concentrated solution without absorption is performed in the following manner. That is, 4 M sodium vaporization was added to the above non-adsorbed portion of the concentrated solution, adjusted to a concentration of 250 mM, and then fed to a 30 ml phenyl-cellulose column equilibrated with the same buffer solution. . After washing with the same buffer, it was eluted with a gradient of 250 mM to 0 mM sodium chloride, and then lysed with a 10 mM imidazole-hydrochloric acid buffer (pH 7.5) containing 10 mM calcium carbonate, followed by dissolution with 10% ethanol was dissolved with 10 mM imidazole-hydrochloric acid buffer solution (pH 7.5) of 10 mM calcium carbonate, and the dissolution portion was separated into 10 ml per bottle, and the sulfated content determined by the above method was collected. Glucuronidates the fucoidan-decomposing active moiety. The sulfated glucuronidated fucoidan-decomposed active fraction was decomposed with 10 mM Miye-hydrochloric acid buffer (pH7.) Containing 100 mM sodium gasification, 10 mM calcium chloride, and 5 mM sodium azide. 5) As the eluent, it was separated through a Sephacryl S-200 column (4.4 X 100 cm). Take 13.5ml per bottle -109- This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Disclosure of the invention (1Q7). The desulfurized glucosino-acid-fucose-decomposing active part determined by the above method was used as the refined unadsorbed part. The purification of the eluted portion of the concentrated solution was performed in the following manner. That is, the above-mentioned eluted part of the concentrated solution was equipped with an out-of-limit filtration device with a partitioned molecular weight of 10,000 hollow fibers, and buffered with 10 mM imidazole-hydrochloric acid containing 100 mM sodium gas and 10 mM calcium gas. Solution (pH 7.5), then fed into a 4 5 ml DEAE-cellulose column equilibrated with the same buffer, washed with the same buffer, and then dissolved in a gradient of 100 mM to 400 mM sodium gaseous solution. Dissolve, dissolve the dissolving fraction in 10 ml per bottle, and collect the sulfated glucuronidated fucoidan decomposing active fraction determined by the above method. The obtained sulfated glucuronidated fucoidan-decomposing active fraction was decomposed with 10 mM micon-hydrochloric acid buffer (ρΗ7 ·, containing 100 mM sodium gas, 10 mM calcium gas, and 5 mM sodium azide). 5) As the eluent, it was separated through a Sephacryl S-200 column (4.4 × 100 cm). Dissolve the dissolution portion in 13.5 ml bottles. The desulfurized glucuronide-fucose-decomposing active part determined by the above method was used as the refined eluted part. (2) Preparation of Sulfated Glucuronidated Fucoidan Oligosaccharides The preparation of the sulfated glucuronidated Fucoidan oligosaccharides was performed using the above-mentioned purified unadsorbed portion and purified eluted portion. That is, 10 grams of crude sulfated glucuronidated fucoidan was partially dissolved in 1 liter containing 250 mM sodium gasification, 20 mM chloride # 5, 5 mM sodium azide, and 1 gram cattle After serum albumin 10 mM Mijun-hydrochloric acid buffer (pH 6.6), 100 mU of the refined dissolution portion and 600 mU of the purified unabsorbed portion were added and allowed to react at 30 ° C for 10 days. Centrifuge the reaction solution to obtain -110- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (1Q8) &quot; ^ ' There is a limit-exceeding / removing device that excludes hollow fiber with a molecular weight of 10,000, and recovers the polysaccharide fraction with a molecular weight of less than 10,000 as the sulfated glucuronidated fucoidan enzyme digestion part 3. (3) Purification of sulfated glucuronidated fucoidan oligosaccharides The above-mentioned sulfated glucuronidated fucoidan enzyme digestion part 3 was processed by a desalination device (micro-Asilaza-G3, Asahi Kasei Industrial company) desalination. To desalted sulfated gluconate to acidify the fucoidan digest part 3, add a bite to a concentration of 5 μM, and add sodium gasification to a concentration of 10 mM, and then feed it in advance An i-liter dEaE-cellulose A-800 column equilibrated with a 5 mM mimic-hydrochloric acid buffer solution (ρΗ7 · 0) containing 10 sodium vapors, washed with the same buffer solution, and then washed with 10 to 4 〇mM &lt; Gradient dissolution of sodium vaporization. The total sugar content of the eluted portion was measured by the phenol-sulfuric acid method, and the total uronic acid content was measured by the carbazole-sulfuric acid method. As a result, there were at least 5 distinct peaks in the dissolved solvent, and the peaks were collected as 'polysaccharides 3- (1) ~ (5)' and concentrated by an evaporator to 40 ml. After that, it was fed into a celluloid GCL-25 column preliminarily equilibrated with 10% ethanol, and dissolved and desalted with 10% ethanol. Thereby, the sulfated glucuronidated fucoidigosaccharides 3- (1) to (5) of the present invention can be obtained, that is, oligosaccharides 3_ (1) to (5). (4) Structural analysis of oligosaccharides For the desalted products of 3- (1) ~ (5) of the above-mentioned vermin, the terminal sugars and sugar composition were reduced by the fluorescent labeling method using 2-amine batches. During analysis, it was found that all the reducing terminal sugars of the oligosaccharide were fucose. Regarding sugar composition, oligosaccharides 3- (2) are formed only from fucose, and oligosaccharides 3- (1) and 3_ (3) ~ (5) are formed from fucose and glucuronic acid. By. Then, determine the sulfuric acid-111-this paper standard is applicable @ g 家 standard (CNS) A4 specification (⑽x297 public love) 1243853 A7 B7 V. Description of the invention (1Q9) content (by turbidimetric method using barium chloride) and The uronic acid content (by the carbazole-sulfuric acid method), and the mass was analyzed by a mass analyzer (API-III, manufactured by Parkinano Roussex Corporation). Furthermore, NMR analysis was performed using a JNM-α 500-type nuclear magnetic resonance apparatus (manufactured by Japan Electronics Corporation). The analysis sample was replaced with heavy water by a fixed method, and then the structure was analyzed. The method of combining sugars is performed using the HMBC method, which is a 1 Η-detection heterogeneous nuclear test method. The assignment of iH-NMR uses the DQF-COSY method and the ΗΟΗΑΗΑ method, and the assignment of 13C-NMR uses the HSQC method. The physical properties of the oligosaccharides 3- (2) to (5) are shown below. (A) The physical properties of the oligosaccharides 3- (2) are analyzed. As a result, it is determined that this substance is the same as the oligosaccharides 1 to (1). Of matter. (b) The physical property quality analysis of oligosaccharide 3- (3) and the assignment results of NMR analysis are shown below. The sulfated glucuronidated fucoidigosaccharide 3-(3) of the present invention Η-NMR The spectrum is shown in Figure 29, the 13 C-NMR spectrum is shown in Figure 30, and the mass spectrum is shown in Figure 31. In Figs. 29 and 30, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). Moreover, in FIG. 31, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値 0. Molecular weight: 1230 MS m / z 1273.4 [M + 2Na + -3H +]-, 625.2 [M + Na + -3H +] 2 ·, 409.2 [M-3H +] 3 · The results of analysis by 1H-NMR and 13C-NMR are shown in Table 10. -112- This paper size applies to China National Standard (CNS) A4 (210X297 mm) 1243853 A7 B7

五、發明説明(11Q 表10 化學位移値(ppm) 13c-nmr [H-NMR 化學位移値、多重度、結合常數 F1-1 96.9 4.47, d,8.0 F1-2 70.7 3.44, dd,8.0, 10.0 F1-3 78.4 3.57, dd,3.0, 10.0 F1-4 68.5 3.85, d,3.0 F1-5 71.3 3.66, q, 6.5 F1-6 16.5 1.13, d, 6.5 F2-1 96.2 4.96, d, 4.0 F2-2 67.1 3.81, dd? 4.0, 10.0 F2-3 75.6 3.90, dd, 3.0, 10.0 F2-4 69.2 3.93, d, 3.0 F2-5 66.8 4.06, q, 6.5 F2-6 16.5 1.09, d, 6.5 F3-1 96.5 4.98, d, 4.0 F3-2 67.4 3.84, dd, 4.0, 11.0 F3-3 77.5 3.97, dd, 2.5, 11.0 F3-4 80.4 4.65, d, 2.5 F3-5 67.2 4.29, q, 6.5 F3-6 16.5 1.13, d,6.5 F4-1 100.0 4.98, d, 4.0 F4-2 68.0 3.75, dd, 4.0, 11.0 F4-3 77.2 3.89, dd,2.5, 11.0 F4-4 80.4 4.61, d, 2.5 F4-5 67.5 4.33, q, 6.5 F4-6 16.5 1.11, d, 6.5 F5-1 99.5 4.95, d,4.0 -113- 本纸張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(111 表1〇(續) 化學位移値(ppm) 13c-nmr b-NMR 化學位移値、多重度、結合常數 F5-2 67.7 3.73, dd, 4.0, 11.0 F5-3 74.0 3.84, m F5-4 68.2 3.89, m F5-5 68.0 4.19, m F5-6 16.0 1.09, d, 7.0 F6-1 94.4 5.00, d, 4.0 F6-2 75.9 3.77, dd, 4.0, 10.5 F6-3 70.0 4.05, dd, 3.5, 10.5 F6-4 73.1 3.70, d, 3.5 F6-5 67.6 4.17, q, 6.5 F6-6 16.0 1.09, d, 6.5 GA1-1 99.5 5.115d, 4.0 GA1-2 71.3 3.45, dd, 4.0, 10.0 GA1-3 73.3 3.64, t, 10.0 GA1-4 72.0 3.35, t, 10.0 GA1-5 72.6 3.96, d, 10.0 GA1-6 176.7 糖組成L -岩澡糖:D -葡糖备酸=6 : 1 硫酸基2分子 再者,1 H-NMR及13C-NMR中尖峰歸屬之編號如下式 (XIV)所示。 -114- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(112 GA 1V. Description of the invention (11Q Table 10 Chemical shift 値 (ppm) 13c-nmr [H-NMR Chemical shift 値, multiplicity, binding constant F1-1 96.9 4.47, d, 8.0 F1-2 70.7 3.44, dd, 8.0, 10.0 F1-3 78.4 3.57, dd, 3.0, 10.0 F1-4 68.5 3.85, d, 3.0 F1-5 71.3 3.66, q, 6.5 F1-6 16.5 1.13, d, 6.5 F2-1 96.2 4.96, d, 4.0 F2-2 67.1 3.81, dd? 4.0, 10.0 F2-3 75.6 3.90, dd, 3.0, 10.0 F2-4 69.2 3.93, d, 3.0 F2-5 66.8 4.06, q, 6.5 F2-6 16.5 1.09, d, 6.5 F3-1 96.5 4.98, d, 4.0 F3-2 67.4 3.84, dd, 4.0, 11.0 F3-3 77.5 3.97, dd, 2.5, 11.0 F3-4 80.4 4.65, d, 2.5 F3-5 67.2 4.29, q, 6.5 F3-6 16.5 1.13 , d, 6.5 F4-1 100.0 4.98, d, 4.0 F4-2 68.0 3.75, dd, 4.0, 11.0 F4-3 77.2 3.89, dd, 2.5, 11.0 F4-4 80.4 4.61, d, 2.5 F4-5 67.5 4.33, q, 6.5 F4-6 16.5 1.11, d, 6.5 F5-1 99.5 4.95, d, 4.0 -113- This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 1243853 A7 B7 V. Description of the invention (111 Table 10 (continued) Chemical shift 値 (ppm) 13c-nmr b-NMR Chemical shift 値, multiplicity, binding constant F5-2 67.7 3.73, dd, 4.0, 11.0 F5-3 74.0 3.84, m F5-4 68.2 3.89, m F5-5 68.0 4.19, m F5-6 16.0 1.09, d, 7.0 F6-1 94.4 5.00, d, 4.0 F6-2 75.9 3.77, dd, 4.0, 10.5 F6-3 70.0 4.05, dd, 3.5, 10.5 F6-4 73.1 3.70, d, 3.5 F6-5 67.6 4.17, q, 6.5 F6-6 16.0 1.09, d, 6.5 GA1-1 99.5 5.115d, 4.0 GA1-2 71.3 3.45, dd, 4.0, 10.0 GA1-3 73.3 3.64, t, 10.0 GA1-4 72.0 3.35, t, 10.0 GA1-5 72.6 3.96, d, 10.0 GA1-6 176.7 Sugar composition L-rock bath sugar : D -glucose acid = 6: 1 sulfate group 2 molecules Further, the number of the peak assignment in 1 H-NMR and 13C-NMR is shown by the following formula (XIV). -114- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (112 GA 1

HCOCOOHHCOCOOH

cn 1cncn 1cn

〔X I VJ〔X I VJ

COCO

CO ΟΗ· Η -115-本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 五、發明説明(113 ) 再者,以下將本物質稱爲6Fuc-2S-lGlcUA。 (c)寡聚糖3-(4)之物性 質量分析及NMR分析之歸屬結果如以下所示,本發明之 硫酸化葡糖醛酸化岩藻寡聚糖3-(4)之1 H-NMR光譜如圖 3 2所示,13 C_ NMR光譜如圖3 3所示,質譜如圖3 4所示。 圖32與圖33中縱軸表示訊號之強度,橫軸表示化學位移値 (ppm)。再者,圖34中縱軸表示相對強度(%),橫軸表示 m / z 値。 分子量·· 1724 MS m/z 894. l[M+3Na+-5H + ]2· 、588.7[M+2Na+-5H + ]3-、 435.6[M+Na+-5H+]4· 藉由1H-NMR及13C-NMR分析之結果如表11所示。 -116- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(114 表1 1 化學位移値(ppm) 13c_nmr ^-NMR 化學位移値、多重度、結合常數 FM 96.4 4.47, d, 7.9 F1-2 70.2 3.44, dd, 7.9, 9.9 F1-3 77.9 3.57, m F1-4 68.0 3.85, m F1-5 70.8 3.66, q, 6.7 F1-6 15.9 1.13, d, 6.7 F2-1 95.9 4.98, d, 4.0 F2-2 67.0 3.85, m F2-3 76.9 3.98, m F2-4 79.9 4.65, m F2-5 66.7 4.29, q, 6.7 F2-6 15.9 1.13, d, 6.7 F3-1 99.4 5.00, d, 4.0 F3-2 67.5 3.75, dd, 4.0, 10.4 F3-3 76.8 3.89, dd, 2.8, 10.4 F3-4 80.0 4.62, d, 2.8 F3-5 66.9 4.35, q, 6.7 F3-6 16.0 1.11, d, 6.7 F4-1 99.0 4.96, d, 4.0 F4-2 67.1 3.74, dd, 4.0, 10.4 F4-3 74.7 3.88, dd,3.1,10.4 F4-4 68.6 3.96, d, 3.1 F4-5 67.4 4.21, q? 6.7 F4-6 15.5 U0,d,6.7 F5-1 94.7 5.04, d,4.0 -117- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(115 表1 1 (續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F5-2 70.8 4.20, dd, 4.0, 10.4 F5-3 70.7 4.32, dd, 2.5, 10.4 F5-4 69.2 5.40, d, 2.5 F5-5 65.7 4.36, q, 6.7 F5-6 15.3 1.02, d, 6.7 乙醯基之ch3 20.5 2.06, s 乙醯基之CO 173.9 F6-1 93.4 4.98, d, 4.0 F6-2 66.6 3.78, dd, 4.0, 10.4 F6-3 77.5 3.82, dd,2.5, 10.4 F6-4 79.8 4.55, d,2.5 F6-5 66.5 4.35, q, 6.7 F6-6 16.0 1.13, d, 6.7 F7-1 99.7 4.96, d, 4.0 F7-2 67.6 3.71, dd, 4.0, 10.4 F7-3 75.6 3.89, dd, 2.8, 10.4 F7-4 79.6 4.64, d, 2.8 F7-5 66.7 4.25, q, 6.7 F7-6 16.2 1.11, d, 6.7 F8-1 97.9 4.96, d, 4.0 F8-2 68.7 3.57, dd, 4.0, 10.4 F8-3 70.2 3.76, dd, 3.1, 10.4 F8-4 72.3 3.66, d, 3.1 F8-5 67.4 4.20, q, 6.7 F8-6 15.4 1.08, d, 6.7CO ΟΗ · Η -115- This paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297 mm) 1243853 A7 B7 5. Description of the invention (113) In addition, this substance is hereinafter referred to as 6Fuc-2S-lGlcUA. (c) The physical property quality analysis of oligosaccharide 3- (4) and the assignment results of NMR analysis are shown below. 1 H-NMR The spectrum is shown in Figure 32, the 13 C_NMR spectrum is shown in Figure 33, and the mass spectrum is shown in Figure 34. In Figs. 32 and 33, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In FIG. 34, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値. Molecular weight 1724 MS m / z 894. l [M + 3Na + -5H +] 2, 588.7 [M + 2Na + -5H +] 3-, 435.6 [M + Na + -5H +] 4 · By 1H-NMR and The results of 13C-NMR analysis are shown in Table 11. -116- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (114 Table 1 1 Chemical shift 値 (ppm) 13c_nmr ^ -NMR chemical shift 値, multiplicity Binding constants FM 96.4 4.47, d, 7.9 F1-2 70.2 3.44, dd, 7.9, 9.9 F1-3 77.9 3.57, m F1-4 68.0 3.85, m F1-5 70.8 3.66, q, 6.7 F1-6 15.9 1.13, d, 6.7 F2-1 95.9 4.98, d, 4.0 F2-2 67.0 3.85, m F2-3 76.9 3.98, m F2-4 79.9 4.65, m F2-5 66.7 4.29, q, 6.7 F2-6 15.9 1.13, d, 6.7 F3-1 99.4 5.00, d, 4.0 F3-2 67.5 3.75, dd, 4.0, 10.4 F3-3 76.8 3.89, dd, 2.8, 10.4 F3-4 80.0 4.62, d, 2.8 F3-5 66.9 4.35, q, 6.7 F3-6 16.0 1.11, d, 6.7 F4-1 99.0 4.96, d, 4.0 F4-2 67.1 3.74, dd, 4.0, 10.4 F4-3 74.7 3.88, dd, 3.1, 10.4 F4-4 68.6 3.96, d, 3.1 F4 -5 67.4 4.21, q? 6.7 F4-6 15.5 U0, d, 6.7 F5-1 94.7 5.04, d, 4.0 -117- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Explanation of the invention (115 Table 1 1 (continued) Chemical shift 値 (ppm) 13c-nmr ^ -NMR Chemical shift 値, more Severe, binding constant F5-2 70.8 4.20, dd, 4.0, 10.4 F5-3 70.7 4.32, dd, 2.5, 10.4 F5-4 69.2 5.40, d, 2.5 F5-5 65.7 4.36, q, 6.7 F5-6 15.3 1.02, d, 6.7 Acetyl ch3 20.5 2.06, s Acetyl CO 173.9 F6-1 93.4 4.98, d, 4.0 F6-2 66.6 3.78, dd, 4.0, 10.4 F6-3 77.5 3.82, dd, 2.5, 10.4 F6 -4 79.8 4.55, d, 2.5 F6-5 66.5 4.35, q, 6.7 F6-6 16.0 1.13, d, 6.7 F7-1 99.7 4.96, d, 4.0 F7-2 67.6 3.71, dd, 4.0, 10.4 F7-3 75.6 3.89, dd, 2.8, 10.4 F7-4 79.6 4.64, d, 2.8 F7-5 66.7 4.25, q, 6.7 F7-6 16.2 1.11, d, 6.7 F8-1 97.9 4.96, d, 4.0 F8-2 68.7 3.57, dd , 4.0, 10.4 F8-3 70.2 3.76, dd, 3.1, 10.4 F8-4 72.3 3.66, d, 3.1 F8-5 67.4 4.20, q, 6.7 F8-6 15.4 1.08, d, 6.7

裝 訂Binding

線 -118-本纸張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(116 表1 1 (續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 GA1-1 99.5 5· 19, d,4.0 GA1-2 71.3 3.47, dd, 4.0, 9.8 GA1-3 73.3 3.58, t, 9.8 GA1-4 72.0 3.37, t, 9.8 GA1-5 72.6 3.81,d5 9.8 GA1-6 176.7 糖組成L·岩藻糖:D-葡糖醛酸=8 : 1 硫酸基4分子 乙醯基1分子 再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式 (IX)所示。 -119- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A7 B7 117 五、發明説明( i X3 OH Η GA 1Line-118- This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (116 Table 1 1 (continued) Chemical shift 値 (ppm) 13c-nmr ^- NMR chemical shift 値, multiplicity, binding constant GA1-1 99.5 5.19, d, 4.0 GA1-2 71.3 3.47, dd, 4.0, 9.8 GA1-3 73.3 3.58, t, 9.8 GA1-4 72.0 3.37, t, 9.8 GA1-5 72.6 3.81, d5 9.8 GA1-6 176.7 Sugar composition L · fucose: D-glucuronic acid = 8: 1 sulfate group 4 molecules acetamido 1 molecule Further, iH-NMR and 13C-NMR The number of the peak assignment is shown in the following formula (IX). -119- This paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) 1243853 A7 B7 117 V. Description of the invention (i X3 OH Η GA 1

nooxnoox

V、* * jV, * * j

本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(118 ) 再者,以下將本物質稱爲8Fuc-4S-lGlcUA_ 1乙醯基。 (d)寡聚糖3-(5)之物性 質量分析及NMR分析歸屬之結果如以下所示,本發明之 硫酸化葡糖醛酸化岩藻寡聚糖3-(5)之1H-NMR光譜如圖 35所示,13C-NMR光譜如圖36所示,質譜如圖37所示。 圖35與圖36中縱軸表示訊號之強度,橫軸表示化學位移値 (ppm)。再者,圖37中縱軸表示相對強度(%),橫軸表示 m / z 値0 分子量:2689 MS m/z 924.0[M+4Na+-7H + ]3* 、687.3[M+3Na+-7H+]4'、 545.3[M+2Na+-7H+]5.、450.5[M+Na+-7H+]6_ 藉由1H-NMR及13C-NMR分析之結果如表12所示。 -121 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853 A7 B7 五、發明説明(119 表12 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F1-1 96.8 4.46, d, 7.9 F1-2 70.5 3.43, dd, 7.9, 10.0 F1-3 78.3 3.57, m F1-4 68.3 3.85, m F1-5 71.2 3.65, q, 6.7 F1-6 16.2 1.12, d, 6.7 F2-1 96.3 4.97, d, 4.0 F2-2 67.3 3.85, m F2-3 77.1 3.97, m F2-4 80.1 4.65, m F2-5 67.1 4.29, q, 6.7 F2-6 16.2 1.12, d, 6.7 F3-1 99.7 4.98, d, 4.0 F3-2 67.9 3.74, m F3-3 77.1 3.88, m F3-4 80.3 4.62, m F3-5 67.3 4.35, q, 6.7 F3-6 16.3 1.11, d, 6.7 F4-1 99.3 4.94, d, 4.0 F4-2 67.4 3.73, m F4-3 75.0 3.87, m F4-4 69.0 3.95, m F4-5 67.7 4.20, q, 6.7 F4-6 15.9 1.10, d, 6.7 F5-1 95.0 5.03, d, 4.0The size of this paper applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (118) In addition, this substance is hereinafter referred to as 8Fuc-4S-lGlcUA_ 1 acetamido. (d) The physical property quality analysis of oligosaccharide 3- (5) and the results of NMR analysis are shown below. The 1H-NMR spectrum of the sulfated glucuronidated fucoidan 3- (5) of the present invention is shown below. As shown in Fig. 35, the 13C-NMR spectrum is shown in Fig. 36, and the mass spectrum is shown in Fig. 37. In Figs. 35 and 36, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). In FIG. 37, the vertical axis represents relative strength (%), and the horizontal axis represents m / z 値 0. Molecular weight: 2689 MS m / z 924.0 [M + 4Na + -7H +] 3 *, 687.3 [M + 3Na + -7H +] 4 ', 545.3 [M + 2Na + -7H +] 5, 450.5 [M + Na + -7H +] 6_ The results of analysis by 1H-NMR and 13C-NMR are shown in Table 12. -121-This paper size is in accordance with Chinese National Standard (CNS) A4 (210 x 297 mm) 1243853 A7 B7 V. Description of the invention (119 Table 12 Chemical shift 値 (ppm) 13c-nmr ^ -NMR Chemical shift 値, more Severity, binding constant F1-1 96.8 4.46, d, 7.9 F1-2 70.5 3.43, dd, 7.9, 10.0 F1-3 78.3 3.57, m F1-4 68.3 3.85, m F1-5 71.2 3.65, q, 6.7 F1-6 16.2 1.12, d, 6.7 F2-1 96.3 4.97, d, 4.0 F2-2 67.3 3.85, m F2-3 77.1 3.97, m F2-4 80.1 4.65, m F2-5 67.1 4.29, q, 6.7 F2-6 16.2 1.12 , d, 6.7 F3-1 99.7 4.98, d, 4.0 F3-2 67.9 3.74, m F3-3 77.1 3.88, m F3-4 80.3 4.62, m F3-5 67.3 4.35, q, 6.7 F3-6 16.3 1.11, d , 6.7 F4-1 99.3 4.94, d, 4.0 F4-2 67.4 3.73, m F4-3 75.0 3.87, m F4-4 69.0 3.95, m F4-5 67.7 4.20, q, 6.7 F4-6 15.9 1.10, d, 6.7 F5-1 95.0 5.03, d, 4.0

裝 訂Binding

線 -122-本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7Line -122- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7

五、發明説明(12Q 表1 2 (續) 化學位移値(ppm) 13c-nmr ^-NMR 化學位移値、多重度、結合常數 F5-2 71.1 4.20, m F5-3 71.1 4.31, m F5-4 69.6 5.39, m F5-5 66.1 4.36, q, 6.7 F5-6 15.6 1.01, d, 6.7 F5之乙醯基之CH3 20.8 2.06, s F5之乙醯基之CO 174.2 F6-1 93.7 4.97, d, 4.0 F6-2 66.9 3.79, m F6-3 77.8 3.82, m F6_4 80.1 4.55, m F6-5 66.9 4.35, q, 6.7 F6-6 16.3 1.12, d, 6.7 F7-1 99.9 4.94, d, 4.0 F7-2 67.9 3.70, m F7-3 75.9 3.88, m F7-4 79.9 4.64, m F7-5 67.1 4.24, q, 6.7 F7-6 16.5 1.11, d, 6.7 F8-1 99.3 4.94, d, 4.0 F8-2 67.4 3.73,m F8-3 75.0 3.87, m F8-4 69.0 3.95, m F8-5 67.7 4.20, q, 6.7 F8-6 15.9 1.10, d, 6.7 -123- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(121 表1 2 (續) 化學位移値(ppm) 13c-nmr lH-NMR 化學位移値、多重度、結合常數 F9-1 95.0 5.03, d, 4.0 F9-2 71.1 4.20, m F9-3 71.1 4.31, m F9-4 69.6 5.39, m F9-5 66.1 4.36, q, 6.7 F9-6 15.6 1.01, d, 6.7 F9之乙醯基之CH3 20.8 2.06, s F9之乙醯基之CO 174.2 F10-1 93.7 4.97, d, 4.0 F10-2 66.9 3.79, m F10-3 77.8 3.82, m F10-4 80.1 4.55, m F10-5 66.9 4.35, q? 6.7 F10-6 16.3 1.12, d, 6.7 F11-1 99.9 4.94, d, 4.0 F11-2 67.9 3.70, m F11-3 75.9 3.88, m F11-4 79.9 4.64, m F11-5 67.1 4.24, q, 6.7 F11-6 16.5 1.11, d, 6.7 F12-1 98.2 4.94, d, 4.0 F12-2 69.1 3.57, m F12-3 70.5 3.75, m F12-4 72.6 3.66, m F12-5 67.7 4.20, q, 6.7 -124- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(122 表1 2 (續) 化學位移値(ppm) 13c-nmr b-NMR 化學位移値、多重度、結合常數 F12-6 15.8 1.07, d,6.7 GA1-1 99.7 5.19, d, 4.0 GA1-2 71.6 3.47, dd, 4.0, 9.8 GA1-3 73.6 3.58, t, 9.8 GA1-4 72.3 3.37, t, 9.8 GA1-5 73.0 3.81, d, 9.8 GA1-6 177.0 GA2-1 99.7 5.19, d, 4.0 GA2-2 71.6 3.47, dd, 4.0, 9.8 GA2-3 73.6 3.58, t,9.8 GA2-4 72.3 3.37, t, 9.8 GA2-5 73.0 3.81, d, 9.8 GA2-6 177.0 糖組成L-岩藻糖:D -葡糖醛酸=12 : 2 硫酸基6分子 乙醯基2分子 再者,iH-NMR及13C-NMR中尖峰歸屬之編號如下式(X) 所示。 -125- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7V. Description of the invention (12Q Table 1 2 (continued) Chemical shift 値 (ppm) 13c-nmr ^ -NMR Chemical shift 値, multiplicity, binding constant F5-2 71.1 4.20, m F5-3 71.1 4.31, m F5-4 69.6 5.39, m F5-5 66.1 4.36, q, 6.7 F5-6 15.6 1.01, d, 6.7 F5 ethynyl CH3 20.8 2.06, s F5 ethynyl CO 174.2 F6-1 93.7 4.97, d, 4.0 F6-2 66.9 3.79, m F6-3 77.8 3.82, m F6_4 80.1 4.55, m F6-5 66.9 4.35, q, 6.7 F6-6 16.3 1.12, d, 6.7 F7-1 99.9 4.94, d, 4.0 F7-2 67.9 3.70, m F7-3 75.9 3.88, m F7-4 79.9 4.64, m F7-5 67.1 4.24, q, 6.7 F7-6 16.5 1.11, d, 6.7 F8-1 99.3 4.94, d, 4.0 F8-2 67.4 3.73, m F8-3 75.0 3.87, m F8-4 69.0 3.95, m F8-5 67.7 4.20, q, 6.7 F8-6 15.9 1.10, d, 6.7 -123- This paper size applies to China National Standard (CNS) A4 specifications (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (121 Table 1 2 (continued) Chemical shift 値 (ppm) 13c-nmr lH-NMR Chemical shift 値, multiplicity, binding constant F9-1 95.0 5.03, d, 4.0 F9-2 71.1 4.20, m F9-3 71.1 4.31, m F9-4 69.6 5.39, m F9-5 66.1 4.36, q, 6.7 F9-6 15. 6 1.01, d, 6.7 F9 ethynyl CH3 20.8 2.06, s F9 ethynyl CO 174.2 F10-1 93.7 4.97, d, 4.0 F10-2 66.9 3.79, m F10-3 77.8 3.82, m F10- 4 80.1 4.55, m F10-5 66.9 4.35, q? 6.7 F10-6 16.3 1.12, d, 6.7 F11-1 99.9 4.94, d, 4.0 F11-2 67.9 3.70, m F11-3 75.9 3.88, m F11-4 79.9 4.64, m F11-5 67.1 4.24, q, 6.7 F11-6 16.5 1.11, d, 6.7 F12-1 98.2 4.94, d, 4.0 F12-2 69.1 3.57, m F12-3 70.5 3.75, m F12-4 72.6 3.66, m F12-5 67.7 4.20, q, 6.7 -124- This paper size is applicable to Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (122 Table 1 2 (continued) Chemical shift 値(ppm) 13c-nmr b-NMR Chemical shift 値, multiplicity, binding constant F12-6 15.8 1.07, d, 6.7 GA1-1 99.7 5.19, d, 4.0 GA1-2 71.6 3.47, dd, 4.0, 9.8 GA1-3 73.6 3.58, t, 9.8 GA1-4 72.3 3.37, t, 9.8 GA1-5 73.0 3.81, d, 9.8 GA1-6 177.0 GA2-1 99.7 5.19, d, 4.0 GA2-2 71.6 3.47, dd, 4.0, 9.8 GA2- 3 73.6 3.58, t, 9.8 GA2-4 72.3 3.37, t, 9.8 GA2-5 73.0 3.81, d, 9.8 GA2-6 177.0 Sugar composition L-rock Sugar: D - glucuronic acid = 12: 2-yl 6 molecules of acetylsalicylic acid molecules 2 Further, iH-NMR and a peak attributable to the number of 13C-NMR by the following formula (X) shown in FIG. -125- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7

本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853 A7 B7 五、發明説明(124 §This paper size applies to Chinese National Standard (CNS) A4 (210 x 297 mm) 1243853 A7 B7 V. Description of invention (124 §

* zy F 1 2 F 1 1 F 1 0 F 9 to -127-* zy F 1 2 F 1 1 F 1 0 F 9 to -127-

本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1243853This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 1243853

再者’以下將本物質稱爲12Fuc_6S_2G1cUA_2乙醯基。 (5)藉由超骨波處理之硫酸化葡糖醛酸化岩藻寡聚糖之調 製 檢有關藉由非酵素方式處理之硫酸化葡糖醛酸化岩藻 聚糖低分子化方法。 Y亦即’ 1周製參考例1 (1)記載之方法得到之來自沖繩海蘊 深I粗硫酸化葡糖酸酸化岩藻聚糖之0. i %水溶液,藉由強 力超音波產生裝置201M(久保田商事公司製)以2〇〇w處理 分鐘。將該處理液藉由陰離子交換樹脂分劃,將其各部 &lt;刀藉由質量分析’找出有分子量762之物質存在之部份。 再者’收集?S部份,藉由脱鹽及凍結乾燥,可得到本發明 T硫酸化葡糖趁酸化岩藻寡聚糖〖_ (丨)。更且,藉由上述 同樣 &lt; 方法’可得到本發明之硫酸化葡糖醛酸化岩藻寡聚 糖1-(2)〜(7)、2-(1)〜及3-(2)〜(5)、。 實例1 2 (Ua-D -葡糖:y:酸酶及内-以-L-岩藻糖荅酶之精製 藉由實例9之方法將岩藻依聚糖分解嗜岩藻菌S I - 1234菌 株培養3次’從各次培養得到之菌體,藉由實例9之方法調 製菌體萃取液,以含有100 mM氣化鈉及10 mM氣化鈣之10 mM咪唑—鹽酸緩衝液(ρΗ7·5)充分透析,離心後,得到上清 液,亦即有本發明之-葡糖:y:酸酶及内岩藻糖 苷酶共存之粗酵素液。以下,本發明之α-D -葡糖苷酸酶 活性藉由實例5(3)記載之方法測定,本發明之内-泛-L-岩 深糖芬酶活性藉由實例5(6)記載之方法測定,並藉此將各 -128- )x 297公釐) 1243853 A7 B7 五、發明説明(126 ) 個酵素精製。 將所得到之粗酵素液饋入以相同緩衝液平衡化之3公升 DEAE-赛璐玢A-800管柱中,用相同緩衝液洗淨後,藉由 100 mM至400 mM之氯化鈉梯度溶析,以平均每瓶200毫升 之方式分取溶出部份,收集本發明之a - D -葡糖甞酸酶活 性部份及本發明之内-a - L -岩藻糖苷酶活性部份。在此時 點,本發明之兩種酵素幾乎呈現相同之行爲特性,無法加 以分離。 將上述兩酵素活性部份,用裝設有分劃分子量爲1萬之中 空纖維之限外過濾機濃縮,用含有100 mM氯化鈉及10 mM 氣化鈣之10 mM咪唑·鹽酸緩衝液(pH7.5)將緩衝液置換。 將得到之酵素液饋入以相同緩衝液平衡化之240毫升 DEAE-赛璐玢A- 800管柱中,用相同緩衝液洗淨後,藉由 100 mM至300 mM之氯化鈉梯度溶析。以每瓶25毫升之方 式分取溶出部份,收集本發明之a - D -葡糖甞酸酶活性部 份及本發明之内-a - L -岩藻糖苷酶活性部份。在此時點, 本發明之兩種酵素幾乎呈現相同之行爲特性,無法加以分 離0 將上述兩酵素活性部份,藉由裝設有分割分子量爲1萬之 中空纖維之限外過濾機濃縮,藉由含有50 mM氯化鈉及 5mM氯化鈣之10mM咪唑-鹽酸緩衝液(pH7.5)將緩衝液置 換。 將得到之酵素液饋入以相同緩衝液平衡化之5 0毫升硫酸 化赛璐玢(生化學工業公司製)管柱中,用相同緩衝液洗淨 -129- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 ___ B7 五I發明説明(127 ) &quot;~ ' 後,用50 mM至1 Μ之氯化鈉梯度溶析。以每瓶5 〇毫升之 方式分取溶出部份,收集本發明之α 葡糖甞酸酶活性 部份及本發明之内-從-L -岩藻糖苷酶活性部份。此時,兩 種酵素可完全分離,以下將各個酵素分別精製。 (2) 内-戊_;L-岩藻糖菩酶之精製 將上述(1 )得到之内-泛-L -岩藻糖芬酶活性部份,用分劃 分子量爲1萬之限外過濾膜濃縮,饋入用含有1〇〇 mM氣化 鈉、10mM氣化鈣及5mM疊氮化鈉之1〇mM咪唑_鹽酸緩衝 液(ρΗ7·5)平衡化之Sephacryl S-200 管柱(4 4 X 100cm)中, 藉由相同之緩衝液溶出。以每一瓶13·3毫升之方式分取溶 出部份’然後收集内-泛-L -岩藻糖茹酶之活性部份。 將知到之内-a - L -岩藥糖苷酶活性部份,饋入用含有工〇 mM氣化鈉及5mM氣化鈣之10 mM咪唑·鹽酸緩衝液(pH7.5 ) 與乙醇混合比爲8 5 ·· 1 5之緩衝液平衡化之苯基赛璐玢管柱 (2·4 X 44 cm)中,藉由相同之緩衝液溶析。以每一瓶3〇毫 升4方式分取溶出部份。得到之活性部份於S d S -聚丙烯醯 胺電泳試驗中顯示均一性質。以此方式,得到本發明之内_ 以-L-岩藻糖苷酶精製物。 (3) a-D -葡糖芸酸酶之精製 將上述(1 )得到之本發明a - D -葡糖:y:酸酶活性部份,用 分劃分子量爲1萬之限外過濾、膜濃縮,饋入用含有丨〇〇 mM 氣化鈉、10mM氣化鈣及5mM疊氮化鈉之10mM咪唑-鹽酸 緩衝液(ρΗ7·5)平衡化之Sephacryl S-200 管柱(4.4 X 100 cm) 中,藉由相同之緩衝液溶析。以每一瓶丨3 · 3毫升之方式分 -130- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853Furthermore, this substance is hereinafter referred to as 12Fuc_6S_2G1cUA_2 ethenyl. (5) Modulation of Sulfated Glucuronidated Fucoidan Oligosaccharides Treated by Ultra-Bone Wave. Check the low molecular weight method of sulfated glucuronidated fucoidan treated by non-enzymatic method. Y is the 0.1-% aqueous solution of the crude sulfated gluconic acid-fucified fucoidan obtained from Okinawa ’s Izumi I, obtained by the method described in Reference Example 1 (1) of 1-week system, with a powerful ultrasonic generation device 201M (Manufactured by Kubota Corporation) at 2000w. This treatment solution was divided by an anion exchange resin, and each part of the knife was identified by mass analysis' to find a part having a substance with a molecular weight of 762. What ’s more? In the S part, by desalting and freeze-drying, the T sulfated glucose of the present invention can be obtained while acidifying fucoid oligosaccharides (_) (丨). Furthermore, by the same &lt; method &apos; as described above, the sulfated glucuronidated fuco-oligosaccharides of the present invention 1- (2) ~ (7), 2- (1) ~, and 3- (2) ~ (5). Example 1 2 (Ua-D -glucose: y: acidase and endo-L-fucosinase purification of fucoidan by the method of Example 9 Cultivate 3 times'. The bacterial cells obtained from each culture were prepared by the method of Example 9 to 10 mM imidazole-hydrochloric acid buffer (ρΗ7.5) containing 100 mM sodium vapor and 10 mM calcium vapor. ) After full dialysis and centrifugation, the supernatant is obtained, which is the crude enzyme solution of the present invention-glucose: y: acidase and endofucosidase coexisting. Hereinafter, the α-D-glucuronide of the present invention Enzyme activity was measured by the method described in Example 5 (3), and the inner-pan-L-rock deep glycosphinase activity of the present invention was measured by the method described in Example 5 (6), and each -128-) x 297 mm) 1243853 A7 B7 5. Description of the invention (126) Refined enzymes. The obtained crude enzyme solution was fed into a 3 liter DEAE-cellulose A-800 column equilibrated with the same buffer solution, washed with the same buffer solution, and subjected to a sodium chloride gradient of 100 mM to 400 mM. Dissolve, and dissolve the dissolution fraction by averaging 200 ml per bottle, and collect the a-D-glucosidase activity part of the present invention and the -a-L-fucosidase activity part of the present invention. . At this point, the two enzymes of the present invention exhibit almost the same behavioral characteristics and cannot be separated. The above two enzymes were concentrated with an out-of-limit filter equipped with a hollow fiber with a molecular weight of 10,000, and concentrated with a 10 mM imidazole · hydrochloric acid buffer solution containing 100 mM sodium chloride and 10 mM calcium carbonate ( pH 7.5) The buffer was replaced. The obtained enzyme solution was fed into a 240 ml DEAE-cellulose A-800 column equilibrated with the same buffer solution, washed with the same buffer solution, and then eluted with a gradient of 100 mM to 300 mM sodium chloride . The dissolution portion was divided into 25 ml bottles, and the a-D-glucosaminidase active portion of the present invention and the -a-L-fucosidase active portion of the present invention were collected. At this point, the two enzymes of the present invention exhibit almost the same behavioral characteristics and cannot be separated. 0 The active part of the two enzymes is concentrated by an external limit filter equipped with a hollow fiber with a molecular weight of 10,000. The buffer was replaced with a 10 mM imidazole-hydrochloric acid buffer (pH 7.5) containing 50 mM sodium chloride and 5 mM calcium chloride. The obtained enzyme solution was fed into a 50 ml sulfated celluloid (manufactured by Biochemical Industry Co., Ltd.) column equilibrated with the same buffer solution, and washed with the same buffer solution. CNS) A4 size (210 X 297 mm) 1243853 A7 ___ B7 Five I Invention Description (127) &quot; ~ ', then elute with 50 mM to 1 M sodium chloride gradient. The dissolution fraction was divided into 50 ml per bottle, and the α-glucosidase activity fraction of the present invention and the inside-from-L-fucosidase activity fraction of the present invention were collected. At this time, the two enzymes can be completely separated, and each enzyme is refined separately below. (2) Refinement of L-fucosylase; L-fucose enzyme is filtered from the active part of L-fucosyl-L-fucose fenase obtained in (1) above, and filtered with a molecular weight of 10,000 outside The membrane was concentrated and fed to a Sephacryl S-200 column (4) equilibrated with 10 mM imidazole-hydrochloric acid buffer (ρΗ7.5) containing 100 mM sodium vapor, 10 mM calcium vapor, and 5 mM sodium azide. 4 X 100 cm), dissolve in the same buffer. Dissolve the dissolving fraction 'in each bottle of 13.3 ml and collect the active fraction of endo-pan-L-fucose. The known content of the active part of a-L-lithokinosidase was fed into a mixture ratio of 10 mM imidazole · hydrochloric acid buffer (pH 7.5) containing ethanol with sodium mM sodium gas and 5 mM calcium gas and ethanol. A phenylcellulose column (2 · 4 X 44 cm) equilibrated with a buffer solution of 8 5 ·· 15 was eluted with the same buffer solution. Dissolve the dissolution portion in 30 ml 4 ways. The obtained active fraction showed homogeneous properties in an S d S -polyacrylamide electrophoresis test. In this way, within the present invention, -L-fucosidase purified product was obtained. (3) Purification of aD-glucosaccharinase The a-D-glucose of the present invention obtained in (1) above: y: acid enzyme active part, filtered with a molecular weight outside the limit of 10,000, membrane concentration , Fed into a Sephacryl S-200 column (4.4 X 100 cm) equilibrated with 10 mM imidazole-hydrochloric acid buffer (ρΗ7.5) containing 〇OOmM sodium vapor, 10mM calcium vapor, and 5mM sodium azide. Dissolve in the same buffer. Divide each bottle into 3 · 3 ml -130- This paper size is applicable to China National Standard (CNS) A4 (210 X 297 mm) 1243853

取溶出部份,然後收集本發明^葡料酸酶之活性部 份。 知ί于到之本發明a_D_葡糖答酸酶部份,以含有3⑼mM 氣化鈉及5mM氣化鈣之1〇 mM咪唑_鹽酸緩衝液充分透 析,饋入用相同緩衝液平衡化之2〇亳升硫酸化-赛璐玢管 柱中’藉由相同之緩衝液洗淨後,用3〇〇 至900 mM之 氣化鈉梯度溶析。以每一瓶1〇毫升之方式分取溶出部份, 然後收集本發明a - D _葡糖菩酸酶之活性部份。 將得到之本發明α - D -葡糖荅酸酶部份,以含有2〇〇 氣化鈉及5 m Μ氣化鈣之丨〇 咪唑-鹽酸緩衝液充分透 析’饋入用相同緩衝液平衡化之2 〇毫升硫酸化-赛璐玢管 柱中’藉由相同之緩衝液洗淨後,用2〇〇 mM至800 mM之 氣化納梯度溶析。以每一瓶7毫升之方式分取溶出部份, 然後收集本發明a - D -葡糖甞酸酶之活性部份。所得到之 活性邵份於S D S -聚丙烯醯胺電泳試驗中顯示均一性質。以 此方式,得到本發明之α - D -葡糖:y:酸酶精製物。 實例1 3 使用實例12(2)得到之本發明内-“ -L-岩藻糖苷酶精製 物及實例12(3)得到之本發明以-D-葡糖甞酸酶精製物,試 驗硫酸化葡糖醛酸化岩藻聚糖之低分子化。首先,爲了調 查乙醯基對於硫酸化葡糖醛酸化岩藻聚糖分解之影響,進 行脱乙醯化硫酸化葡糖醛酸化岩藻聚糖之調製。 (1)脱乙醯化硫酸化葡糖醛酸化岩藻聚糖之調製 將藉由參考例1 (1)之方法調製之硫酸化葡糖醛酸化岩藻 -131 - 本紙張尺度適用中國國家標準(CNS) Α4規格(210Χ 297公釐) 1243853 A7 ____B7 五、發明説明(129 ) 聚糖200毫克溶解於20毫升之1N氫氧化鈉中,於25 °C下處 理20小時,繼而以含有2〇〇 mM氣化鈉及50 mM氣化鈣之20 mM咪唑-鹽酸緩衝液(ρΗ6·6)充分透析,得到脱乙醯化硫酸 化葡糖醛酸化岩藻聚糖。 (2)各基質之分解 對參考例1 ( 1 )之方法調製之硫酸化葡糖醛酸化岩藻聚糖 及藉由上述(1)之方法調製之脱乙醯化硫酸化葡糖醛酸化岩 澡聚糖,平均每200毫克添加本發明之以-D-葡糖:y:酸酶 150 &quot; u及本發明之内-α - L-岩藻糖甞酶1 mU,於25 °C進 行分解反應。再者,此等反應液各成分之最終濃度,硫酸 化葡糖路酸化岩藻聚糖爲6.7毫克/毫升,牛血清白蛋白爲 〇· 1毫克/毫升,氣化鈉爲200 mM,氣化鈣50 mM ,咪唑爲 20 mM,pH調整爲6.6。結果,雖反應開始時硫酸化葡糖 酸酸化岩藻聚糖與脱乙醯化硫酸化葡糖醛酸化岩藻聚糖之 分子量約略相等,但2日反應後之平均分子量,硫酸化葡 糖酸酸化岩藻聚糖約爲195萬,而脱乙醯化硫酸化葡糖路 酸化岩藻聚糖約爲27,000。 亦即’可確$忍若要藉由本發明之α-D -葡糖替酸酶及本 發明之内-a - L-岩藻糖荅酶以良好效率得到硫酸化葡糖醛 酸化岩藻寡聚糖’必須脱乙醯化。再者,若使實例1記載 之粗酵素及部份精製酵素作用於硫酸化葡糖醛酸化岩藻聚 糖,則彳于到之暴聚糖幾乎未帶有乙醯基,又若使實例!丨(i) β己載之精製未吸著部份及精製溶出部份作用於硫酸化葡糖 醛酸化岩藻聚糖,則生成帶有乙醯基之寡聚糖,由此可推 -132-The eluted portion was taken, and then the active portion of the glucosidase of the present invention was collected. After knowing the a_D_glucoamidase part of the present invention, it was fully dialyzed with a 10 mM imidazole_hydrochloric acid buffer solution containing 3⑼mM sodium gas and 5mM calcium gas, and fed into 2 which was equilibrated with the same buffer. After being washed with the same buffer solution in a 0 liter sulfated-cellulose column, it was eluted with a gradient of 300 to 900 mM sodium vaporized sodium. Dissolve the dissolving portion in 10 ml per bottle, and then collect the active portion of the a-D-glucogluconic acid of the present invention. The obtained α-D-glucuronidase part of the present invention was fully dialyzed with 0-imidazole-hydrochloric acid buffer containing 200 g of sodium gas and 5 m of calcium gas, and fed into an equilibrium with the same buffer. After being washed with the same buffer solution in a 200 ml sulfated-cellulose column, the solution was eluted with a gasification nano gradient of 200 mM to 800 mM. The dissolution fraction was divided into 7 ml per bottle, and then the active fraction of a-D-glucosaminidase of the present invention was collected. The obtained active ingredients showed homogeneous properties in an S D S -polyacrylamide electrophoresis test. In this way, the α-D-glucose: y: acidase purified product of the present invention was obtained. Example 1 3 The endo-"-L-fucosidase purified product of the present invention obtained in Example 12 (2) and the -D-glucosaminidase purified product of the present invention obtained in Example 12 (3) were tested for sulfate Low molecularization of glucuronidated fucoidan. First, in order to investigate the effect of acetamyl on the decomposition of sulfated glucuronidated fucoidan, deacetylated sulfated glucuronidated fucoidan (1) Deacetylated Sulfated Glucuronidated Fucoidan Modified Sulfated Glucuronidated Fucoid -131, prepared by the method of Reference Example 1 (1)-This paper is applicable to this paper Chinese National Standard (CNS) A4 specification (210 × 297 mm) 1243853 A7 ____B7 V. Description of the invention (129) 200 mg of glycan was dissolved in 20 ml of 1N sodium hydroxide, and then treated at 25 ° C for 20 hours, and then A 20 mM imidazole-hydrochloric acid buffer (ρΗ6.6) containing 200 mM sodium vapor and 50 mM calcium vapor was thoroughly dialyzed to obtain deacetylated sulfated glucuronidated fucoidan. (2) Each Decomposition of the matrix: Sulfated glucuronidated fucoidan prepared by the method of Reference Example 1 (1) and by the method of (1) above The prepared deacetylated sulfated glucuronidated rock bath glycan is added with -D-glucose: y: acidase 150 &quot; u and within the present invention per 200 mg on average -α-L- Fucolytic enzyme 1 mU, decomposition reaction at 25 ° C. Furthermore, the final concentration of each component of these reaction solutions, sulfated glucoside acidified fucose is 6.7 mg / ml, bovine serum albumin is 0.1 mg / ml, sodium vaporized at 200 mM, calcium vaporized at 50 mM, imidazole at 20 mM, and the pH was adjusted to 6.6. As a result, sulfated gluconate acidified fucoidan and deacetylammonium at the beginning of the reaction The molecular weight of the sulfated glucuronidated fucoidan is approximately equal, but the average molecular weight after 2 days of reaction, the sulfated glucuronidated fucoidan is about 1.95 million, and the deacetylated sulfated The acidified fucose is about 27,000. That is, it can be assured that the α-D-glucosidase and the a-L-fucosinase of the present invention can be obtained with good efficiency. Sulfated glucuronidated fuco-oligosaccharides must be deacetylated. Furthermore, if the crude enzyme and partially purified enzyme described in Example 1 are used, Sulfated glucuronidation of fucoidan, the resulting glycans have almost no ethyl acetate, and if it is an example! (I) Refined unabsorbed and refined dissolution part of β It acts on sulfated glucuronidation of fucoidan to form an oligosaccharide with acetamyl group, which can be inferred -132-

1243853 A71243853 A7

斷本發明之岩藻依聚糖分解嗜岩藻菌SI- 1234菌株能生產 可將硫酸化葡糖醛酸化岩藻聚糖之乙醯基游離之岩藻依聚 糖脱乙醯酶。 實例1 4 檢討關於岩藻依聚糖分解嗜岩藻菌SI- 1234菌株生產之可 將硫酸化葡糖醛酸化岩藻聚糖之乙醯基游離之岩藻依聚糖 脱乙醯酶。 (1)岩藻依聚糖脱乙醯酶之純化 首先,確立用於測定藉實例11(1)之方法調製之本發明 岩藻依聚糖分解嗜岩藻菌s I- 1234菌株之粗酵素溶液中存 在之岩藻依聚糖脱乙醯酶活性之反應系。 亦即,於100微升之50 mM咪唑-鹽酸緩衝液(pH7 5)、1〇 微升之4M氣化鈉、1微升之1M氣化鈣、40微升之1%硫酸 化葡糖趁酸化岩藻聚糖及29微升之水中添加2〇微升之岩藻 依聚糖脱乙酿酶溶液,於3 0 t反應3小時後,藉由市售之 醋酸定量用套組(F -醋酸套組,羅修代阿古語史替克斯公司 製)測定游離出來之乙醯基。其結果,平均每1毫升培養液 中本發明之岩藻依聚糖脱乙醯酶活性約爲2mU。 另一方法爲將寡聚糖3-(4)之還原性末端用2 -胺基吡啶螢 光標識者做爲基質,藉由以下之反應系,測定岩藻依聚糖 脱乙醯酶之活性。 反應系 75微升50mM磷酸鈉之緩衝液(pH7.5) 28.5微升水 -133- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)The fucoidan-decomposing strain Fugillella SI-1234 of the present invention can produce a fucoidan deacetylase which can free sulfated glucuronidated fucoidan from the acetyl group. Example 1 4 Fucoidan degrading fucoidan deacetylase produced by fucoidan-degrading Fucoidophila SI-1234 strain, which can free sulfated glucuronide to the acetyl group of fucoidan. (1) Purification of fucoidan deacetylase First, a crude enzyme for determining the fucoidan-degrading fucobacterium s I-1234 strain of the present invention prepared by the method of Example 11 (1) was established. Reaction system of fucoidan deacetylase activity present in solution. That is, 100 microliters of 50 mM imidazole-hydrochloric acid buffer (pH 75), 10 microliters of 4M sodium gasification, 1 microliter of 1M calcium gasification, and 40 microliters of 1% sulfated glucose while Acidified fucoidan and 29 μl of water were added with 20 μl of fucoidan deacetylase solution. After reacting for 3 hours at 30 t, a commercially available acetic acid quantitative kit (F- Acetate kit (manufactured by Rothschild Argus Stiks) was used to measure the free acetamidine. As a result, the fucoidan deacetylase activity of the present invention was about 2 mU per 1 ml of the culture medium. Another method is to use the 2-aminopyridine fluorescent marker as the reducing end of the 3- (4) oligosaccharide as the substrate, and measure the fucoidan deacetylase activity by the following reaction system. . Reaction system 75 microliters of 50mM sodium phosphate buffer solution (pH7.5) 28.5 microliters of water -133- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)

裝 訂Binding

線 1243853 A7 _ __B7 _____ 五、發明説明(131 ) 9微升4M氣化鈉 15微升3毫克/毫升牛血清白蛋白 15微升4微微莫耳/微升寡聚糖3-(4)之螢光標識物 7.5微升岩藻依聚糖脱乙醯酶溶液 將上述所有成分混合後,於30 °C反應1小時,於100 °c處 理1 0分鐘後進行離心,將上清液以下列條件進行HPLC分 析,測定脱乙醯化量。 裝置:L - 6200型(日立製作所製) 管柱:L -管柱(4.6χ 250 mm,財團法人化學品檢查協會 製) 溶析液:含有〇·5 % 丁醇之50 mM醋酸-三乙胺緩衝液 (ρΗ5·0) 檢測:螢光檢測器F - 1150(曰立製作所製),激發波長320 ηιπ ’赏光波長4〇〇 nm。Line 1243853 A7 _ __B7 _____ V. Description of the invention (131) 9 microliters of 4M sodium vaporization 15 microliters 3 mg / ml bovine serum albumin 15 microliters 4 picomoles / microliters of oligosaccharide 3- (4) 7.5 microliters of fluorescein fucoidan deacetylase solution mixed all the above components, reacted at 30 ° C for 1 hour, treated at 100 ° C for 10 minutes, and centrifuged. The supernatant was as follows: The conditions were analyzed by HPLC to determine the amount of deacetylation. Apparatus: L-6200 (manufactured by Hitachi, Ltd.). Column: L-column (4.6 x 250 mm, manufactured by Chemical Inspection Association). Eluent: 50 mM acetic acid-triethyl containing 0.5% butanol. Detection of amine buffer (ρΗ5.0): Fluorescence detector F-1150 (manufactured by Yori Manufacturing Co., Ltd.), excitation wavelength 320 nm, and light wavelength 400 nm.

流速:1毫升/分鐘 管柱溫度:40°C 1單位之本發明岩藻依聚糖脱乙醯酶,係指上述反應系中 於1分鐘時間將1微莫耳乙醯基鍵結切斷之酵素量。再者, 由於若將上述反應系中之乙醯基鍵結切斷,則形成與實例 5 ( 1)所得到之硫酸化葡糖醛酸化岩藻寡聚糖丨_ ( 3 ) p A化物 相同之構造,因此爲確認乙驢基被切斷之基質之管柱保持 時間,使用該P A化物。被切斷之乙醯基之量係藉由下式東 得。 數學式6 -134- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐^ ^----- 1243853 A7 __—— ____B7 五、發明説明(132 ) ~ ~- DA/6〇x〇.〇 15=U/ml DA :被切斷之乙醯基之量(微莫耳) 6 〇 ··反應時間(分鐘) 0.015 :酵素液量(毫升) ^由、上述之方法測定之情況,平均每丨毫升培養液中本發 明石藻依聚糖脱乙酿酶之活性爲〇· 8 mU /毫升。 將上述之粗酵素溶液50毫升,饋入用含有i〇〇mM氣化 鋼1 〇 mM 1化#5及5mM疊氮化鈉之1〇 mM味吨_鹽酸緩衝 液(ρΗ7·5)平衡化之Sephaeryl S2〇〇 管柱(4 4 χ ι〇〇 , 藉由相同之緩衝液溶出。以每一瓶13毫升之方式分取溶出 部份,藉由上述方法測定各部份所含有本發明岩藻依聚糖 脱乙醯酶之活性。從溶出液量算出本發明岩藻依聚糖脱乙 醯酶之分子量約爲3萬〜5萬。 收集上述之活性部份,調查本發明之岩藻依聚糖脱乙醯 δ母之性貝。其結果如圖1〜圖2所示。亦即,圖1表示最佳 ρ Η値,圖2表示最佳溫度。 如圖1所示,本發明之岩藻依聚糖脱乙醯酶之最佳pH値 約在6〜9.1之範圍内,最佳溫度在23〜45。〇之範圍内。 (2)使用岩藻依聚糖脱乙醯酶進行從各種岩藻依聚糖脱乙 酿基之反應 構築以下之反應系,以測定各種岩藻依聚糖含有之乙醯 基量。 在反應中使用下列表13所示之來自海藻之岩藻依聚糖。 反應系 -135- ^紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)Flow rate: 1 ml / min. Column temperature: 40 ° C. 1 unit of fucoidan deacetylase of the present invention refers to the above reaction system which cuts off 1 micromolar acetamyl bond in 1 minute. The amount of enzyme. Furthermore, if the acetamyl bond in the above reaction system is cut off, the same formation as the sulfated glucuronidated fuco-oligosaccharide obtained in Example 5 (1) 丨 (3) p A compound is formed. This structure is used to confirm the column retention time of the substrate in which the substrate is cut off. The amount of acetophenone that was cut off was obtained by the following formula. Mathematical formula 6 -134- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm ^ ^ ----- 1243853 A7 __—— ____B7 V. Description of the invention (132) ~ ~-DA / 6 〇x〇.〇15 = U / ml DA: the amount of acetamyl group cut off (micromolar) 6 〇 ·· reaction time (minutes) 0.015: the amount of enzyme solution (ml) ^ measured by the method described above In this case, the average activity of the fucoidan deacetylating enzyme of the present invention in 0.8 ml of culture medium is 0.8 mU / ml. 50 ml of the above-mentioned crude enzyme solution is fed into a gasification solution containing 100 mM. Steel 10 mM 1 # 5 and 5 mM sodium azide in 10 mM ton-hydrochloric acid buffer (ρΗ7.5) equilibrated Sephaeryl S200 column (4 4 x 〇〇〇〇, by the same Buffer solution dissolution. Dissolve the dissolution fraction in 13 ml per bottle, and determine the activity of fucoidan deacetylase of the present invention by the method described above. Calculate the rock of the present invention from the amount of the dissolution fluid. The molecular weight of fucoidan deacetylase is about 30,000 to 50,000. The above active fractions are collected, and the fucoidan deacetylated δ mother of the present invention is investigated. The results are shown in Figs. 1 to 2. That is, Fig. 1 shows the optimal ρ Η 値, and Fig. 2 shows the optimal temperature. As shown in Fig. 1, the fucoidan deacetylase of the present invention is the best. The pH is in the range of 6 to 9.1, and the optimal temperature is in the range of 23 to 45.0. (2) Using fucoidan deacetylase to deacetylate from various fucoidan The reaction builds the following reaction system to determine the amount of acetofluorene contained in various fucoidan. The fucoidan derived from seaweed shown in the following Table 13 is used in the reaction. The reaction system -135- ^ Paper scale applicable China National Standard (CNS) A4 (210 X 297 mm)

裝 訂Binding

1243853 A7 B7 五、發明説明(133 ) 60微升1%岩藻依聚糖 50微升100mM磷酸鈉之緩衝液(pH7.5) 10微升4M氣化鈉 20微升3毫克/毫升牛血清白蛋白 3 0微升水 30微升岩藻依聚糖脱乙醯酶 將上述所有成分混合後,於3 0 °C反應2 1小時,藉由上述 之醋酸定量套組測定生成之醋酸量。再者,將各個岩藻依 聚糖以1N氫氧化鈉於25 °C處理18小時,藉由上述之醋酸 定量套組測定生成之醋酸量。其結果如表1 3所示。 表1 3 海藻 使用脱乙醯酶之情況 使用氫氧化鈉之情況 沖繩海落蕩 13.6 17.2 海蘊藻 n.d. 1.74 囊狀岩蕩 0.91 15.4 結節囊葉藻 \ 0.69 7.74 加格眉昆布 1.27 4.40 眞昆布 2.00 11.3 阿拉美藻 1.70 3.77 裙帶菜雌株 2.70 30.3 黑巨藻 3.80 22.9 梨形大囊傘藻 1.46 12.9 南極杜維利藻 1.84 15.3 -136- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(134 ) 毫克·乙醯基/公克·岩藻依聚糖 n . d .:未測定 如表1 3所示,可確認本發明之岩藻依聚糖脱乙醯酶爲作 用於來自各種海藻之岩藻依聚糖而將乙醯基加水分解之酵 素。再者,藉由與使用氫氧化鈉進行非特異性地脱乙醯化 之情況比較,可確認本發明之岩藻依聚糖脱乙醯酶對來自 沖繩海蘊藻之岩藻依聚糖(亦即硫酸化葡糖醛酸化岩藻聚糖) 之乙醯基具高特異性。 實例1 5 (1)本發明之硫酸化葡糖醛酸化岩藻聚糖之主要構造解析 爲決定藉由實例7調製之精製硫酸化葡糖醛酸化岩藻聚糖 部份之全構造及硫酸化葡糖醛酸化岩藻聚糖之切斷部位, 進行NMR分析。NMR分析歸屬之結果如以下所示,本發明 之硫酸化葡糖醛酸化岩藻聚糖之1 H-NMR光譜如圖3 8所 示,13C-NMR光譜如圖39所示。圖38與圖39中縱軸表示 訊號之強度,橫軸表示化學位移値(ppm)。再者,紅外線 光譜如圖40所示。圖40中縱軸表示透過率(%),橫軸表示 波數(cm·1)。藉由1H_NMR及13C-NMR之分析結果如表14 所示。 -137- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(135 ) 表14 化學位移値(ppm) 13c-nmr ^-NMR FM 94.8 5.03 F1-2 71.0 4.10 F1-3 72.0 4.20 F1-4 69.4 5.31 F1-5 66.8 4.33 F1-6 15.4 1.01 乙醯基之ch3 20.5 2.07 乙酿基之CO 175.0 - ch3 20.5 2.07 F2-1 94.5 5.01 F2-2 67.0 3.85 F2-3 76.6 3.85 F2-4 80.0 4.63 F2-5 66.9 4.33 F2-6 16.0 1.10 F3-1 99.2 4.96 F3-2 67.0 3.80 F3-3 76.6 3.88 F3-4 80.0 4.63 F3-5 66.9 4.24 F3-6 16.0 1.10 F4-1 99.2 4.96 F4-2 67.2 3.73 F4-3 74.7 3.85 F4-4 68.7 3.95 F4-5 67.4 4.18 -138- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(136 ) 表14(續) 化學位移値(ppm) 13c_nmr ^-NMR F4-6 16.0 1.10 GA1 -1 99.6 5.18 GA1-2 71.2 3.47 GA1-3 72.4 3.63 GA1-4 71.8 3.42 GA1-5 72.6 3.87 GA1-6 177.0 - 藉由表1 4所示之歸屬,本發明之硫酸化葡糖醛酸化岩藻 聚糖,爲如下式(XV)所示,F1之岩藻糖爲π鍵結,而其 他重複5糖中F4之岩藻糖係在第3位鍵結者。再者,關於乙 醯基,可確認每重複5糖有1殘基,且主要键結於F 1岩藻糖 之第4位。亦即,可判定硫酸化葡糖醛酸化岩藻聚糖爲具 有重覆下列所示主要骨架之構造者。 -139- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 裝 訂1243853 A7 B7 V. Description of the invention (133) 60 microliters 1% fucoidan 50 microliters 100mM sodium phosphate buffer (pH7.5) 10 microliters 4M sodium gasification 20 microliters 3 mg / ml bovine serum 30 microliters of albumin, 30 microliters of fucoidan deacetylase, mixed all the above components, and reacted at 30 ° C for 21 hours. The amount of acetic acid produced was determined by the above-mentioned acetic acid quantitative kit. Furthermore, each fucoidan was treated with 1N sodium hydroxide at 25 ° C for 18 hours, and the amount of acetic acid produced was measured by the above-mentioned acetic acid quantitative kit. The results are shown in Table 1 and 3. Table 1 3 Cases of using deacetylase in seaweeds Cases of using sodium hydroxide Okinawa sea drop 13.6 17.2 sea algae nd 1.74 cystic rock swing 0.91 15.4 nodular cyst leaf algae \ 0.69 7.74 Gagrim kumbu 1.27 4.40 11.3 Alamea 1.70 3.77 Wakame female 2.70 30.3 Black giant algae 3.80 22.9 Pyrococcus auricula 1.46 12.9 Duveriania antarctica 1.84 15.3 -136- This paper size applies to China National Standard (CNS) A4 (210 X 297 male) 1243853 A7 B7 V. Description of the invention (134) mg · Ethyl / g · fucoidan n.d .: Not determined As shown in Table 13, it can be confirmed that the Acetylase is an enzyme that acts on fucoidan derived from various seaweeds to hydrolyze acetamyl. Furthermore, by comparing with the case of non-specific deacetylation using sodium hydroxide, it can be confirmed that the fucoidan deacetylase of the present invention is effective against fucoidan from algae from Okinawa ( That is, the acetyl group of sulfated glucuronidated fucoidan is highly specific. Example 1 5 (1) The main structure analysis of the sulfated glucuronidated fucoidan of the present invention was determined to determine the complete structure and sulfated part of the refined sulfated glucuronidated fucoidan prepared in Example 7. The cut site of glucuronidated fucoidan was analyzed by NMR. The results of the NMR analysis are shown below. The 1 H-NMR spectrum of the sulfated glucuronidated fucoidan of the present invention is shown in FIG. 38 and the 13C-NMR spectrum is shown in FIG. 39. In Figs. 38 and 39, the vertical axis represents the signal strength, and the horizontal axis represents the chemical shift 値 (ppm). The infrared spectrum is shown in Fig. 40. In Fig. 40, the vertical axis represents the transmittance (%), and the horizontal axis represents the wave number (cm · 1). The analysis results by 1H-NMR and 13C-NMR are shown in Table 14. -137- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (135) Table 14 Chemical shift 値 (ppm) 13c-nmr ^ -NMR FM 94.8 5.03 F1 -2 71.0 4.10 F1-3 72.0 4.20 F1-4 69.4 5.31 F1-5 66.8 4.33 F1-6 15.4 1.01 Acetyl group ch3 20.5 2.07 Ethyl group group CO 175.0-ch3 20.5 2.07 F2-1 94.5 5.01 F2-2 67.0 3.85 F2-3 76.6 3.85 F2-4 80.0 4.63 F2-5 66.9 4.33 F2-6 16.0 1.10 F3-1 99.2 4.96 F3-2 67.0 3.80 F3-3 76.6 3.88 F3-4 80.0 4.63 F3-5 66.9 4.24 F3-6 16.0 1.10 F4-1 99.2 4.96 F4-2 67.2 3.73 F4-3 74.7 3.85 F4-4 68.7 3.95 F4-5 67.4 4.18 -138- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (136) Table 14 (continued) Chemical shift 値 (ppm) 13c_nmr ^ -NMR F4-6 16.0 1.10 GA1 -1 99.6 5.18 GA1-2 71.2 3.47 GA1-3 72.4 3.63 GA1-4 71.8 3.42 GA1- 5 72.6 3.87 GA1-6 177.0-With the attribution shown in Table 14, the sulfated glucuronidated fucoidan of the present invention is represented by the following formula (XV), the fucoid of F1 It is a π bond, while other sugars repeated 5 F4 lines of fucose bonded at position 3 persons. Furthermore, it was confirmed that the acetyl group has one residue per 5 sugars and is mainly bonded to the fourth position of F 1 fucose. That is, it can be judged that the sulfated glucuronidated fucoidan has a structure that overlaps the main skeleton shown below. -139- This paper size applies to China National Standard (CNS) Α4 size (210 X 297 mm) binding

1243853 A7 B7 五、發明説明(137 )1243853 A7 B7 V. Description of the invention (137)

-140--140-

本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1243853 A7 B7 五、發明説明(138 ) 產業上利用之可能性 藉由本發明可提供新穎之岩藻依聚糖脱乙醯酶、q-D-葡糖甞酸酶及内-π - L -岩藻糖甞酶,其可被用於解析硫酸 化葡糖醛酸化岩藻聚糖之構造及再現性良好地製造硫酸化 葡糖醛酸化岩藻聚糖之低分子化物。又,本發明提供該酵 素之製造方法。再者,藉由使用該酵素,可提供各種比例 脱乙醯化之脱乙醯化硫酸化葡糖醛酸化岩藻聚糖、各種比 例脱葡糖醛酸化之脱乙醯化脱葡糖醛酸化硫酸化葡糖醛酸 化岩藻聚糖及硫酸化葡糖醛酸化岩藻寡聚糖,彼等可做爲 糖鏈工學用試藥。再者,提供能使該酵素使用效率良好之 添加物。再者,提供生產能分解來自各種褐藻類之硫酸化 多糖之酵素之微生物。 序列表 SEQ ID NO: 1 :被設計用於擴增16S rDNA區之寡核苷酸引 子。 SEQ ID N0:2 :被設計用於擴增16S rDNA區之寡核甞酸引 子。 -141 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐)This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 1243853 A7 B7 V. Description of the invention (138) Possibility of industrial utilization The invention can provide novel fucoidan deacetylase, qD-glucosidase and endo-π-L-fucosinase, which can be used to analyze the structure and reproducibility of sulfated glucuronidate fucose and produce sulfated glucuronidation with good reproducibility Low molecular weight of fucoidan. The present invention also provides a method for producing the enzyme. Furthermore, by using the enzyme, various ratios of deacetylated deacetylated sulfated glucuronidated fucoidan, and various ratios of deacetylated degluconated degluconated deglycosylated can be provided. Sulfated glucuronidated fucoidan and sulfated glucuronidated fucoidan, which can be used as sugar chain engineering reagents. Furthermore, an additive is provided which can make the use of the enzyme efficient. Furthermore, there are provided microorganisms that produce enzymes capable of decomposing sulfated polysaccharides from various brown algae. SEQUENCE LISTING SEQ ID NO: 1: An oligonucleotide primer designed to amplify the 16S rDNA region. SEQ ID N0: 2: Oligonucleotide primers designed to amplify the 16S rDNA region. -141-This paper size applies to China National Standard (CNS) A4 (210X 297 mm)

裝 訂Binding

1243853 A7 B7 五、發明説明(139 ) 序列表 &lt;110&gt;塔卡拉徐州公司 &lt;120&gt;硫酸化葡糖醛酸化岩藻寡聚糖 &lt;130&gt; &lt;150&gt;JP 2000-186346 &lt;151〉2000-06-21 &lt;160&gt;3 &lt;2101 &lt;211&gt;20 &lt;212&gt;DNA &lt;213&gt;人造序列 &lt;220&gt; &lt;223〉被設計用於擴增16S rDNA區之寡核甞酸引子。 &lt;400〉 1 agagtttgat cctggctcag &lt;210〉2 &lt;211&gt;191243853 A7 B7 V. Description of the Invention (139) Sequence Listing &lt; 110 &gt; Takala Xuzhou Company &lt; 120 &gt; Sulfated Glucuronidated Fucoidan &lt; 130 &gt; &lt; 150 &gt; JP 2000-186346 &lt; 151 〉 2000-06-21 &lt; 160 &gt; 3 &lt; 2101 &lt; 211 &gt; 20 &lt; 212 &gt; DNA &lt; 213 &gt; Artificial Sequence &lt; 220 &gt; &lt; 223> Designed to amplify the oligos of the 16S rDNA region甞 Acid primers. &lt; 400〉 1 agagtttgat cctggctcag &lt; 210〉 2 &lt; 211 &gt; 19

&lt;212〉DNA -142- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A7 B7 五、發明説明(14〇 ) &lt;213〉人造序列 &lt;220&gt; &lt;223&gt;被設計用於擴增16S rDNA區之寡核苷酸引子 &lt;400〉2 ggctaccttg ttacgactt &lt;210&gt;3 &lt;211&gt;1535&lt; 212〉 DNA -142- This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1243853 A7 B7 V. Description of the invention (14) &lt; 213> Artificial sequence &lt; 220 &gt; &lt; 223 &gt; Oligonucleotide primers designed to amplify 16S rDNA region &lt; 400> 2 ggctaccttg ttacgactt &lt; 210 &gt; 3 &lt; 211 &gt; 1535

&lt;212&gt;DNA &lt;213&gt;岩藻依聚糖分解嗜岩藻菌SI-1234菌株 &lt;400〉3 gagattcttt gtattgaagc 60 taacacgtga gcaatctgcc 120 ggaLgtgata cgccaactca 180 gctcgcggcc tatcagcttg 240 ggtctgagag gatgatcagc 300 cagcagtttc gaatcattca 360 tgaaggcctt cgggtcgtaa 420 ccctgagtta acctggagag 480 ggagactgca agcgttactc 540 gtcaggtgtg aaatctcggg 600 tattggaggg gtaagcggaa 660 agtgaacgct ctcggtggat ctaaagatcg tgttggtagt ttggtgaggt cacactggaa caatgggggc acctctgtca gaagcagtgg ggattcactg gctcaacctc ggcggcgtgg ttataaagat gaatagctcg attaaagcU aaaggctcac ctgagacacg aaccctgatg ccagggagca ctaactccgt ggcgtaaagg gaaactgcgc ttaagacatg gaaagtggca aggaaactcg gtaatggcgc caaggcaaag gtccagacac gtgcaacgcc acaagcaggt gccagcagcc gtgcgtaggc ctgaaactgt caagtcgaac aacgggtgcg aatLaatgcc tttaggagga acgggtagct ctacgggtgg gcgtgaggga tcatagcctg gcggtaatac ggatagatgt ctatctagag -143- 本紙張尺度適用中國國家標準(CNS) A4規格(210x 297公釐) 1243853 A7 B7 五、發明説明(141 ) tttctggtgt agcggtgaaa tgcgtagata tcagaaggaa caccaatggc gaaggcagct 720 tactggacaa atactgacgc Lgaggcacga aagcatgggt agcgaaaggg attagatacc 780 cctgtagtcc atgccgtaaa cgttgcacac taggtcttgg gggtttcgac cctttcagga 840 ccccagctaa cgcgataagt gtgccgcctg aggactacgg ccgcaaggct aaaactcaaa 900 ggaattgacg ggggcccgca caagcggtgg agcatgtggt ttaattcgat gcaacgcgaa 960 gaaccttacc taggcttgac atgtaatgga cgattttcag agatgaattt ttcccttcgg 1020 ggctgttaca caggtgctgc atggccgtcg tcagctcgtg tcgtgagatg tttggttaag 1080 tccagcaacg agcgcaaccc tcgtccttag ttgccagcac gtaatggtgg ggactctaag 1140 gagacaaact ctcLttgaga gLgggaaggt ggggatgacg tcaggtcagt atggccctta 1200 cgcctagggc tacacacgtg ctacaatgcc cggtacaata ggacgcaata ccgcgaggtg 1260 gagcaaatcc tcaaaaccgg gcccagttcg gattggagtc tgcaactcga ctccatgaag 1320 tcggaatcgc tagtaatgac gtatcagcta tgacgtcgtg aatacgttcc cgggccttgt 1380 acacaccgcc cgtcacatca tgaaagccgg ttttgcccga agtacgtgag ctatccctcg 1440 ggaggcagcg tcctaaggca gggctggLga ttgggatg 1478 -144- 本紙張尺度適用中國國家榡準(CNS) A4規格(210 x 297公釐)&lt; 212 &gt; DNA &lt; 213 &gt; Fucoidan Decomposition Fucoidophile SI-1234 strain &lt; 400〉 3 gagattcttt gtattgaagc 60 taacacgtga gcaatctgcc 120 ggaLgtgata cgccaactca 180 gctcgcgcggatgaggat gatat gatat acctggagag 480 ggagactgca agcgttactc 540 gtcaggtgtg aaatctcggg 600 tattggaggg gtaagcggaa 660 agtgaacgct ctcggtggat ctaaagatcg tgttggtagt ttggtgaggt cacactggaa caatgggggc acctctgtca gaagcagtgg ggattcactg gctcaacctc ggcggcgtgg ttataaagat gaatagctcg attaaagcU aaaggctcac ctgagacacg aaccctgatg ccagggagca ctaactccgt ggcgtaaagg gaaactgcgc ttaagacatg gaaagtggca aggaaactcg gtaatggcgc caaggcaaag gtccagacac gtgcaacgcc acaagcaggt gccagcagcc gtgcgtaggc ctgaaactgt caagtcgaac aacgggtgcg aatLaatgcc tttaggagga acgggtagct ctacgggtgg gcgtgaggga tcatagcctg gcggtaatac ggatagatgt ctatctagag -143- This paper size applies to Chinese National Standard (CNS) A4 size (210x 297 mm) 1243853 A7 B7 V. Description of invention (141) tttctggtgt agcggtgaaa tgcgta gata tcagaaggaa caccaatggc gaaggcagct 720 tactggacaa atactgacgc Lgaggcacga aagcatgggt agcgaaaggg attagatacc 780 cctgtagtcc atgccgtaaa cgttgcacac taggtcttgg gggtttcgac cctttcagga 840 ccccagctaa cgcgataagt gtgccgcctg aggactacgg ccgcaaggct aaaactcaaa 900 ggaattgacg ggggcccgca caagcggtgg agcatgtggt ttaattcgat gcaacgcgaa 960 gaaccttacc taggcttgac atgtaatgga cgattttcag agatgaattt ttcccttcgg 1020 ggctgttaca caggtgctgc atggccgtcg tcagctcgtg tcgtgagatg tttggttaag 1080 tccagcaacg agcgcaaccc tcgtccttag ttgccagcac gtaatggtgg ggactctaag 1140 gagacaaact ctcLttgaga gLgggaaggt ggggatgacg ctacaatgcc cggtacaata ggacgcaata ccgcgaggtg 1260 gagcaaatcc tcaaaaccgg gcccagttcg gattggagtc tgcaactcga ctccatgaag 1320 tcggaatcgc tagtaatgac gtatcagcta tgacgtcgtg aatacgttcc cgggccttgt 1380 acacaccgcc cgtcacatca tgaaagccgg ttttgcccga agtacgtgag ctatccctcg 1440 ggaggcagcg tcctaaggca gggctggLga ttgggatg 1478 -144- present scale paper tcaggtcagt atggccctta 1200 cgcctagggc tacacacgtg Applicable to China National Standard (CNS) A4 specification (210 x 297 mm)

Claims (1)

申請專利範圍Patent application scope •-種岩藻依聚糖脫乙醯酶’其特徵為具有下列物理化學 性質: ⑴作用於硫g复化葡糖路酸化岩蒸聚糖及硫gt化葡糖酿 酸化岩藤寡聚糖’而將乙醯基加水分解,使醋酸游離; (Π)最佳p Η值為約6〜9 · 1之範圍; (ΠΙ)最佳溫度在約23〜45t:之範圍内。 種a - D -葡糖$•酸酶,其特徵為具有下列物理化學性 質: (I) 作用於脫乙醯化硫酸化葡糠醛酸化岩藻聚糖及脫乙 醯化硫酸化葡糖醛酸化岩藻募聚糖,而將a_D-葡糠醛酸 基鍵結加水分解,使D-葡糖醛酸游離; (II) 最佳p Η值為約5 · 8〜7 · 8之範圍 (in)最佳溫度在約14〜29c之範圍。 3 · —種内_ a _ L -岩藻糖智:酶,其特徵為具有下列物理化學 性質: (I)作用於脫乙醯化硫酸化葡糖醛酸化岩藻聚糖及脫乙 醯化硫酸化葡糖醛酸化岩藻募聚糖,而將^ - L—岩藻糠基 内向式加水分解’生成在還原性末端具有L _岩藻糖之募 聚糖; (Π)最佳pH值為約4.5〜7.5之範圍; (III) 最佳溫度在約2 3〜4 2 °C之範圍内。 4 · 一種製造申請專利範圍第1項之岩藻依聚糖脫乙醯酶之方 法’其特徵為培養具有該酵素生產能力之微生物,再從 其培養物取得該酵素。 本紙張尺麟财關緖準(CNS)域格_χ 297公g 1243853 丨· •、申請專利範圍 5.:種:造申請專利範圍第2項之“ _ 法,其特徵為培養且右兮觖主 W捃甘之方 其培養物取得該酵素。 俽玍物再從 6· 一種製造申請專利範圍第3項之内_ ” 法,其特徵為培養具有㈣“ “糖甘蛛之方 其培養物取得該酵素。’、月匕力之微生物,再從 7· -種脫乙醯化硫酸化葡糖駿酸化岩藻聚糖之製造方法, 其特徵為使申請專利範圍第1項之岩藻依聚糖脫乙醯酶作 用於硫酸化葡糖酸酸化岩藻聚糖,以取得除去至少ι分子 以上乙醯基之脫乙醯化硫酸化葡糖醛酸化岩藻聚糖。 8·=申5月專利靶圍第7項之脫乙酿化硫酸化葡糖醛酸化岩藻 聚糖之製這方法,其特徵為在氯化鈉、鈣鹽及/或蛋白質 共存下進行。 、 9. 一種脫乙醯化硫酸化葡糖醛酸化岩藻聚糖或其鹽,其係 藉由申請專利範圍第7項之方法得到。 1〇#種脫乙醯化脫葡糖醛酸化硫酸化葡糖醛酸化岩藻聚糖 之製造方法,其特徵為使申請專利範圍第2項之α _D_葡 糖4酸S學作用於脫乙醯化硫酸化葡糖駿酸化岩藻聚糖, 以取得除去至少1分子以上葡糖醛酸殘基之脫乙醯化脫葡 糖醛酸化硫酸化葡糖醛酸化岩藻聚糖。 11·如申請專利範圍第1 〇項之脫乙醯化脫葡糖醛酸化硫酸化 葡糖醛酸化岩藻聚糖之製造方法,其特徵為在氯化鈉、 妈鹽及/或蛋白質共存下進行。 12. —種脫乙醯化脫葡糖醛酸化硫酸化葡糖醛酸化岩藻聚糖 2 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公董) 1243853• -Specific fucoidan deacetylase 'is characterized by the following physical and chemical properties: ⑴ action on sulfur g double-glucose acidified rock steamed glycan and sulfur gt-glucose fermented rock oligosaccharide' The acetamidine is hydrolyzed to dissociate the acetic acid; (Π) The optimal p Η value is in the range of about 6 ~ 9 · 1; (Π) The optimal temperature is in the range of about 23 ~ 45t :. A-D-glucose acid enzyme, which is characterized by the following physical and chemical properties: (I) acts on deacetylated sulfated glucofurfurate acidified fucose and deacetylated sulfated glucuronide Fucoids collect glycans, and a-D-glucuronic acid bond is hydrolyzed to dissociate D-glucuronic acid; (II) The optimal p Η value is in the range of about 5 · 8 ~ 7 · 8 (in) The optimum temperature is in the range of about 14 ~ 29c. 3 · —Intraspecific _ a _ L-Fucose Chi: Enzymes, which are characterized by the following physical and chemical properties: (I) Acting on deacetylated sulfated glucuronidated fucoidan and deacetylated Sulfated glucuronidation of fucoidan, and the inward hydrolytic decomposition of ^ -L-fucosyl furfuryl 'to generate a polysaccharide that has L_fucose at the reducing end; (Π) Optimal pH It is in the range of about 4.5 to 7.5; (III) The optimal temperature is in the range of about 2 3 to 4 2 ° C. 4 · A method for manufacturing fucoidan deacetylase from the patent application No. 1 is characterized by culturing a microorganism having the enzyme production ability, and then obtaining the enzyme from its culture. CNS domain of this paper _χ 297 g g 1243853 丨 · • Patent application scope 5 .: Kind: The "_ method" of the second patent application scope is characterized by cultivation and right The owner obtains the enzyme from the culture of Gan Zhifang's formula. The glutinous compound is obtained from the 6th of a kind of manufacturing application patent within the scope of the "_" method, which is characterized by the cultivation of "" Get the enzyme. ', The microorganism of the moon dagger force, and then from 7--a method of deacetylating sulfated glucosamine acid fucoidan production method, characterized in that the application of the first scope of the patent scope of fucoidan deacetylation The amylase acts on sulfated glucuronidated fucoidan to obtain a deacetylated sulfated glucuronidated fucoidan that removes at least one molecule of ethylamyl. 8 · = The method for preparing the deacetylated sulfated glucuronidated fucoidan in the seventh target of the patent application in May, which is characterized in that sodium chloride, calcium salt and / or protein coexist. 9. A deacetylated sulfated glucuronidated fucoidan or a salt thereof, which is obtained by a method according to item 7 of the scope of patent application. A method for producing 10 # deacetylated deglucouronated sulfated glucuronidated fucoidan, which is characterized in that the α_D_glucose 4 acid in the second patent application scope acts on the Acetate the sulfated gluconate and acidify the fucoidan to obtain a deacetylated and deglucourated sulfated glucuronate fucoidan by removing at least one molecule of glucuronic acid residues. 11. The manufacturing method of deacetylation, deglucouration, sulfated glucuronidation, and fucoidan according to item 10 of the scope of the patent application, which is characterized by coexistence of sodium chloride, mother salt and / or protein. get on. 12. —A kind of deacetylated deglucouronated sulfated glucuronidated fucoidan 2 This paper size applies to China National Standard (CNS) A4 specification (210X297 public director) 1243853 或其鹽,其係藉由申請專利範圍第丨〇或丨丨項之方法得 到。 13· —種硫酸化葡糖醛酸化岩藻募聚糖之製造方法,其特徵 為使岩藻依聚糖脫乙醯酶、α _ D -葡糖茹酸酶及内· α l _ 岩藻糠茹酶作用於硫酸化葡糖醛酸化岩藻聚糖而取得硫 酸化葡糖醛酸化岩藻寡聚糖。 14. 一種硫酸化葡糖醛酸化岩藻募聚糖之製造方法,其特徵 為使a - D-葡糖:y:酸酶及内_ α .^岩藻糖甞酶作用於經鹼 處理之脫乙醯化硫酸化葡糖醛酸化岩藻聚糖而取得硫酸 化葡糖醛酸化岩藻募聚糖。 15·如申研專利範圍第^ 3或丨4項之硫酸化葡糖酸酸化岩藻募 I糖之製造方法’其特徵為可在氣化納、I弓鹽及/或蛋白 質共存下進行。 16· —種硫酸化葡糖醛酸化岩藻寡聚糖或其鹽,其係藉由申 請專利範圍第1 3〜1 5項中任何一項之方法得到。 17· 一種具有從下列通式(I)〜(m)選出之化學結構之糖化合 物或其鹽: -3- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 六、申請專利範圍 *Or its salt, which is obtained by the method of the scope of application of the patent application. 13. · A method for producing sulfated glucuronidated fucoidan, which is characterized in that fucoidan deacetylase, α_D-glucosaccharase and endo-α l_ fucoidan The furfur enzyme acts on sulfated glucuronidated fucoidan to obtain sulfated glucuronidated fucoidan. 14. A method for producing sulfated glucuronidated fucoidan, characterized in that a-D-glucose: y: acidase and endo_α. ^ Fucosinase act on alkali-treated Deacetylated sulfated glucuronidated fucose to obtain sulfated glucuronidated fucoidan. 15. The manufacturing method of sulfated gluconate acidified fucoid I sugar according to item 3 or 4 of Shenyan's patent scope is characterized in that it can be performed under the coexistence of gasification sodium, sodium salt and / or protein. 16. A sulfated glucuronidated fuco-oligosaccharide or a salt thereof, which is obtained by a method according to any one of claims 13 to 15 of the scope of patent application. 17. A sugar compound or a salt thereof having a chemical structure selected from the following general formulae (I) to (m): -3- This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) 1243853 VI. Scope of patent application * 〇 I_〇 I_ 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 申請專利範園 I~~I ►—IThis paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) 1243853 Patent application park I ~~ I ►—I X XX X 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1243853 A8 B8 C8 D8 申請專利範圍 〔I 二;IThis paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) 1243853 A8 B8 C8 D8 Patent application scope [I II; I 本紙張尺度適用中國國家標準(CNS) A4規格(210x 297公釐) 43 2 3 5 8 8 8 8 8 A BCD 、申請專利範圍 (式中,R為Η ’ SO3H或CH3CO,以及η為〇以上之整數) 18· —種硫酸化葡糖醛酸化岩藻聚糖或其鹽,其特徵為具有 下列物理化學性質: (1) 構成糖:含有岩藻糖及葡糖醛酸,其莫耳比為 3 5 〜4 4 ·· 1 0, (2) 以下列通式(V111)表示之硫酸化糠做為構成糖之必 需成分者· 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1243853 A8 B8 C8 D8 申請專利範園This paper size applies the Chinese National Standard (CNS) A4 specification (210x 297 mm) 43 2 3 5 8 8 8 8 8 A BCD, patent application scope (where R is SO 'SO3H or CH3CO, and η is above 〇 (Integer) 18 · —A sulfated glucuronidated fucoidan or a salt thereof, which is characterized by the following physical and chemical properties: (1) Constituting sugar: contains fucose and glucuronic acid, and its molar ratio 3 5 ~ 4 4 ·· 1 0, (2) The sulfated bran represented by the following general formula (V111) is used as an essential component of sugar. · This paper size applies the Chinese National Standard (CNS) A4 specification (210 X (297 mm) 1243853 A8 B8 C8 D8 Patent Application Park 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 8 8 8 8 A B c D 1243853 々、申請專利範圍 (式中,R 為 Η,S03H 或 CH3CO)。 19.如申請專利範圍第1 8項之硫酸化葡糖醛酸化岩藻聚糖, 其特徵為該η在1〜5000之範圍内。 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐)This paper size is in accordance with China National Standard (CNS) A4 (210 X 297 mm) 8 8 8 8 A B c D 1243853 々, patent application scope (where R is Η, S03H or CH3CO). 19. The sulfated glucuronidated fucoidan according to item 18 of the patent application, characterized in that the η is in the range of 1 to 5000. This paper size applies to China National Standard (CNS) A4 (210X297 mm)
TW090115173A 2000-06-21 2001-06-21 Glucuronofucan sulfate TWI243853B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000186346 2000-06-21

Publications (1)

Publication Number Publication Date
TWI243853B true TWI243853B (en) 2005-11-21

Family

ID=37154615

Family Applications (1)

Application Number Title Priority Date Filing Date
TW090115173A TWI243853B (en) 2000-06-21 2001-06-21 Glucuronofucan sulfate

Country Status (1)

Country Link
TW (1) TWI243853B (en)

Similar Documents

Publication Publication Date Title
JP3555766B2 (en) Apoptosis inducer
US6277616B1 (en) Endo-fucoidan-lyase
US20060166335A1 (en) Glucuronofucan sulfate
EP1466969A1 (en) Sulfated fucan
SkjÅk-Bræk et al. Selective acetylation of mannuronic acid residues in calcium alginate gels
MOU et al. Structural analysis of kappa‐carrageenan oligosaccharides released by carrageenase from marine cytophaga MCA‐2
TWI243853B (en) Glucuronofucan sulfate
US7041656B2 (en) Sulfated fucoglucuronomannan
KR100903771B1 (en) Sulfated Fucan oligosaccharide
EP1514923A1 (en) Enzyme for decomposition of sulfated fucan derived from sea cucumber
JP3916394B2 (en) Fucose sulfate-containing polysaccharide
JP3991043B2 (en) Sugar compounds
Ha Kinetics and Technology Functionality of Microbial Fucoidanase
JP3506672B2 (en) Sulfated-fucose-containing polysaccharide
Kusaykin et al. Glycobiology Advance Access published September 7, 2015
TW200400195A (en) Apoptosis inducer
JPH04187094A (en) Production of chitin decomposition product
JP2001218580A (en) Enzyme for decomposition of polysaccharide containing endo-form fucose sulfate
KR20130121381A (en) Xyloglucanase of streptomyces coelicolor